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Abstract 
The aim of this project was to evaluate the effects of probiotics, prebiotics and synbiotics 
on the gut ecosystem, immune function and growth parameters of broiler. The first 
study screened naturally occurring Campylobacter levels in four local sites and revealed 
the NTU broiler research unit and the NTU animal unit laying hens were Campylobacter 
free, but a small holding with laying hens was positive and the commercial broiler farm 
was negative until thinning, after which it was positive. The second study investigated 
possible delivery routes of a novel strain of Lactobacillus johnsonii (FI9785) into broiler 
chicken gut and concluded feed was the optimum method for delivery. A third study 
compared the effect L. Johnsonii FI9785 supplied via feed to control and showed no 
significant difference in the CFU of caecal Campylobacter, no significant (p≤0.05) effects 
on growth performance and serum uric acid concentration over 4 weeks. However, 
mucin layer thickness in the jejunum was significantly (P≤0.05) increased. Concentration 
of IgA in the serum blood of probiotic treated birds was also increased but IgM and IgG 
were not significantly altered.   
Study 4 involved isolation and in vitro screening of candidate probiotic isolates of lactic 
acid bacteria and a prebiotic from Jerusalem artichoke plant (JA). All tests confirmed the 
isolates had the characteristics of lactic acid bacteria and have an inhibition activity 
toward Campylobacter.  All isolates belonged to the genus of Lactobacillus and all 
retained viability during freezing and drying and the poultry gastrointestinal 
environment, indicating all were potential probiotic agents. Assessment of JA inulin 
levels indicated the plant to be a potentially good prebiotic source with these isolates.  
Study 5 investigated in vivo effects of the Lactobacillus isolates (probiotic), JA powder 
(prebiotic), synbiotic (mix of pre and probiotic). Caecal content were negative for 
Campylobacter throughout but at day 7, abundance of Firmicutes phyla were higher 
(p≤0.05) than control for all of supplements treatments and abundance of 
Faecalibacterium genus numerically increased in all treatments but significantly (p≤0.05) 
only in 5% prebiotic and probiotic supplemented diets. At day 42, abundance of genus 
of Erysipelotrichaceae decreased in all treatments.  Assessment of growth performance 
showed JA had no effects but probiotic and synbiotic supplementation caused a 
degradation in the body weight and increased feed intake. Supplements downregulated 
the cytokine expression IFNγ, IL-10 and IL-6 in the ileum tissue but showed no effect in 
the bursa tissue. 
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Chapter 1 
Literature Review
 1 
 
 Literature Review   
1.1 Introduction  
The poultry industry has grown rapidly since Second World War and the volume of 
poultry products continues to increase (FAO, 2009). The Food and Agriculture 
Organisation of the United Nations reported that about 23 billion broiler chickens were 
produced worldwide in 2016 (FAO, 2018). Therefore broiler chickens are raised in high 
stocking densities and new strains are genetically selected for very fast growth. Over 
past 50 years, the growth rate of broiler have increased by over 300% due to intense 
genetic selection (Knowles, et al. 2008). However selection for fast growth has some 
side effects such as limited disease resistance, poor skeletal integrity and heart failure. 
In addition, intensive rearing of broiler chicken has raised a particular issue with disease. 
Diseases are now considered by many to be the most important obstacle for poultry 
sector itself and for public health (van Asselt, et al. 2018).  
Antibiotics have been used widely for prevention and treatment of infectious disease in 
farm animals alongside their utilization for human medication for many decades (Edens 
2003) to improve the performance of broiler chicken (Allen and Stanton 2014). The 
numerous disease challenges impacting on the poultry industry have prompted the 
sector to routinely use antibiotics for the prevention and treatment of disease, as well 
as for their growth promoting effects. Heat production from individual birds combined 
with environmental heat presents a major additional challenge to meat poultry 
production in hot countries such as Iraq. This stressor increases the vulnerability of birds 
to infectious disease, enhancing gut health of meat chickens in hot countries is a priority 
commercial poultry production. There is now a growing interest in non-EU countries to 
follow Europe in reducing in-feed antibiotics due to concerns over antibiotic resistance 
(Lea, 2013).  
Use of in-feed antibiotics led to improved feed conversion efficiency and reduced 
pathological load associated with poultry production. The greatest problem with 
antibiotics for poultry as well as for human is antibiotic–resistant bacteria (Nhung, 
Chansiripornchai and Carrique-Mas 2017). In broiler chickens this has made controlling 
disease hard because there are many antibiotics previously used in the poultry 
production which now fail to treat many disease cases. In addition, this presents a major 
risk for humans as some antibiotics considered important for human health have lost 
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their efficacy. These reasons together prompted the EU to ban using antibiotics as 
growth promoters and trying to reduce its therapeutic use on the poultry farms as well 
as encouraging other, non-EU countries to reduce their use of antibiotics as growth 
promoters (European Commission, 2005).  However, banning or decreasing using 
antibiotics in poultry farms results in increased mortality rate, feed intake and decrease 
body weight and growth rate which means increased cost of production and an 
increased probability of contaminating poultry products intended for human 
consumption.  
The gastrointestinal tract (GIT) is one of the most important system of organs in poultry 
– not only for nutrition but also as a route for disease entry and for its other, indirect 
effects on bird performance. (Huyghebaert, Ducatelle and Immerseel 2011) stated that 
the quality and quantity of GIT microflora and morphological structure of the inner lining 
(mucosal layer and epithelial cells) have a strong correlation with livestock performance 
and feed efficiency. Enteric pathogens of animals constitute a direct source for food 
contamination therefore, poultry production is considered as one of the most important 
sources for human infection (Santini, et al. 2010). One of the main causes for these 
illnesses is the contamination of poultry meat by Campylobacter, which is reported as 
an organism that is very easily spread among the birds especially in high population 
densities such as those associated with intensive poultry production (Santini, et al. 
2010). Currently, there is a growing interest to use alternatives to antibiotics in poultry 
farms to improve the health of these birds and to produce fewer contaminated 
products.    
1.2  Digestive system of broiler chickens  
The gastrointestinal tract (GIT) of poultry, specifically broiler chickens, compromises of 
the oesophagus which continues down past the crop, proventriculus, and gizzard, then 
continues through the small intestine (duodenum, jejunum, ileum), includes the caeca 
and  ends at the colon and cloaca (Pan and Yu 2014). 
 Crop & Oesophagus  
The majority of bird species have a crop, the main role is as a transient store for 
consumed food (Svihus 2014a). The crop is a necessity for birds as the feed storage 
capacity of gizzard and proventriculus is limited (Jackson and Duke 1995). In broiler 
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chickens, the crop may store between 5 to 10 g of feed but there is no secretion of 
enzymes or absorption of nutrients in this region of the gastrointestinal tract (Svihus 
2014a).  
 
Figure 1:1 Broiler chickens gastrointestinal tract Poultry Hub, (2018)   
 Proventriculus and Gizzard  
The proventriculus and gizzard are the stomach compartments of birds. The 
proventriculus is a mixing organ where feed and enzymes are mixed before entering the 
gizzard. Hydrochloric acid and pepsinogen are secreted by the proventriculus and then 
mixed with contents in the gizzard (Svihus 2014a). The main function of gizzard is 
grinding feed material, as the bird does not have teeth.  
 Small Intestine   
The small intestine in broiler chickens consists of three sections: duodenum, jejunum 
and ileum, located between the gizzard and caeca.  The duodenum is the first part of 
the small intestine in which pancreatic and bile ducts release enzymes and bile salts to 
neutralise the acidic contents from the gizzard and continue the process of digestion 
(Duke 1986). The first section of the small intestine is referred to as the duodenum, and 
forms adherent loop around the pancreas. The second section, the jejunum, ends at the 
 4 
 
yolk sack residue (Meckel’s diverticulum) and has a key role, as large proportion 
nutrients digested and absorbed here (Wu, et al. 2013). The last segment of the small 
intestine is the ileum which ends at the ileo-caeco-colonic junction (Nkukwana, et al. 
2015). The function of this final section is mainly nutrient absorption and it has been 
recently proposed that there is a significant role of the ileum in digestion and absorption 
of starch in broiler chickens. (Svihus 2014b) Svihus (2014b) observed that total starch 
digestion may increase from 91 to 99% from the beginning to the end of the ileum 
respectively.  
 Caeca  
Caeca are formed as two paired, blind-ended pouches located at the junction of the 
ileum and colon (McLelland 1989). In most avian species, the caeca are the unique 
features of the digestive tract and various sizes and forms are associated with different 
species (Clench 2015). The functions associated with the caeca are breakdown of fibre 
and storage of undigested material in addition to absorption of electrolytes and water, 
which give the caeca some importance in the gut (Svihus 2014a). Depending on the bird 
species, caecal material is generally retained 3-4 times longer than faecal material (Duke 
1986). Caeca of broiler chickens have been observed to undergo morphological change 
as a result of different dietary components, such as increased fibre content or 
fermentable content of food (Jozefiak, et al. 2011, Rehman, et al. 2007). These 
morphological changes in the caeca as a result of shifts in diet indicate that the function 
of the caeca may include fermentation of dietary compounds (Svihus, Choct and Classen 
2013). In the caeca of birds fermentation occurs selectively for some feed stuffs such as 
fibre (carbohydrate) as each bird contains a unique microbiota (Waite and Taylor, 2014).  
 Colon and cloaca  
The large intestine of birds is relatively short and the avian colon is located between the 
caeca and the cloaca. In birds, its main function is water and electrolyte reabsorption - 
unlike the fermentative role of the colon in mammals as fermentation in the avian 
digestive tract predominantly occurs in the caeca (Lei, et al. 2012). The cloaca has no 
digestive function, but serves as the exit cavity for the digestive and urogenital systems. 
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1.3 Microbiota in the gastrointestinal tract 
The gut microbiota is a topic that been widely studied because of its impact on health 
and performance (Roto, Rubinelli and Ricke 2015, Apajalahti and Vienola 2016). The gut 
microbiota is home to one of the biggest bacterial populations on earth, its level ranging 
from 108 to 1014cfu/g of digesta (Apajalahti, Kettunen and Graham 2004a, Gill, et al. 
2006). It  have been found that microorganisms that comprise the microbiota of gut  
directly impact the health of the host, which can provide protection against the damage 
that may occur to the epithelial layer, and they can promote the development of a 
healthy immune system (Brisbin, Gong and Sharif 2008b, Hoffmann, et al. 2009). In 
addition commensal bacteria, in the animal gut can aid in digestion and absorption of 
nutrients as well as contribute to the enhancement of nutrient utilization (Delzenne and 
Cani 2011). Meanwhile there is a second group of harmful bacteria, which may be 
involved in infection, intestinal putrefaction and toxin production (Jeurissen, et al. 
2002). Research has suggested that better growth and fewer health issues in poultry 
could achieve if early development of a mature and diverse microbiota (Munyaka, 
Khafipour and Ghia 2014). This is in part due to healthy competition among 
microorganisms. The gut microbiota generally refers to the intestinal regions and most 
studies focus on the duodenum, jejunum, ileum and caeca (Roto, et al. 2015). Caeca 
have been given most attention and their contents (digesta) exhibit the most diverse 
bacterial communities, which in turn, indicate its potential for impact on host health 
(Pan and Yu 2014).  Microbiota in the gut plays an important role in the health of the 
GIT through several different mechanisms. A primary example is competitive exclusion 
of pathogenic bacteria by different mechanisms such as reducing available attachment 
sites on the epithelium, increasing mucin production and reducing pH and competition 
for nutrients. Other protective effects of microbiota are via selective stimulation of the 
immune system; production of compounds, like antimicrobial compounds such as 
bacteriocin and production of short-chain fatty acids (SCFA) (Kogut 2013). Different 
components of the GI tract vary in their biochemical properties such as oxygen content 
and pH, which can pose a selective pressure on the microbial community. The 
oesophagus, crop and cloaca are considered semi-oxic environments, facilitating 
communities of aerobes, micro-aerobes and facultative anaerobes. The sections of the 
GI tract located between the crop and cloaca are dominated by obligate or facultative 
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anaerobes, including members of the Firmicutes and Proteobacteria (Hird, et al. 2015, 
Waite and Taylor 2015).  (Wei, Morrison and Yu 2013) stated that Firmicutes, 
Bacteroidetes and Proteobacteria were the largest phyla which accounted for >90% of 
all the sequences. (Pan and Yu 2014) stated that there are about 13 phyla of bacteria, 
however, Firmicutes, Bacteroidetes, and Proteobacteria accounted more than 90% of 
the intestinal bacteria of broiler chickens. (Amit-Romach, Sklan and Uni 2004) stated 
that the different sections of the small intestine possess similar microbiota and are 
dominated by Lactobacilli and Clostridia at the genera level.  
The proventriculus is usually acidic which likely poses the first screening of 
microorganisms entering the digestive tract with feed (Beasley, et al. 2015) and likely 
biases the resident microbiota towards acidophiles. Stomach acidity varies among bird 
notably having most acidic stomachs, suggesting a possible role of diet in shaping acidity 
(Roggenbuck, et al. 2014). The importance of the caeca comes from the fact that it is 
considered to as act as a reservoir of microbiota in the broiler chickens, the diversity of 
which is generated in the caeca offering an important section to study pathogens such 
as Campylobacter (Thibodeau, et al. 2015, Yan, et al. 2017). Also fermentation in the 
avian digestive tract predominantly occurs in the caeca (Lei, et al. 2012). However 
microbial communities of the caeca are distinct from the rest of the GI tract (Sohail, et 
al. 2015). Table 1.1 gives insight into typical taxa and genera of microbiota associated 
with each region of the gastrointestinal tract but the immense influence of external 
factors on colonisation means that each situation will vary from this example. 
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Table 1.1 Surveyed bacteria along the gastrointestinal tract of broiler chickens.  
Gut site and 
CFU 
pH Taxa Genus 
Crop 
(10^8-10^9) 
4-6 Firmicutes Lactobacillus 
  Actinobacteria Bifidobacteria 
  Proteobacteria Enterobacter 
Gizzard 
(10^7-10^8) 
2-5 Firmicutes Lactobacillus, Enterococcus 
Small 
intestine 
(10^8-10^9) 
6-7.5 Firmicutes Lactobacillus, Clostridium, Ruminococcus 
  Proteobacteria Escherichia, Enterococcus 
Caeca(10^10-
10^11 
5-5.7 
Firmicutes (44-
56%) 
Faecalibacterium, Pseudobutyrivibrio, 
Subdoligranulum, Acetanaerobacterium, 
Lactobacillus, Clostridium, Megamonas, 
Sporbacter, Peptococcus, Ruminococcus 
Campylobacter (Hermans, et al. 2011) 
  Fungi Candida 
  
Bacteroidetes 
(23-46%) 
Bacteroides 
  
Proteobacteria 
(1-16%) 
Escherichia, Bilophila 
  
Archaea 
(0.81%) 
Methanobrevibacter(woesei,thaueri), 
Methanobacterium, Methanosphaera, 
Methanothermus, 
Methanothermobacter, Methanopyrus, 
Methanococcus 
Large 
intestine 
7 Proteobacteria Escherichia , other 
Data adapted from (Yeoman, et al. 2012). 
The concept of host factors affecting microbial diversity offers the opportunity to use 
established and healthy microbiomes to generate a working GIT microbial profile. 
However, this may prove to be quite challenging as it has been found that broiler 
chickens interacting together in the same conditions, receiving the same feed, and of 
the same age and sex still display uniquely dominant bacterial communities (van der 
Wielen, et al. 2002). The quantity and profile of microflora in the GIT are very important 
as there is a dynamic balance between the beneficial and pathogenic bacteria in gut. 
When this balance is altered through any type of physiological or environmental stress, 
the disruption can lead to disease (Thursby and Juge 2017, Sugiharto 2016). This 
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disruption to the GIT is reflected by an overall reduction in bird health and gut function, 
resulting in deteriorating production performance (Gaggia, Mattarelli and Biavati 2010).  
1.4  Culture-free methods to study the gut microbiota 
Traditional methods for assessing gut microbiota involve culturing diluted intestinal 
samples on selective media under specific incubation conditions. This technique has a 
number of limitations. Firstly the selective media limits the microbes cultured to 
particular species or genera, so offers no insight into the range of microbiota. Also most 
gut microbiota are anaerobic and require a very low concentration of oxygen to survive, 
so any air exposure during plating will damage or kill some species, so they are not 
represented at enumeration (Walker et al., 2014). Intestinal microbiota that are 
identified from culture-based methods may be incomplete and inaccurate because only 
10 to 60% of the total intestinal tract bacteria are culturable (Gong 2007). Several studies 
have used 16s rDNA clone libraries to investigate the distribution of microorganisms in 
different regions of the gastrointestinal tract (Wang, et al. 2004). These have confirmed 
earlier information from cultural studies, indicating a major shift between the stomach, 
small intestine and large intestine in non-ruminant mammals and man, with the more 
dense and complex anaerobically dominated communities occurring in the large 
intestine (Russell and Rychlik 2001). These studies have expanded the knowledge about 
the gut microbiota and has found that only about 10% of the identified caecal bacterial 
16S rDNA sequences represent previously known bacterial species, and the remaining 
sequences belong to new species or even new genera (Apajalahti, Kettunen and Graham 
2004b). Representatives of the same groups of bacteria, described in the cultivation 
studies, were found using molecular methods, although the species were found in 
different abundance among the cloned sequences (Bjerrum, et al. 2006). Culture-
independent methods have revealed that there is a highly diverse bacterial community 
in the caeca, which mainly comprise Gram-positive bacteria (Zhu, et al. 2002, Gong 
2007). Subsequently this method using molecular and sequencing technique are 
recognized as able to provide a more comprehensive representation of the microbiome 
(Zhu, et al. 2002, Lan, et al. 2002). 
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1.5  Microbial development of the broiler chickens  
. In the commercial production of poultry, chicks are hatched away from their parents, 
which will affect the development of gut microbiota (Stanley, et al. 2013a). In addition 
they are hatched from disinfected eggs in very clean hatchery (Methner, et al. 1997). 
The gastrointestinal (GI) tract of poultry come in contact with exogenous 
microorganisms after hatch immediately which then becomes a warm home for a 
complex microbiome with majority anaerobic bacteria (Pan and Yu 2014). Then as chicks 
growing the diversity of the microbiome will become varied until it reaches a relatively 
stable. Consequently the initial colonization of the GIT by non-pathogenic microbiota in 
newly hatched chicks will be strongly affected by the microorganism that present in the 
hatchery or the environment of housing (Schokker, et al. 2015). Therefore using 
competitive exclusion products that contain complex microbiota from healthy adult 
hens to colonise young chicks can therefore prevent the infection with 
pathogens (Norris and Ngambi 2006, Havenstein, Ferket and Qureshi 2003).   
The initial gut colonizers are the facultative anaerobes and soon, within a week after 
hatching, Firmicutes representatives begin to appear, then finally, representatives 
of Bacteroidetes become part of the intestinal tract microbiota (Videnska, et al. 2014). 
However, the gastrointestinal tract of poultry may contain more than 650 microbial 
species (Apajalahti, et al. 2004a). A recent evaluation of the ecology of the microflora of 
the broiler chickens intestine using 16s rRNA confirms that Lactobacillus is the 
predominant genus in young birds, while in older broiler chickens Bifidobacteria are 
dominant (Amit-Romach, et al. 2004). 
A balanced intestinal microbial population is generally considered to be the chief 
characteristic of a healthy and well-functioning gastrointestinal tract. Chicks establish a 
protective microflora within the first couple of days after hatching which then develops 
with age (Gabriel et al., 2006). Within one day after hatching, the ileum and caeca that 
were previously sterile contain 108 and 109 bacteria per gram of content respectively 
(Apajalahti, et al. 2004a) then after 3 days this will increase to 109 and 1011 per gram of 
content respectively. Afterward the numbers will remain relatively stable until 30 days 
of age (Gabriel, et al. 2006). Coliforms and Enterococci were found to be the most 
dominate microbial in the gut of the chicks initially. Lactobacillus bacteria colonise 
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broiler chickens gut slowly, but finally, they become the most dominant species in the 
upper part of the GI tract (Apajalahti, et al. 2004a). The broiler chickens gizzard 
microbiota is highly similar to crop microbiota (Sekelja, et al. 2012): lactobacilli 
comprising 43% of the gizzard microbiota in the domestic broiler chickens GI tract (Gong 
2007). Lactobacilli are expected in the gizzard because these bacteria tolerate acidic 
environments, and also produce acids (Amit-Romach, et al. 2004).  
In the caeca the bacterial population is more diverse, especially with the slow turnover 
of the digesta (1 to 2 times a day) which can result in the development of more and 
different types of bacteria. However although there is an incredibly diverse range of 
microorganisms in the gut microbiota of poultry, the most abundant are primarily 
anaerobic (Pan and Yu 2014) probably because there is low to zero oxygen levels 
available in the lumen (Sun and O'Riordan 2013). 
1.6 Protective role of the gastrointestinal microbiota in broiler 
chickens  
Intestinal bacteria play an important role in host health which comes from different 
effects on; nutrition, infection, morphology and immunity. In addition the microbiota 
contributes to vitamin and amino acid production (Apajalahti, 2005). Moreover, broiler 
chickens gut microbiota can act as a reservoir of pathogenic or antibiotic resistant 
bacteria which can be transferred to other microorganisms including pathogens, which 
in turn can spread to humans by consuming their products (Zhou, Wang and Lin 2012).  
The most studied broiler chickens microbiota are from caeca as a sampling site because 
of the importance of it in health, production and the wellbeing of broiler chickens 
(Stanley, et al. 2015). In the avian host, caeca generally have a more important role 
preventing infectious disease than the mammalian caecum, where the preimarly role is 
digestion for energy. It is considered to be a multi-purpose organ that is vital to the birds 
physiology; as there is a very dense microbial community which makes the caeca to be 
considered as a powerhouse for fermentation (Clench 2015) resulting in the production 
of energy metabolites that can aid birds to achieve the  requirements of energy (Lei, et 
al. 2012). (McBride and Kelly 1990) reported that about 23% of whole body energy 
consumption is utilized by the GIT and liver. Also it was reported that the microbiota 
present in the broiler chickens intestinal tract significantly increased the metabolizable 
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energy associated with broiler chickens feed, indicating that the gut microbiota are 
responsible for the additional dietary energy that is utilized (Hegde, Rolls and Coates 
1982).  
The indigenous microflora are considered to be a key component in protecting the gut 
from pathogen invasion.  The GIT of the mature bird is much more resistant to pathogen 
colonization compared with newly hatched neonates whose GIT is sterile and highly 
susceptible (Nurmi and Rantala, 1973; Mead, 1998). Therefore to maintain the intestinal 
microflora balance in animals it is important to prevent diseases by controlling the 
overgrowth of potential pathogenic bacteria. The control of infections through a non-
antibiotic approach is urgently required. The natural bacterial flora (e.g. probiotic 
bacteria) represents a promising alternative therapy.  
The protective influence of maternal transfer of enteric microflora is known for various 
warm-blooded species, including humans. Unfortunately, in many poultry operations, 
transfer of microflora from the hen to her offspring no longer occurs, because chicks are 
raised separately from parent flocks. The concept of accelerating development of the 
normal enteric microflora, thereby increasing the resistance of young poultry to 
infection, was first described by (Nurmi and Rantala 1973). These researchers collected 
microflora from the alimentary tract of mature broiler chickens and used it to inoculate 
newly hatched chicks, thereby reducing considerably Salmonella colonization. This 
strategy has been called ‘competitive exclusion’, ‘the Nurmi effect’ or ‘probiotic 
supplementation’ and, subsequently, numerous studies have demonstrated reductions 
in Salmonella colonization of poultry using mixed, undefined enteric cultures. In an early 
example, (Schoeni and Doyle 1992) isolated caecum-colonizing bacteria that produced 
anti-Campylobacter metabolites from C. jejuni-free hens and demonstrated that these 
isolates could protect chicks against a subsequent challenge with C. jejuni. In other 
studies, bacterial strains isolated from washed caeca were shown to possess 
hydrophobic properties and their use improved the efficacy of competitive exclusion 
cultures in broiler chickens (Stavriac and D'aoust 1993). A competitive exclusion culture 
was developed from the microflora occurring in the same niche as that occupied by 
Campylobacter, using scrapings of intestinal mucosa ((Stern, 2008; Stern, 1994). 
(Koenen, et al. 2004) developed a method for in vitro selection of lactic acid bacteria 
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with immuno-modulating properties in broiler chickens. The mechanisms that gut 
microbiota can protect the host from pathogenic are listed in table 1.2.  
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Table 1.2. Defence mechanisms of the avian gastrointestinal tract.  
Mechanism Mode of action 
Physical barriers   
Mucin Mucin secretion and type  affect microflora 
pH  Low pH of upper GIT inhibits growth of some enteric 
bacteria 
Nutrient 
competition  
Bacteria must compete with the GIT for nutrients  
Peristalsis  Movement of digesta and mucin prevents bacterial 
adherence 
Oxygen tension The anaerobic environment of the GIT and inhibits some 
microbes 
Gut microflora  
Competition for 
adhesion  
Bacteria compete for adhesion sites 
Nutrient 
competition  
Bacteria compete for nutrients 
Bacteriocins  Antimicrobial compounds produced by other bacteria to 
inhibit competitors 
Bacteriophages  Viruses that replicate within and lyse specific bacteria 
Short-chain fatty 
acids  
 Antimicrobial compounds that can inhibit the growth of 
some bacteria 
Competitive 
exclusion  
 
Mature microflora  Microflora from healthy adults and protects neonates 
Mucosal scrapings  Microflora collected from mucosal scrapings that reduce 
Campylobacter 
Immuno-
modulation  
Probiotic bacteria that stimulate an immune response 
Bactericidal 
compounds  
Caecal bacteria that secrete metabolites bactericidal to C. 
jejuni 
In vitro 
competition  
Enteric bacteria that outcompete pathogens in vitro 
Mucosal immunity   
Immune 
surveillance  
M cells and phagocytes constantly monitor the GIT for 
pathogens 
Defences  Antimicrobial peptides expressed in the villus crypts 
Secretory IgA  Secreted by B cells to bind to bacteria and prevent bacterial 
attachment 
Mucin secretion  Regulated by pattern-recognition receptors; flow and type 
affect microflora 
  
  Adapted from (Perry 2006) 
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1.7 Diversity in gut microbial communities  
Microbiota characterization has been studied to investigate the changes in broiler 
chickens microbiota within the gut caused by many factors. It has been documented that 
broiler chickens microbiota responds to changes in feed (Siragusa, et al. 2008, Jozefiak, 
et al. 2011), litter composition (Cressman, et al. 2010), antibiotics (Lin, et al. 2013) and 
probiotic addition to feed (Lee, et al. 2011, Nakphaichit, et al. 2011), disease (Stanley, et 
al. 2012, Juricova, et al. 2013) and stress (Lan, Sakamoto and Benno 2004, Burkholder, 
et al. 2008).  
The gastrointestinal tract of poultry essentially is coated in a dense layer of commensal 
bacteria. In general, the crop and the caeca contain the most complex microbial 
communities. Meanwhile, there is less colonization in the rest of GIT because of the 
unfavourable environment. In the duodenum for instance there are numerous enzymes 
and  antimicrobial compounds present in high level, such as bile salts, in addition there 
is the rapidly changing environment due to reflux from the jejunum to the gizzard 
(Gabriel, et al. 2006). Going down the GIT, the ileum and caeca will become more 
favourable environments as they contain fewer enzymes and antimicrobial compounds; 
therefore  concentrations of commensal bacteria will increase, which will be around 
109 and 1011 cfu/g, respectively (Thompson, et al. 2012). (Stanley, et al. 2013b)  found 
that the microbiota in the broiler chickens individually of each single bird of three trials 
which were similar in feed and all conditions. The authors identified that there was a 
variation from batch to batch across the three trials and in addition they found that the 
variations were large within each trial. Hence, it seems individual bird to bird variation 
is normal in the gut microbiota of broiler chickens. 
1.8  Human pathogenic bacteria in the avian gastrointestinal tract  
Understanding the strategies by which zoonotic bacteria survive and adapt in the avian 
gut is important, as a major mode of carcass contamination occurs during processing, 
when edible meat is exposed to intestinal contents. Campylobacter and Salmonella are 
the most prevalent pathogens derived from poultry that infect humans through 
foodborne illness (CDC, 2004). Also Salmonella is still one of the most prevalent food 
safety risks and has always been associated with poultry products (de Oliveira, et al. 
2014). Other foodborne pathogens, including Listeria monocytogenes and Clostridium 
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perfringens, can also colonize the avian gut and are potentially pathogenic to humans. 
Enteric E. coli isolates from avian species tend to be non-pathogenic to humans; 
however, there is some evidence that broiler chickens can be colonized by E. coli 
0157:H7, a highly pathogenic organism (Ferens and Hovde 2011).  
1.9  Concept of probiotics 
The previous descriptions of intestinal microbiota focus on healthy situations where the 
balance of microbiota is tipped towards a high percentage of beneficial bacterial. 
However, modern poultry production often involves a variety of challenges that invoke 
deviation from this situation, so there is opportunity for interventions to re-establish   a 
high percentage of beneficial bacterial through the use of probiotic supplements.  The 
relative meaning of probiotic is “for life” which is originally derived from Greek language 
that is currently used to name the bacteria which associated with beneficial effects in 
animals and humans. There are many definitions that have been proposed for the term 
probiotics such as Fuller (1989) “a live microbial food supplement that beneficially 
affects the host animal by improving its intestinal microbial balance”. However 
according to the currently defined by FAO/WHO, probiotics were defined as “live 
microorganisms which, when administered in adequate amounts confer a health benefit 
on the host” (Fijan 2014). 
(Stanley, et al. 2013b) has reported that in the broiler chickens, colonisation of the gut 
is thought to start immediately after hatch, which means that the hatching environment 
can affect the microbial profile significantly. In the commercial poultry production, it is 
argued that the timeframe for maturity of broiler chickens has been significantly 
reduced, in which it appears that gut microbiota can stabilise within three days after 
hatching  (Apajalahti, et al. 2004a) then it remain reasonably constant until day 30 of 
age (Lu, et al. 2003a). However in the poultry industry, there are some factors that can 
affect the gut profile of birds. Firstly chicks will hatch away from their parents and 
secondly the strict hygiene implemented in the commercial hatcheries or/with washing 
or fumigation of the eggs prior to hatching (Varmuzova, et al. 2016a) will reduce the 
bacterial load in these environments and mean that the spread of bacteria is limited 
(Donaldson, et al. 2017). Therefore, chicks that are hatched in hatcheries will be exposed 
to a diverse range of bacteria from the surrounding environment rather than from their 
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parent. These environments include hatchery, transport, and the farm (Stanley, et al. 
2013b). (O'Dea, et al. 2006) reported that exposure to pathogenic bacteria can be 
avoided by exposing chicks to beneficial bacteria like probiotic bacteria. (Methner, et al. 
1997) reported that inoculation of newly hatched broiler chickens with gut microbiota 
of donor hens can prevent against colonization of Salmonella spp.   
 Probiotic Microorganisms  
Species of a wide range of different genera of microorganisms (Lactobacillus, 
Bifidobacterium, Bacillus , Saccharomyces, Aspergillus, Candida, 
Lactococcus,  Streptococcus, Enterococcus, Bacillus and E. coli),  as well as undefined 
mixed cultures which have a beneficial effect on performance of broiler chickens 
through different mechanisms have been added to broiler chickens diets (Lutful Kabir 
2009) (Patterson and Burkholder 2003). Lactic acid bacteria (LAB) are Gram-positive 
bacteria that are natural inhabitants of the gastrointestinal (GI) tracts of mammals, 
including humans. They include Lactobacilli, Lactococci, Enterococci, Streptococci, 
Leuconostoc and Pediococci (Pessione 2012) in addition to Bifidobacterium (Sule, et al. 
2014).  Also there are variety of genera and species thereof that have been used as 
probiotic organisms in humans or animals. Probiotic species used in broiler chickens 
diets usually belong to Lactobacillus, Streptococcus, Bifidobacterium, 
Bacillus,   Enterococcus, Aspergillus, Saccharomyces and Candida (Lutful Kabir 2009). The 
most common species currently being used as probiotic, isolated from the intestinal 
tract are Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus casei, 
Lactobacillus helveticus, Lactobacillus lactis, Lactobacillus salivarius, Lactobacillus 
plantarum, Streptococcus thermophilus, Enterococcus faecium, Enterococcus faecalis, 
Bifidobacterium spp. and Escherichia coli (Fuller 1989). Organisms from the 
Lactobacillus genus are Gram-positive, facultatively anaerobic, catalase-negative, non-
spore-forming rod-shaped bacteria. This genus is composed of over 170 species 
(Goldstein, Tyrrell and Citron 2015a) and can ferment carbohydrates and produce lactic 
acid as a major end-product (Cortón, et al. 2000). Species of Lactobacillus such as Lb 
salivarius, Lb reuteri and Lb fermentum are common species in the broiler chickens gut 
and they have been used previously as probiotic organisms to improve the health and 
performance of broiler (Olnood, Beski, Choct, et al. 2015, Shokryazdan, et al. 2017). 
(Santini, et al. 2010) selected Lactobacillus isolates from different sources and they 
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found that some of these isolates were able to inhibit the growth of Campylobacter. Also 
(Ghareeb, et al. 2012) found that Lb. salivarius and Lb. reuteri, Enterococcus faecium and 
Pediococcus acidilactici inhibited the growth of Campylobacter jejuni.    
  Characteristics and properties of probiotics 
Probiotics to be active as supplement should have some specified criteria and 
characteristics : (1) non-pathogenic bacteria (Hardy, et al. 2013), and  (2) resistant to 
gastric pH and processing/storage, to allow them to persist in the intestinal tract, (3) 
they are able to produce inhibitory compounds and (4) compounds that modulate 
immune responses (Patterson and Burkholder 2003). Lactobacilli and bifidobacteria are 
well-documented examples of beneficial bacteria and the most common use as 
probiotic, they are beneficial and indigenous to the human and broiler chickens GIT 
(Olnood, Beski, Iji, et al. 2015, Walter 2008). Lactobacilli belong to big group collectively 
referred to as lactic acid bacteria, which metabolize carbohydrates and produce lactic 
acid as the primary end product (Sun, et al. 2015). Bifidobacteria are often associated 
with lactic acid bacteria for their production of lactic acid, however, they are 
phylogenetically distinct. Bifidobacteria are Gram-positive, and heterofermentative 
(Pokusaeva, Fitzgerald and van Sinderen 2011). Bifidobacteria also digest 
oligosaccharides to use it as carbon and energy sources, they produce lactic acid, acetic 
acid, ethanol, and formic acid (Van der Meulen, Avonts and De Vuyst 2004). In addition, 
they can prevent pathogenic bacteria by competing for nutrients as they are capable of 
internalizing simple sugars remaining in the environment, (Roto, et al. 2015). Lactobacilli 
and bifidobacteria are both known to be members of the intestinal microbiota in animals 
and humans; their presence is important to maintain the gut microbiota (Hemarajata 
and Versalovic 2013).  
1.10 Modes of action of probiotics 
Gut microbiota plays an important role in the health of the GIT through many different 
mechanisms as previously summarised in table1:2. A primary example is competitive 
exclusion of pathogenic bacteria by different methods such as reducing available 
attachment sites on the epithelium, increasing mucin production, reducing pH and 
competition for nutrients. Other protective effects of microbiota are through selective 
stimulation of the immune system; production of compounds like antimicrobial 
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compounds such as bacteriocins and production of short-chain fatty acids (SCFA) (Clavijo 
and Florez 2018). Key features of probiotic bacteria are the capability of manipulating 
the gut microbiota to host advantage via three main mechanisms as detailed below:  
  Competitive exclusion 
In the lower intestines, the complex lining with bacteria can work as a barrier to prevent 
pathogenic bacteria from colonization. Infection will occur without these barriers in 
place: the lining of the intestines when the bacteria settle first will make other 
microorganisms to compete for space and nutrients in order to survive and colonize in 
the intestine (Hardin 1960, Gabriel, et al. 2006, Lawley and Walker 2013). Therefore 
infection by pathogens can be prevented by establishing the early foundation of a 
mature GIT microbiota, as the beneficial bacteria will compete with the pathogenic 
bacteria (Salmonella) for space and nutrients (Gleeson, Stavric and Blanchfield 1989, 
Crhanova, et al. 2011). Naturally, rapid colonization of members from the parents gut 
microbiome will occur when chicks hatched in the presence of maternal faecal contents 
(Lutful Kabir 2009). Researchers stated that native microflora can compete with 
pathogenic microbes for essential nutrients which can be a limiting factor in colonization 
of the gut by invading pathogens (Lan, et al. 2005, Woo and Ahn 2013). For example, for 
almost all species of bacteria, iron is essential as it is an important component of many 
proteins. Therefore, iron acquisition during infection of a human host is a challenge that 
must be surmounted by every successful pathogenic microorganism. Iron is essential for 
bacterial and fungal physiological processes such as DNA replication, transcription, 
metabolism, and energy generation via respiration (Ratledge and Dover 2000, Caza and 
Kronstad 2013). (Deriu, et al. 2013) found that probiotic of E. coli (Nissle) 
outcompetes Salmonella for iron in the inflamed gut and reduced  S. Typhimurium 
colonization in mouse models.  
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    Antimicrobial substances  
Probiotic organisms can either by themselves produce or indirectly induce the host cells 
to produce peptides that interfere with pathogens and prevent invasion of epithelium 
cells such as anti-bacterial protein defences, cathelicidins and bacterial/permeability-
inducing protein (BPI) which display an antimicrobial activity against wide variety of 
microorganisms (Kelsall 2008). Probiotics have shown the capability to inhibit the 
growth of pathogens due to production of a variety of antimicrobial factors such as 
defences,  bacteriocin, hydrogen peroxide, nitric oxide, and short chain fatty acid (SCFA) 
which will reduce the pH of the lumen (Henningsson, Björck and Nyman 2001).  Some 
are able to produce H2O2 which is one important mode of action of LAB to be used as 
probiotic as an antimicrobial agent against pathogenic bacteria (Servin 2004).   
Another substance produced by organisms such as Lactobacillus and Bifidobacterium 
spp. are SCFA that are organic acids resulting from fermentation of indigestible 
carbohydrates in the GIT (Liu, Gibson and Walton 2016). The predominant SCFA present 
in the GIT are acetic, propionic and butyric acids (Rios-Covian, et al. 2016). SCFA increase 
from undetectable levels in the caeca of day-old broilers to the highest concentrations 
at 15 days of age (van Der Wielen, et al. 2000). SCFA have been reported to inhibit 
growth or reduce levels of S. Enteritidis, S. Typhimurium, S. Pullorum, E. coli, C. jejuni 
and C. coli (van Der Wielen, et al. 2000, Chaveerach, et al. 2004). Although not fully 
understood, the antibacterial mechanisms include bacteriostatic and bactericidal 
properties, depending on the physiological status of the bacteria and the physico-
chemical characteristics of the external environment (Jones and Ricke 2003). SCFA that 
are not dissociated can diffuse across bacterial lipid membranes and decrease the 
intracellular pH which then can  cause cellular damage or death of those microbes that 
are sensitive to such conditions (van der Wielen, et al. 2002). Furthermore, other 
mechanism that SCFA can also depress bacterial growth, since additional energy is 
required to return the internal pH of the cells to homeostatic levels (Van Immerseel, et 
al. 2004).  
 Al-Tarazi and Alshawabkeh (2003) reported that the administration of formic and 
propionic acids via feed reduced S. pullorum related mortality in broilers by 58% and 
caecal colonization by 75%. While the direct, oral administration of SCFA has had limited 
success, utilizing probiotics and/or prebiotics to increase SCFA is more effective. The 
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effectiveness of butyric acid, the optimal acid for preventing bacterial 
invasion/colonization (Van Immerseel, et al. 2004), was increased by supplementing the 
diet with fructo-oligosaccharide and Bifidobacterium spp. (Blay et al., 1999; Kaplan and 
Hutkins, 2000). Corrier et al. (1990) fed dietary lactose to broiler chickens in combination 
with a competitive exclusion preparation and demonstrated a significant increase in 
lactic acid, a decrease in caecal pH and a 3.5–4.0 log reduction in S. Typhimurium. The 
combined treatment also increased concentrations of acetic, propionic and butyric acids 
in the caeca of these birds. (Donalson, et al. 2008) treated chicks with a competitive 
exclusion preparation and found that concentrations of propionic acid were increased 
and that treated birds had greater protection from caecal colonization by S. 
Typhimurium. Also a contributing factor to the inhibition of pathogen growth was the 
drop in cytoplasmic pH which occurred when SCFA were present (Mani-López, García 
and López-Malo 2012). In addition, pH is another physico-chemical factor that provide 
an unfavourable for bacterial pathogens segments of the gastrointestinal tract (Beasley, 
et al. 2015).  
  Bacteriocins  
Bacteriocins are peptides or proteins that are produced by bacteria which can kill or 
inhibit the growth of other bacteria (Cleveland et al., 2001). Bacteriocins have activity 
against a number of pathogenic, Gram-negative bacteria (Mota-Meira et al., 2000; 
Arques et al., 2004) and are one of the proposed mechanisms of action of competitive 
exclusion preparations (Nurmi and Rantala, 1973; Mead, 2000; Patterson and 
Burkholder, 2003). The administration of bacteriocins isolated from L. salivarius and 
Paenibacillus polymyxa reduced Campylobacter colonization to undetectable levels in 
the caeca of broiler chickens and turkeys (Stern et al., 2005; Cole et al., 2006), whereas 
106 cfu/g of Campylobacter were detected in the caeca of control birds. 
 Cost of beneficial bacteria  
Beneficial bacteria in the gut have many advantages to the host, however, these bacteria 
need nutrients to grow and be active, which will draw from the nutrient reservoir in the 
gut. Therefore they will compete with host the on the nutrients in the gut as this bacteria 
may use these nutrients such as simple carbohydrate and mineral (Wasielewski, Alcock 
and Aktipis 2016).  (Fak and Backhed 2012) reported that a strain of Lactobacillus reuteri 
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(ATCC PTA 4659) caused a loss of weight when administrated to human. Although the 
commensal bacteria has benefit to the host by competing with pathogenic bacteria, an 
overgrowth of these bacteria can be detrimental to the host by excessive uptake of 
nutrients making them limited to the host (Zaidel and Lin 2003). The presence of the gut 
microbiota increases the cost of energy by altering the rate of energy-consuming 
reactions (Muramatsu, Nakajima and Okumura 1994). For example, the amount of 
dietary energy spent to maintain gut will increase as a result of stimulation and renewal 
of epithelial lining from pathogen attachment (Yang, IJI, and Choct 2009). Therefore, 
through a variety of mechanisms, commensal bacterial can divert nutrients from the diet 
of host as energy sources, so those nutrients are unavailable to the host for growth and 
maintenance.  
1.11  Probiotic effects on poultry  
  Probiotic effects on performance 
Overall, probiotic supplements have been shown to have inconsistent effects on 
performance in poultry. (Haghighi, et al. 2006) found that oral gavage of chicks at day 1 
with probiotics (Lactobacillus acidophilus, Bifidobacterium bifidum, and Streptococcus 
faecalis) resulted in improved IgG and IgA levels in probiotic treatments. (De Cesare, et 
al. 2017) found that using Lactobacillus acidophilus D2/CSL (CECT 4529) in the chicks the 
body weight was improved at day 15 of age.  
(Panda, et al. 2000) did not find any significant difference in the BWG of broiler chickens 
that were given feed containing probiotics L. acidophilus and Streptococcus faecium 
compared with control. (Awad, et al. 2009) found that adding supplement of probiotic 
had no effect on the body weight at day 35 along with body weight gain, meanwhile 
symbiotic supplementation affected these parameters significantly (p≤0.05). (Sarangi, 
et al. 2016) observed that using prebiotic, probiotic and synbiotic in feed of broiler 
chickens did not affect the body weight, feed intake and FCR up to day 42 of age. 
(Salehimanesh, Mohammadi and Roostaei-Ali Mehr 2016) reported that using the 
additives of prebiotic, probiotic and synbiotic in the broiler rations had not been 
significantly BW and gain.  
(Mountzouris, et al. 2010) found that using the probiotic PoultryStar ME (Biomin GmbH, 
Herzogenburg Austria) that was comprised of 5-bacterial species Lactobacillus 
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reuteri DSM 16350, Enterococcus faecium DSM 16211, Bifidobacterium animalis DSM 
16284, Pediococcus acidilactici DSM 16210 and Lactobacillus salivarius DSM 16351) in 
the diet of broiler, improved the body weight, body weight gain and feed conversion 
rate (FCR) of these broiler chickens. Also it was demonstrated that using probiotic 
supplementation of  Bactocell (Pediococcus acidilactici  109 CFU/g)  improved the body 
weight and daily weight gain and feed conversion ratio  of broiler chicks at late ages (3–
6 weeks and at the end of age 6 weeks) significantly (Alkhalf, Alhaj and Al-Homidan 
2010). (De Cesare, et al. 2017) investigated the effects of the probiotic dietary 
supplementation of Lactobacillus acidophilus D2/CSL (CECT 4529) on productive 
performance, and found that this supplementation improved the FCR of the broiler. 
Another study conducted by (Li, et al. 2014) studied the effects of Bacillus subtilis, 
Rhodopseudomonas palustris, Candida utilis and Lactobacillus acidophilus in broiler 
chickens feed on broiler growth performance. They found that this probiotic treatment 
improved the growth of broilers significantly as the body weight was bigger and FCR was 
lower at 42 days of age in the probiotic treatments.  Also broiler chickens diet inoculated 
with LactoFeed which consists of  2.5 × 1010 CFU/kg of each Lactobacillus acidophilus, 
Lactobacillus casei,  Bifidobacterium thermophilum and Enterococous 
faecium  improved the body weight and FCR at day 42 of broiler (Zarei, Lavvaf and 
Motamedi Motlagh 2018). However other studies found that there was no significant 
effects on the performance of broiler chickens. (Eckert, et al. 2010) stated that 
administering a Lactobacillus-based probiotic either by drinking water or feed improved 
the body weight significantly compared with control treatment from 15 days of age until 
48 days. Eckert et al., (2010) also reported that Lactobacillus via drinking water can 
improve the body weight and feed conversion of broiler chickens within commercial 
environments. (Mountzouris, et al. 2007) conducted an experiment of adding a mixture 
of different species of probiotic which contained 2 Lactobacillus strains, 1 
Bifidobacterium strain, 1 Enterococcus strain, and 1 Pediococcus strain in broiler diets 
for 6 weeks. They added probiotic either with feed or water which were compared with 
control (basal diet). Then they studied the effects of these treatment on performance of 
the broiler. They found that overall body weight, feed intake, and feed conversion ratio, 
were not affected by the probiotic supplement. (Olnood, et al. 2015), studied the effects 
of adding of four Lactobacillus strains (Lactobacillus johnsonii, Lactobacillus 
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crispatus, Lactobacillus salivarius and an unidentified Lactobacillus sp.). Compared with 
control on performance of broiler chickens, they found that the probiotic supplement 
had no significant effect on weight gain, feed intake and feed conversion rate (FCR) 
during the 6-week of age.   
 Probiotic effects on mucin in broiler chickens  
Mucin dynamics can also be altered by dietary supplements. Fernandez et al. (2000) fed 
broiler chickens a diet containing xylanase, which reduces C. jejuni colonization by 
decreasing the viscosity of caecal mucous, altering gut transit time and possibly by 
‘flushing’ C. jejuni from the GIT. (Forte, et al. 2018) found that using Lactobacillus 
acidophilus in the broiler chickens feed as probiotic improved the thickness of mucin of 
the ileum. (Deplancke and Gaskins 2001) stated that there is a symbiotic relationship 
between commensal bacterial colonization and the host and also these bacteria typically 
enhanced the secretion of mucus. (Smirnov, Sklan and Uni 2004) Smirnov et al. (2004) 
observed that goblet cell density was greater in the ileum and jejunum and mucin 
glycoprotein levels were lower in the duodenum of chicks fed antibiotic growth 
promoters. In the same study, use of probiotics increased the goblet cell cup in the lower 
intestines of chicks. In vitro studies utilizing L. plantarum 299v demonstrated the ability 
of probiotics to inhibit enteropathogenic organisms by inducing the expression of 
intestinal mucin genes ((Mackenzie, et al. 2010). (Tsirtsikos, et al. 2012) found that using 
probiotic (PoultryStar ME, Biomin GmbH, Austria) containing Lactobacillus reuteri, 
Lactobacillus salivarius, Enterococcus faecium, Bifidobacterium animalis 
and Pediococcus acidilactici increased the thickness of the mucus layer in the duodenum 
of broilers.  
    Probiotics and gut microbiota  
(Swiatkiewicz, Koreleski and Arczewska-Wloek 2011) studied the effect on the 
performance of diet supplementation with selected prebiotics (control (none); inulin, 70 
g/kg; oligofructose, 70 g/kg) in a 6-week experiment of broiler They found that at 21 or 
42 d of age, there was an effect of inulin or oligofructose on performance of broilers 
compared with control which has no supplements. Also (Olnood, et al. 2015), studied 
the effects of adding of four Lactobacillus strains: Lactobacillus johnsonii, Lactobacillus 
crispatus, Lactobacillus salivarius and an unidentified Lactobacillus sp. on the gut 
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microbial profile and production performance of broiler chicken. It was found that 
probiotic supplements tended to increase the number of total anaerobic bacteria in the 
ileum and caeca, and the number of LAB and lactobacilli in the caeca.  
(Dibaji, et al. 2014) investigated the efficacy of different levels (0.075%   to 0.0375%) of 
a synbiotic (Biomin Imbo, consisting of:  Enterococcus faecium and fructo-
oligosaccharides) compared with control basal diet (synbiotic free) over a  42-d feeding 
period, and then measured the microbial population in the caeca. They found that the 
addition of different levels of synbiotic increased the numbers of lactobacilli in the 
caecal contents of broiler chickens. At the same time this supplement reduced 
Escherichia coli and total coliform populations in the intestines of broiler chickens. 
(Mountzouris, et al. 2007) conducted an experiment of adding a mixture of different 
species of probiotic which contained 2 Lactobacillus strains, 1 Bifidobacterium strain, 1 
Enterococcus strain, and 1 Pediococcus strain in broiler diets for 6 weeks. They added 
probiotic either with feed or water which were compared with control (basal diet) and 
diets containing antibiotic (Avilamycin). Then they studied the effects of these additions 
on the caecal microbial ecology. Their results indicated that in the caecal microflora 
composition concentrations of bacteria belonging to Bifidobacterium spp., Lactobacillus 
spp., and Gram-positive cocci were significantly higher in probiotic treatments in water 
or feed compared with the control and antibiotic treatments. (Fukata, et al. 1999) found 
that addition of Lactobacillus to broiler chickens feed did not bring about differences in 
lactobacilli or Bifidobacterium in broiler chickens caeca at day 7 or day 21.  Hong Park, 
(2016) stated that when adding prebiotic-based Mannanoligosaccharide (MOS) the 
abundance of the Faecalibacterium genus was increased in the treatment compared 
with the control.  Faecalibacterium is also known as one of the butyrate-producing 
genera (Wang, Lilburn and Yu 2016, Egshatyan, et al. 2016, Pryde, et al. 2002). Butyrate 
has been shown to have anti-inflammatory activity (Van Immerseel, et al. 2010, Celasco, 
et al. 2014). Also Ramirez-Farias, et al. (2009) and (Wang, et al. 2017) when they used 
prebiotic and probiotic respectively. Blautia is a genus belong to the 
phylum Firmicutes which has been traditionally believed to carry genes related to 
polysaccharide metabolism which is thought to enhance the efficiency of energy 
harvesting by the host (Kasai, et al. 2015).  During this metabolism, acetate is also 
produced (Kettle, et al. 2015, Turroni, et al. 2016), Most of the bacteria within the 
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Firmicutes phylum are considered to be butyrate producers in the gut microbiota of 
broiler chickens (Varmuzova, et al. 2016b), which correlates with the health of the host 
and has been shown to improve intestinal defence and protect the host against lethal 
infection (Fukuda, et al. 2011).  
(Krumbeck, et al. 2015) found that when using a prebiotic (galactooligosaccharides) in 
humans they observed an increase in the Blautia genus. van Zanten, et al. (2014) found 
that the addition of a synbiotic to human food did not increase the abundance of Blautia, 
but actually brought about a decrease compared with the non-treated control. The 
genus Erysipelotrichaceae was decreased in the caecal content at day 42. The 
importance of these bacteria is in inflammation which is related to disorders of the 
gastrointestinal tract in humans (Chen, et al. 2012, Dinh, et al. 2015). Neveling, et al. 
(2017) added probiotic strains that were isolated from broiler chickens which consisted  
of L. crispatus, L. gallinarum,  L. johnsonii, L. salivarius, Enterococcus faecalis and  
Bacillus  amyloliquefaciens to the broiler chickens diet and found degradation decrease 
in  the abundance of this Erysipelotrichaceae genus, while Tanner, et al. (2014) found 
that using FOS in swine feed increased the abundance of Erysipelotrichaceae. 
Meanwhile at day 42 abundance of Erysipelotrichaceae was decreased in the treatments 
of supplements compared with control so it may be concluded that these supplements 
modified the gut microflora in a mildly positive manner, as this genus is used as indictor 
for inflammation (Palm, et al. 2014) and these supplements caused a degradation in this 
bacteria.  
  Probiotic efficacy and  in vitro pathogen inhibition  
(Kizerwetter-Swida and Binek 2005) isolated 16 different strains of Lactobacillus from 
the broiler chickens gut and examined them for their potentially probiotic properties to 
inhibit the growth of enteropathogenic bacteria (Salmonella Enteritidis, Escherichia coli 
and Clostridium perfringens) by using the supernatants from Lactobacillus. Their results 
demonstrated that some isolates have an in vitro antagonistic effect against 
enteropathogenic bacteria especially in controlling necrotic enteritis caused by C. 
perfringens. Shokryazdan, et al. (2014) used 9 strains of Lactobacillus isolated 
from  human milk, infant faeces, and fermented grapes and dates and examined them 
for their antimicrobial activity toward twelve pathogenic human strains 
including  Candida albicans (ATCC 44831), Enterococcus faecium (ATCC 
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51558), Staphylococcus epidermidis (ATCC 12228), Propionibacterium acnes (ATCC 
6919), E. coli (ATCC 29181), Shigella sonnei (ATCC 25931), Helicobacter pylori (ATCC 
43579),  Enterobacter cloacae, Vibrio parahaemolyticus, Listeria 
monocytogenes,  Klebsiella pneumoniae (K36) and Staphylococcus aureus (S244). They 
found that all the isolated Lactobacillus strains, except L. acidophilus HM1, exhibited 
strong inhibition on the growth of Staphylococcus epidermidis (ATCC12228), 
Enterobacter cloacae, and Listeria monocytogenes , and the three L. casei strains (BF1, 
BF2, and BF3) showed strong activities against Helicobacter pylori and good inhibition 
against Staphylococcus aureus. Moreover they found that inhibitory effects of 
the Lactobacillus strains were due to their organic acid production.  
In an attempt to colonize newly hatched chicks with a mature and healthy microbiome 
that will discourage pathogenic bacteria from colonizing, chicks have been 
experimentally inoculated with competitive exclusion culture mixtures (Nurmi and 
Rantala 1973, Nisbet 2002). Introduction of the competitive exclusion cultures has 
proven to be effective in protecting young animals from enteric pathogens and several 
reviews have been written on various aspects of this research (Callaway, et al. 2008). 
Several investigators have attempted to exploit and improve the competitive exclusion 
phenomenon by mimicking properties of efficacious bacteria, using defined cultures or 
by measuring beneficial effects within the GIT. For example, Schoeni and Doyle (1992) 
isolated caecum-colonizing bacteria that produced anti-Campylobacter metabolites 
from C. jejuni-free hens and demonstrated that these isolates could protect chicks 
against a subsequent challenge with C. jejuni.  
1.12 The immune system 
The first level of defence from exogenous pathogens that colonize host cells and tissues 
is the gastrointestinal tract, it is also the largest organ with immune properties (Surai 
2013). Modern strains of chicken and particularly broilers have developed very fast 
growth but these developments impact on health of these birds as there are negative 
relationship between body weight and immunity. For example there is a relationship 
between the acute phase of immune response and feed intake and productivity, and the 
consumption of nutrients will increase up to 10% to maintain growth and development 
(Klasing 2007a).  
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The immune function of the gut comes from different features. The most essential is the 
gut-associated lymphoid tissue (GALT). GALT includes; lymphoid aggregate located 
within lamina propria, Meckel’s diverticulum, payer’s patches and caecal tonsils. These 
structures of lymphoid tissue are distributed throughout the gut which is considered the 
intestinal arm of immunity (Peralta, et al. 2017).  
 Generation of intestinal immune response 
As gut microbiota are in close contact with cells of the gut-associated immune system,  
T- or B-cell-mediated immune responses can be modulated by the commensal bacteria 
or their structural components, either locally or systemically as a result of interactions 
between host cells and these bacteria (Macpherson, et al. 2000). Gut microbiota or its 
products, may play a role in the development of immune response. It has been found 
that the broiler chickens GALT will reach its functional maturity by week 2 of age, and 
involves cells of the immune system, such as  T and B cells, natural killer (NK) and 
macrophages 4 and 18 (Haghighi, et al. 2005). Possibly, the immune response can be 
generated in the foregut as well, though primary responses most likely start in the 
hindgut, bursal duct, bursal sac, and spleen.  
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 Mucins and gut immunity  
The intestinal epithelium has a range of mechanisms to protect the body against the 
invasion of intestinal pathogens.  The first factor is the mucin layer, which include two 
layers: an inner and outer layer. The outer layer can be colonised by microorganisms as 
this layer is loose and exposed to the bacteria that enter to the gut, while the inner layer 
prevents the bacteria from adhering to the epithelium (Hansson and Johansson 2010). 
Therefore mucus represents the first line of defence to foreign pathogenic bacteria 
(Brisbin, Gong and Sharif 2008a). Mucin is synthesized and secreted by goblet cells that 
cover the epithelium of the intestinal tract (Smirnov, et al. 2004), forming a gel that 
adheres to the mucosal surface (Forstner et al., 1995). Gastrointestinal mucin acts as the 
luminal barrier and a primary line of defence against invading pathogens (Moncada, 
Kammanadiminti and Chadee 2003). This mucous layer in the gut may prevent bacteria 
to pass to epithelial cells through mucous which is first layer that the bacteria need it in 
order to adhere to and invade, to make infection (Ribet and Cossart 2015). The mucosal 
layer of the GIT covers the epithelial surface and acts as an interface between the 
external and internal environment. Its function is as a medium for protection, lubrication 
and transport between the epithelial cells and lumen (Perry 2006).  
   Gut-associated lymphoid tissue (GALT) 
There is a correlation between functional maturity of the intestine and complete 
development of a local immune system. The induction and development of responses 
of immunity occur mainly in GALT and in the spleen as broiler chickens do not have 
lymph nodes like mammals, GALT is considered to be one of the fundamental 
immunological phenomena which including in birds the immune response or reflex to 
antigens (Klipper, Sklan and Friedman 2001).  Lymphoid follicles in caecal appendices 
are quite frequent around this area especially in caecal tonsils (Surai 2013). Meanwhile 
there are no lymphoid follicles in the colon of birds, which instead occur in the terminal 
part that opens into the cloacal bursa which is involved in primary and secondary 
immune responses, and in the bursal duct mucosa and submucosa contain many 
lymphoid follicles (Casteleyn, et al. 2010). The Bursa of Fabricius is considered to be an 
important immune organ with functions of a peripheral lymph node and is a source of 
differentiation of B-lymphocytes in the birds (Parra, Takizawa and Sunyer 2013).  
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   Cytokines  
Cytokines are the proteins produced by different cells which act as signals to regulate 
and activate cells and tissue during inflammatory and immune responses (Wigley and 
Kaiser 2003). Cytokines play an important role in the immune response, therefore 
studying cytokines will give more understanding on how probiotic and prebiotics work 
on the immunity as cytokines are considered as key for the immune response. 
Furthermore there are interactions between the cells of the gut-associated lymphoid 
tissue (GALT) which are in contact with the intestinal microbiota, known as cellular cross 
talk, the function of cytokines depends on the secreting cell. One of the important 
parameters to investigate the effects of pre- and probiotic on immunity is to measure 
the level of cytokines. (Brisbin, et al. 2010a) assumed that probiotic bacteria may be able 
to induce the production of cytokines which in turn regulate both innate and adaptive 
immune responses. Lactobacilli can induce cytokines type IL-1B, IL-10, IL-12, IL18 and 
IFN-γ (Brisbin, et al. 2010a).  
IL-10 is a cytokine that has an anti-immune and anti-inflammatory activity (Mosser and 
Zhang 2008).  The key role of this cytokine is inhibiting the production and function of 
pro-inflammatory cytokines, which in turn will regulate the inflammatory responses 
(Yamana, et al. 2004). It has a crucial role in modulating immune and inflammatory 
responses during infection with viruses, bacteria, fungi and protozoa (Couper, Blount 
and Riley 2008). (Cyktor and Turner 2011) indicated that one of the most important roles 
of IL-10 is to regulate the immunity at the site of infection when it occurs, which means 
that it will be produced in the case of inflammation or when pathogens enter.  
IL-6 is considered to be multifunctional cytokine in both pro-inflammatory and anti-
inflammatory role. It is a key cytokine in infection and inflammation and can support the 
maintenance of immune reactions (Hunter and Jones 2015). IL-6 is an inflammatory 
cytokine, which provides a protective role during a bacterial infection (Dube, et al. 2004).  
Interferon-γ (IFN-γ) is considered to be one of the pro-inflammatory cytokines (Dinarello 
2000). It has a pivotal role in host defence, it is considered as a hallmark of innate and 
adaptive immunity as is produced in response to infection (Mühl and Pfeilschifter 2003). 
Here, IFN-γ has been chosen as a marker for immune response in inflammation in an 
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early stage. (Dube, et al. 2004) stated that IFN-γ could be induced and upregulated in 
the case of inflammation. (P. Kaiser, et al. 2000) found that the level of IFN-γ was 
increased in the broiler chickens tissues that were infected with Escherichia coli or 
strains of Salmonella compared with uninfected tissue. Firstly, the treatments may have 
had a direct biochemical effect on the immune system, or the treatments may have 
indirectly affected the gastrointestinal immune system by modulating the intestinal 
tract microbiome, which in turn produced metabolites that biochemically altered the 
immune system. The most likely of these two mechanisms is that IFN-γ has been induced 
in control and upregulated compared with treatments.  
(Haghighi, et al. 2008) used treatments of Salmonella serovar Typhimurium only and 
Salmonella with a probiotic mixture of Lactobacillus acidophilus, Bifidobacterium 
bifidum, and Streptococcus faecalis, and found that the level of IFN-γ in the caeca of 
broiler chickens was increased in the first treatment, while in the treatment of 
Salmonella with probiotic the level of this interferon was decreased. (Huang, et al. 2015) 
observed that when they added the prebiotic inulin to the diet of the broiler, they found 
that there was a decrease in the level of IFN-γ and IL-6 at day 21 but there was no effect 
at day 42. These findings also agree with the findings reported by (Janardhana, et al. 
2009), who found that there was no difference between control and treatments when 
they added a prebiotic (fructo-oligosaccharide) to broiler chickens feed. Also, (Brisbin, 
et al. 2010b) found that Lactobacillus reuteri and Lactobacillus salivarius did not induce 
the production of IFN-γ and IL-10 in the caecal tonsil cells of broiler chickens.  
(Y. Shang, et al. 2015) found that adding prebiotic (Fructooligosaccharide) to the broiler 
chickens feed did not induce IL-10 in the ileum tissue compared with control. 
Meanwhile, these findings do not agree with findings of (Yitbarek, et al. 2015)  when 
they used a synbiotic in broiler chickens feed, as they found that IFN-γ was upregulated 
in the synbiotic treatments compared with control.  (Kareem, et al. 2017) examined the 
effects of different combinations of inulin and postbiotics (secretions of probiotic) on 
ileum cytokine expression in the broiler chickens, and found that IFN-γ was upregulated 
by the addition of the treatments, and IL-6 was downregulated in the tissue of ileum of 
the broiler. The administration of pre, pro or synbiotics decreased the inflammation, 
damaged the tissue of the colon, and induced the secretion of IL-10 in this tissue as well, 
and downregulated the production of IFN-γ (Foye, et al. 2012).   
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1.13  Methods of probiotic manufacture and delivery  
For beneficial activities of probiotic supplementation, there needs to be an appropriate 
amount of probiotic bacteria which should be alive and remain functional at the site of 
action (Cook, et al. 2012). It has been stated that a large loss of viability occurs when 
orally administered bacteria passage through the stomach, because of high acid and 
presence of bile salt. The loss in viability will lower the efficacy of the supplement (Cook, 
et al. 2012). It has been shown that Bifidobacteria are sensitive with low survival to 
stresses occurring during production, storage and consumption of these 
microorganisms. (Doleyres and Lacroix 2005) recommend that probiotics should be 
present at a minimum level of 6 log colony forming units (CFU)/g in a food product or 7 
log CFU/g at the point of delivery (Doleyres and Lacroix 2005, J. Kim, et al. 2016). 
There are several factors that can negatively affect the viability of probiotic bacteria 
during manufacture and/or storage, for example temperature, water activity and other 
food ingredients. However the main reason for reduced viability is the high temperature 
during manufacturing processes, this is because of most probiotics have low thermo-
resistance (Vesterlund, Salminen and Salminen 2012). Hence, an ideal delivery system is 
needed which can protect probiotic bacteria from adverse conditions during production 
and storage and in the acidic gastric environment, that finally make sufficient amount of 
probiotics available at the site of action (J. Kim, et al. 2016). In terms of delivery, there 
are several different ways of supplying probiotics to broiler chickens such as, mist 
spraying, via feed, oral gavage, application to vent lip, and via drinking water  (Olnood, 
et al. 2015) and even delivering probiotic by injection of  the egg at the end of incubation 
(de Oliveira, et al. 2014) and spraying the  litter that broiler chickens reared on (Olnood, 
et al. 2015).   
1.14  Prebiotic supplements 
Prebiotic materials were defined by (Gibson and Roberfroid 1995), as “a non-digestible 
food ingredient that beneficially affects the host by selectively stimulating the growth 
and/or activity of one or a limited number of bacteria in the colon and thus improves 
health.” This definition was modified to include the requirements for resistance to the 
acidic gastric environment, gastrointestinal absorption, gastric enzymes, and 
fermentation by the gastrointestinal microbiota meanwhile stimulate the growth of 
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beneficial bacteria in the intestine (Roberfroid 2007). Another definition of prebiotic is 
a ‘’selectively fermented food ingredient that beneficially affects the host by a selective 
stimulation of the growth and/or activity of one or a limited number of bacteria in the 
colon and is not digested by the host digestive enzymes’’ (Gibson, et al. 2004). As 
prebiotics are indigestible by the upper gastrointestinal tract (GIT) they enter the lower 
GIT where they are considered as a substrate for health-promoting bacteria, such as 
Bifidobacteria and Lactobacilli, thus modulating the microbiota in the gut (Gibson and 
Roberfroid 1995). Oligosaccharides are the main nutritional source, which is reflected in 
their residence in ecological niches rich in carbohydrate-containing substrates, most 
commonly plant material, spoiled or fermented foodstuffs, and mucosal membranes of 
humans and animals (Walter 2008). 
1.15 Prebiotic effects in poultry and other animals 
 Effects on intestinal microbiota 
Prebiotics have been studied using different substances to investigate the effects on the 
gut microbiota. (Konosonoka, et al. 2015) carried out a study to investigate the effects 
of a combination of the dried Jerusalem artichoke as a prebiotic alongside probiotic 
bacteria (1 × 10^8 cfu-g-1 Lactobacillus reuteri   1 × 10^8 cfu·g-1 )  fed to  broiler chicks 
from 1 to 42 days old on the presence of bacteria of the family Enterobacteriaceae and 
lactic bacteria in the ileum part of intestinal tract. Their results established that 
supplementation of the broiler basic feed with 0.5 % dry powder prebiotic in 
combination with probiotics improved the level of the favourable lactic acid bacteria in 
the ileum part of the intestinal tract. (Nabizadeh 2012) conducted an experiment of 3 
levels treatments of inulin (0%, 0.5%, or 1%) for 42 days on broiler chicken to evaluate 
the effectiveness of this prebiotic supplement on the intestinal microbiota of broiler 
chickens compared with the control group and found that Inulin inclusion had no effect 
on Bifidobacteria, Lactobacilli and E. coli counts in ileal contents, but these supplements 
significantly increased Bifidobacteria counts and decreased E. coli counts in caecal 
contents. Also, Shang and colleagues (2010), found adding inulin to layer hen feed, did 
not affect lactobacilli but Bifidobacterium numbers increased.  Samal et al., (2016) found 
that adding 6% of JA powder into rat feed similarly found improved total count of 
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Bifidobacterium in the caecum. Rebole et al., (2010) also found that adding inulin to the 
laying hens’ diet led to an increase in Bifidobacterium in the caecal content. 
 Effects of prebiotics on poultry performance   
(Konosonoka, et al. 2015) carried out a study to investigate the effects of a combination 
of the dried Jerusalem artichoke as a prebiotic and probiotic bacteria (1 × 10^8 cfu-g-1 
Lactobacillus reuteri 1 × 10^8 cfu·g-1) fed to broiler chicks from 1 to 42 days old on the 
productivity of broilers and feed conversion. Their results established that 
supplementation of the broiler basic feed with 0.5 % dry powder prebiotics in 
combination with probiotics increased the live weight of the broiler chicks by 2.1 %, the 
feed consumption for obtaining 1 kg of live weight decreased by 3.2 %, the cholesterol 
level in the meat of broiler chicks was reduced by 22.7 mg·(100 g)-1, moreover,  the 
quality of the meat was improved by the synbiotic supplements in comparison with the 
control group. (Nabizadeh 2012) conducted an experiment of 3 levels treatments of 
inulin (0%, 0.5%, or 1%) for 42 days on broiler chicken to evaluate the effectiveness of 
this prebiotic supplement on the performance of broiler chickens. Their results showed 
that live body weight on day 42 was significantly increased when the diets were 
supplemented with 1% inulin. However liveability, body weight gain, feed intake and 
feed conversion ratio were not significantly affected in birds fed diets with supplements 
in comparison with the control group.  
1.16 Prebiotic, probiotic and synbiotic use in poultry 
Researchers have indicated that use of JA in broiler chickens diet has a beneficial effect 
on growth performance and suppresses potential pathogens in caeca of broilers. 
(Kleessen, et al. 2003) evaluated the effect of the fructan-rich Jerusalem artichoke, or 
topinambur (administered as 0.5% topinambur syrup in drinking water), on cultural 
numbers of selected caecal bacteria (total aerobes, Enterobacteriaceae, Bdellovibrio 
spp., and Clostridium perfringens) and levels of bacterial endotoxins as well as on body 
weights of broiler chickens for 35 days.  They found that administration of JA resulted a 
significant increase in caecal counts of B. bacteriovorus and reduced the level of total 
aerobes, Enterobacteriaceae, and C. perfringens significantly. Also they observed that 
on day 35 of the trial period the body weight was increased in the JA treated birds.  
(Abdel-Hafeez, et al. 2017) conducted a broiler chickens trial to investigate the effects 
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of probiotic, prebiotic and synbiotic on broiler performance, blood parameters, carcass 
characteristics, and feed cost of production from 1 to 56 days of age.  Group 1 were fed 
on a control diet while the other groups were given the same control diet supplemented 
either with a probiotic (Enhancer, USA, Bacillus licheniformis and Bacillus subtilis) with 
1.0, 0.5, and 0.25 kg of prebiotic (Bio-Mos, USA, mannan-oligosaccharides (MOS) 
derived from the cell wall of certain strains of Saccharomyces cerevisiae) group 2, 
synbiotic (half the amounts of the used probiotic and prebiotic) group 3. They found that 
chicks fed diets supplemented with probiotic, prebiotic and synbiotic exhibited higher 
body weight and feed efficiency than chicks fed the control diets. The lowest feed cost 
per kg of weight gain was observed in the birds fed diets supplemented with synbiotic, 
probiotic and prebiotic. (Saiyed, et al. 2015) and his colleagues stated that feeding 
supplement of synbiotic has a beneficial effect over probiotic and prebiotic when used 
alone. They added prebiotic, probiotic and synbiotic in the broiler diet compared with  
control, probiotic (of Lactobacillus acidophilus, Lactobacillus casei, Pediococcus 
acidilactici, Bacillus subtilis and Saccharomyces boulardii) in the feed  100 g/tonne of 
feed, prebiotic (of Mannan Oligo-Saccharide in which Mannan and Glucan were 
included) in the feed  at 500 g/tonne of feed, probiotic + prebiotic 100 g/tonne and 500 
g/tonne of feed, respectively and probiotic + prebiotic  50 g/tonne and 250 g/tonne of 
feed. They found that body weight gain was not affected by the supplements 
significantly but the feed intake was decreased in the synbiotic treatment significantly, 
meanwhile European performance efficiency factor (EPEF) was improved at all 
treatments. 
1.17 Synbiotic  
  A synbiotic can be defined as nutritional supplement comprising the mixture of both 
prebiotic and probiotic ingredients. When synbiotic supplements are consumed, the 
prebiotics and probiotics may work synergistically in the gut, thereby may give the 
benefits of both (de Vrese and Schrezenmeir 2008) . One of the purposes of using a 
synbiotic is to overcome possible survival difficulties for probiotics bacteria. Therefore 
the rationale to use synbiotics, may be based on observations showing the improvement 
of survivability of the probiotic bacteria during the passage through the upper intestinal 
tract (Pandey, Naik and Vakil 2015). In a human study it was claimed that using a 
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synbiotic has some benefits:  1) Increase the levels of lactobacilli and bifidobacteria, 2) 
Improve the function of liver, 3) Improve the ability of immunomodulation (Zhang, et al. 
2009). 
 Inulin  
(Slavin 2013a)Inulin is one of the most effective and most commonly used prebiotics 
(Slavin 2013). It is a storage carbohydrate in many plants. It is widely distributed in a 
variety of plants being present in more than 30,000 vegetable products (Wichienchot, 
et al. 2011). It occurs in fruits and vegetables, for example chicory, Jerusalem artichoke, 
globe artichoke, onion, leek, garlic, asparagus, bananas and in the stem of some cereals, 
such as wheat, oats, soybeans, rye and barley (Slavin 2013b, Mensink, et al. 2015). 
However, the main sources that are used commercially to extract inulin are usually roots 
of chicory (Cichorium intybus) and tubers of Jerusalem artichoke (Helianthus tuberosus) 
(Kaur and Gupta 2002). Where the industry processes of extraction are similar 
(Apolinário, et al. 2014). The chemical inulin is not simply one molecule but it is a 
polydisperse β (2-1) fructan. The chain lengths of these fructans range from 2–60 units, 
with an average DP of ~10 (Mensink, et al. 2015). Inulin has a specific structure which is 
the presence of the β-glycosidic bond, with the degree of polymerization (DP) has the 
range between 2 to 60 (van de Wiele, et al. 2007). Which make it unable to be 
hydrolysed by the digestive enzymes in the upper gastrointestinal tract of humans and 
non-ruminant animals like poultry (Buclaw 2016). Unchanged, the prebiotic reaches the 
large intestine, where it undergoes fermentation and becomes a substrate for some 
strains of healthy bacteria (Miremadi and Shah 2012).  
 Jerusalem artichoke as a readily available source of prebiotic in 
Iraq 
Jerusalem artichoke (Helianthus tuberoses) is a member of Asteraceae family which is 
native to North America (Žaldarienė, Jurgita and Judita 2013). Jerusalem artichoke can 
be grown in different climate conditions, therefore it is cultivated in North America, 
Europe and Southeast Asia (Puangbut, et al. 2012). All parts of the Jerusalem artichoke 
plant are used for different applications as well as a food, such as using plant-tops for 
biomass and animal feed, whilst the tubers can be use as non-food chemical production 
(Stanly et al., 2008). The majority carbohydrate storage plant is as starch whereas in 
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contrast in Jerusalem artichoke carbohydrate is stored as inulin (Stanly et al., 2008).  In 
the industrial production of inulin chicory is used as the major crop (Abou-Arab, Talaat 
and Abu-Salem 2011). However, the Jerusalem artichoke (JA) tuber has a large amount 
of inulin approximately 14–19 % (Lingyun, et al. 2007, Saengkanuk, et al. 2011), so it 
should be a valuable source for inulin production. Also JA is preferable to chicory 
especially in Iraq as it more widely available and lees expensive. Inulin that is produced 
from the Jerusalem artichoke tuber has an undesirable flavour and a significant colour 
which has traditionally made industry neglect JA for inulin production (Srinameb, et al. 
2015). Therefore it became in less demand for human which in turn means it can be 
used as a cheap substance in animal. Also JA is available in Iraq with low cost during 
winter from October until April.  
There are different important nutrients found in artichoke in addition to inulin, such as 
protein, iron, calcium and potassium (Stanley et al., 2008). Gafaar et al., (2010) found 
that Jerusalem artichoke tubers have 7.55% crude protein, 5.72% ash 6.51% crude fibre 
and 72.99% inulin. In another study on the chemical composition of Jerusalem artichoke 
by Nadir et al.,(2011) they found that the dry matter of artichoke consisted of 5.47% 
protein, 6.64% ash , 5.88% crude fibre and 77.7% inulin.  Whereas, El-Hofi (2005) argued 
that the dry basis of the tubers of Jerusalem contained 73.50 % inulin, 8.26% crude 
portion, 5.92% crude fibre 6.82 and ash. In a study on the Iraqi Jerusalem artichoke 
Alsharafani (2006) found that Iraqi Jerusalem artichoke contains 76.52 % moisture, 
0.40% fat, 6.06% protein, 2.24% ash and 9.60% inulin. As JA powder contains inulin 
therefore it can be used as a nutrient source for beneficial bacteria such as Lactobacillus 
and Bifidobacterium. Both (Kunová, et al. 2011, Nagpal and Kaur 2011) stated that some 
lactic acid bacteria are able to use inulin as source of carbon in the media. In addition JA 
as a raw plant contains other nutrients such as minerals (Lachman 2008) which in turn 
may be considered beneficial for lactic acid bacteria.  
1.18  Campylobacter as a target pathogen in poultry production  
Campylobacterosis is an acute gastro-enteric disease in humans significant worldwide 
through its impact on public health (Bless, et al. 2016). It commonly appears that the 
intestinal environment of all avian species (including wild birds) is favoured by this 
bacteria (Newell and Fearnley, 2003). However the poultry products are implicated as 
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the main source of infection in humans: 97% of recorded Campylobacterosis cases in 
humans are through this route (Wilson et al., 2008). It has been reported that only thirty 
five colony-forming units (cfu) which need 24 h after entering the broiler chickens gut 
to be sufficient for the successful establishment of Campylobacter infection (Mohan 
2015).  Regarding the initial age for Campylobacter colonization of the chick GIT, there 
is a wide discrepancy between reported studies. (Potturi-Venkata, et al. 2007) concludes 
it is not detectable before 10 days post-hatch, while Newell (2002) claims that this 
organism can be detected at 2-3 weeks post hatch. Nevertheless, there is consensus that 
Campylobacter can spread among birds within a flock quickly. Consequently a flock with 
Campylobacter established in some birds will reach up to 100% positive within a few 
days and they remain so until slaughter (Stern 2008). For these reasons, it is difficult to 
control Campylobacter presence during processing of poultry meat (Potturi-Venkata, et 
al. 2007).  
Many strategies are currently being used to control or even to reduce the amount of 
this bacteria in the poultry products but contamination of meat remains a problem (FSA, 
2015). One approach is the use of probiotic bacteria to increase the ability of the 
microbiota in maintaining health of the GIT via the mechanisms described earlier, in 
particular the capacity of certain strains to compete with Campylobacter for the 
intestinal adhesion sites required for colonisation (Santini, et al. 2010). (Kleessen, et al. 
2003) concluded control of intestinal pathogens during the earliest phases of broiler 
production may be the best strategy for the reduction of human pathogens on 
processed broiler carcasses. The recent ban on antibiotics in poultry feed has served to 
focus much attention on alternative methods of controlling the gastrointestinal 
microbiota. 
1.19 Aims and objectives 
The overall aim of this study was to evaluate new isolates of Lactobacillus as 
probiotic feed supplements for poultry both when fed alone and with Jerusalem 
artichoke plant as an affordable source of prebiotic. The objectives set out to meet this 
aim were: 
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1. Optimisation of Lactobacillus johnsonii delivery to poultry and evaluation of its 
effects on the inhibition of Campylobacter, immune function and performance 
of meat chicken. 
2. Isolation and in vitro evaluation of new strains of Lactobacillus from free range 
poultry as probiotic agents 
3. In vivo evaluation of new strains of Lactobacillus from free range poultry as 
probiotic agents in meat poultry 
4. Investigation into the effects of Jerusalem artichoke as prebiotic agents in meat 
poultry when fed alone and in combination with a probiotic supplement. 
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2 Material and Methods 
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2.1    Introduction  
This chapter provides an overview of the studies undertaken and how they correspond 
to subsequent thesis chapters with a detailed account of the generic materials and 
methods employed. Five studies were conducted in all (shown in table 2.1), including a 
pilot screening of naturally occurring Campylobacter levels in the local area, two 
investigations into a novel strain of Lactobacillus johnsonii and a major study into the 
efficacy of a newly developed mix of Lactobacillus (LB) isolates with Jerusalem artichoke. 
Study 1 assessed natural occurrence levels of Campylobacter in free range and research-
housed poultry. Study 2 determined the optimum method of administering LB to chicks 
in the pre-starter period (up to d5) on the colonisation of the intestinal tract with the 
LB.  Study 3 utilised the most efficacious method to deliver LB and monitored the level 
of Campylobacter colonisation in birds fed LB for 7 days compared with a control group 
without probiotic over a 28 day trial period. Study 4 involved isolation and screening of 
candidate probiotic isolates of lactic acid bacteria and prebiotic (Artichoke Jerusalem) 
and efficacy assessment in vitro.  Study 5 investigated the in vivo efficacy of the 
candidate probiotic isolates of lactic acid bacteria when fed alone and in combination 
with Jerusalem artichoke.  
Table 2:1 Description of individual studies conducted 
Study Areas investigated Chapter 
Study 1 
Natural occurrence levels of Campylobacter in free range 
and research-housed poultry 
3 
Study 2 
(Coded  bird 
trial LB01) 
Effect of differing methods of administering Lactobacillus 
to chicks in the pre-starter period (up to d5) on the 
colonisation of the intestinal tract with the LB. 
4 
Study 3 
(Coded  bird 
trial LB02) 
Level of Campylobacter colonisation in birds fed LB for 7 
days compared with a control group without probiotic 
over a 28 day trial period. 
4 
Study 4 
 
Isolation and characterisation  of candidate probiotic 
isolates of lactic acid bacteria and efficacy assessment in 
vitro 
5 
Study 5 
(Coded bird 
trial LB03) 
Investigation the in vivo efficacy of the candidate probiotic 
isolates of lactic acid bacteria when fed alone and in 
combination with Jerusalem artichoke. 
 
6, 7 and 
8 
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2.2 Excreta sample collection     
Screening for the presence of Campylobacter was carried out on excreta samples. Fresh 
excreta samples with normal appearance were collected into sterile universal tubes 
using a sterile spatula. Samples from outside the house were collected in the morning 
to avoid sunlight degradation. During the research trials samples were collected from 
different pens in triplicate. These samples were immediately placed in an ice box then 
transferred directly to the microbiology laboratory for preparation and screening. 
Additionally, fresh excreta from bird vent were collected in swab tubes before 
transporting on ice to the culture labs.   
2.3 Bird sample collection     
Caecal samples were collected post mortem by placing excised caeca in bags and 
transporting to the culture labs on ice, where the caeca were opened and samples 
collected using a charcoal swab.  
2.4 Culturing Campylobacter  
One gram of excreta was weighed into 9ml of phosphate buffered saline (PBS) then 
homogenised well by vortexing  (Stuart, UK) before serial dilutions down to 10^-5 in PBS 
were prepared from the sample. 100µl of these dilutions were cultured on CCDA agar 
(Oxiod, UK) and incubated at 37°C in a microaerobic cabinet (Don Whitley DG250 
Anaerobic Workstation, UK) with the following microaerobic atmosphere; 5% O2, 10% 
CO2 and 85% N2 for 48 hours. After the 48 hour incubation, growth of Campylobacter 
was assessed by enumeration of the small grey colonies on each plate.  
2.5 Birds and Husbandry  
Institutional and national guidelines for the care and use of animals (Animal Scientific 
Procedures Act, 1986) were followed and all experimental procedures involving animals 
were approved by the School of Animal, Rural and Environmental Sciences Ethical 
Review Group. For all trials, birds were sourced from PD Hook Cote hatchery, Oxford, 
and birds were feather sexed on day of hatch and collected by NTU personnel to reduce 
travel stress. On commencement of each trial, one day old male Ross 308 chicks were 
weighed individually to ensure uniformity of size across and within pens, before random 
allocation to mesh sided pens bedded on wood shavings. The chicks were housed in 
preheated 0.64m2 pens in a purpose built, insulated poultry house. The birds were 
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bedded on clean wood shavings (to a depth of approximately 3cm) and fresh shavings 
were added into the pens as required. Birds were always allowed ad libitum access to 
the treatment diets and water for the duration of the trial.  With care taken to ensure 
the birds ate and drank as soon as possible. The lighting regimen was as detailed in 
appendix I, up to Day 6 post hatch, and then a 6hr: 18hr ratio of dark: light was 
maintained for the rest of the study period, in accordance with commercial practice. 
Temperature was set at 31°C on day 1 and reduced by approximately 1°C per day until 
21°C was reached. Temperatures were recorded daily from both ends of the unit, health 
checks made twice daily and heating and ventilation adjusted depending on bird 
behaviour. Fan speed was adjusted to maintain room temperature and humidity. 
Unhealthy or unusually sized chicks were discarded from the trial on arrival. Birds were 
individually weighed and only birds between 38 and 46 g were placed. Chicks were 
weighed by pen on Day 1 and allocated to a dietary treatment on arrival. Commercial 
guidelines for the care and husbandry of Ross 308 broilers were followed in all studies 
(Aviagen, 2014). Any mortalities were recorded along with the date and weight of the 
bird and reason if culled.  All birds sampled were euthanized by cervical dislocation as 
advised in Welfare of Animals at the Time of Killing (WATOK) regulations (DEFRA, 2015).  
2.6  Diet Formulation 
All trial diets were manufactured on site and fed as mash. The particle size of each diet 
was uniform, consistent and typical for broiler diets milled through a 3mm screen. The 
composition and analysis of all the trial diets are provided in the corresponding chapter. 
When making the diets, each ingredient was individually weighed out and mixed dry for 
five minutes in a ribbon mixer (Rigal Bennett, Goole, UK) before addition of oil. The diets 
were then mixed for a further five minutes. Where probiotic supplements were added 
to the diet, this was undertaken as an additional, final step. For each diet manufacture 
day, diets without probiotic were manufactured first, and the mixer was cleaned with 
alcohol and left unused for 5 days before being used for any diet not due to contain a 
probiotic supplement. The mixer was brushed down at various stages throughout the 
mixing process to ensure oil clumps were removed. In all studies, diets were randomly 
allocated to pens within the room, to eliminate any effect of room position. 
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2.7 Feed Intake measurement 
Initially, individual weighed bags of feed were prepared containing precisely weighed 
feed quantities for each treatment. Each pen of birds were fed from their designated 
bag throughout the trials. Extra feed was added to the bags if required and the quantity 
recorded. Uneaten food remaining in the troughs on weigh days was tipped back into 
the labelled feed bag for each pen, taking care to remove droppings and shavings where 
necessary. Total feed eaten was calculated as the difference between remaining feed in 
the bag the amount weighed into the bag. Spillages of feed was not easy to account for 
spillages were mixed with the droppings and shavings, but spillages were recovered 
from the floor and added to the remaining feed total – acknowledging that this measure  
may contribute to inaccurate measurement of feed intake.   
2.8 Bird Weights 
For all bird trials, chicks were weighed on arrival, and any outside the range of 38-45g 
were not included in the trial. Birds were distributed into pens based on average weight 
per pen, ensuring there were no significant differences in starting pen weight between 
dietary treatments. Birds were weighed using a top pan balance (Mettler Toledo, 
Leicester, UK) on days specified in each trial protocol (see relevant chapters for details). 
2.9 Body Weight Gain 
The body weight gain was calculated by the difference between each two periods 
(weeks).  
2.10 Diet chemical analyses   
 Crude Protein Determination 
Protein content of each diet was analysed using the Kjeldahl method (AOAC official 
method 2001.11) (Peter and Baker 2001, Tahir, et al. 2012). Approximately 1 gram of 
sample was weighed into distillation tubes (Foss Cat No. 10000155) in duplicate. Both a 
copper and selenium catalyst tablet (Fisher Scientific, UK) was added to each tube. 12.5 
ml of concentrated nitrogen-free sulphuric acid was then added to each tube, and they 
were heated in a digestion unit (1007 Digester, Foss Tecator, UK) set at 450°C for 45 
minutes. Once digestion was complete, the distillation tubes were left to cool for a 
minimum of 20 minutes and 75ml of distilled water was added to each tube.  The tubes 
were then distilled in a distillation unit (2100 Kjeltec, Foss Tecator, Cheshire, UK) then 
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50ml of 10M sodium hydroxide was added to the samples, distilled for 3 minutes, the 
resulting ammonia was expelled into conical flasks containing 2ml 4% boric acid with 
indicator, causing a colour change from orange to blue. The boric acid was then titrated 
back to the original colour using 0.1M HCl in a burette and the volume of acid used was 
recorded. Starch was used as a blank.  % nitrogen was calculated by:  
1.4 x (V1-V2) x M / W  
where: 
W= Original weight of sample  
V1= Volume of acid to titrate sample  
V2= Volume of acid to titrate blank  
M=Molarity of acid  
Protein content was calculated by nitrogen content x 6.25 (standard multiplier). 
 Extractable Fat Analysis 
Samples of diets were analysed for extractable fat content by the Soxhlet method (AOAC 
official method 2003.05). Approximately 5g of sample was accurately weighed into an 
extraction thimble. A flat bottomed flask containing approximately 0.25g of anti-
bumping granules was accurately weighed. Petroleum ether (150ml) was added to the 
flask. The thimble was inserted into the bottom of the distillation unit, the distillation 
apparatus was connected to the condenser and the flask was attached to the apparatus 
and seated in the heating mantle (set to 40-60°C). The samples were left to extract for 
approximately 18 hours, then the remaining ether was boiled off on a hotplate and left 
to evaporate. The flasks were reweighed and extractable fat content was calculated by: 
(M2-M1 / M0) x 100 = % extractable fat 
Where: 
M0=Original weight of sample  
M1= Weight of flask plus anti-bumping granules  
M2=Weight of flask plus fat and anti-bumping granules 
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 Dry Matter Analysis 
Dry matter content of the diet and excreta was analysed by weighing approximately 5-
10g of finely ground sample into pre-weighed crucibles. The crucibles were then dried 
in a drying oven set at 105°C for approximately 4 days, until the weight was constant. 
The dried samples were then cooled in a desiccator and reweighed. 
  Mineral Analysis 
Mineral content of each diet was analysed by accurately weighing approximately 2-5g 
of sample, into a pre-weighed ceramic crucible. The crucibles were then placed in a 
muffle furnace (Nabertherm, B180) for approximately 14 hours at 650°C. The ashed 
samples were then cooled in a desiccator and reweighed.  
 Gross energy analysis 
Gross energy of the feed and excreta was measured using a bomb calorimeter 
(Instrument 1261, Parr Instruments, Illinois, USA) according to the  (Rutherfurd, Chung 
and Moughan 2007, Woyengo, Kiarie and Nyachoti 2010). Pellets of feed sample, 
weighing approximately 1g, were made by adding a small amount of water to the sample 
before pelleting it with a pellet press (Parr Instruments, USA). The pellets were dried 
overnight in a drying oven at 105°C, before being weighed into tin crucibles (Sartorius 
CP1245) and placed in the calorimeter. The bucket in the bomb jacket was filled with 2 
litres of water. Fuse wire (10cm) was threaded through the hole, ensuring the wire 
touched the pellet. The bomb was then assembled, ensuring the top was tightly screwed 
on, and then filled with oxygen. Once filled, the bomb was put into the bucket of water, 
the electrodes were pushed into the calorimeter, and the lid of the bomb jacket was 
shut. Sample weight was entered and the process was started; the calorimeter 
measured energy produced (MJ/kg) when the pellet is combusted. 
2.11   Mucin adherent layer thickness   
A section of gastrointestinal tract was analysed for mucin adherent layer thickness by 
the method used by (Smirnov, et al. 2004). A 1cm section of jejunum was gently flushed 
with distilled water and then placed in 10g/l Alcian blue (in 160mmol/l sucrose with 
50mmol sodium acetate) for 2 hours. The tissue was then washed in 250mmol/l sucrose 
to remove excess dye. Bound dye was extracted using 10g/l docusate sodium salt 
overnight at room temperature. The supernatant was then centrifuged at 700 x g for 10 
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minutes to remove particulate matter and the absorbance read at 620nm (JENWAY, 
7315 Spectrophotometer, Bibby Scientific Ltd, UK) against a curve of diluted Alcian blue. 
Results are expressed as µg Alcian blue released per cm2 tissue. Two replicate gut 
samples were analysed per pen from the each bird. 
2.12    Immunoglobulin measurement  
Immunoglobulins A, M and G were analysed in pooled plasma using ELISA kits specific 
for chicken plasma from Bethyl laboratories. Plates were coated with antibody specific 
for the immunoglobulin to be measured and then blocked overnight and washed before 
diluted samples then these samples were added to the plate and incubated for one hour. 
HRP conjugated detection antibody was added at an appropriate dilution for an hour 
before adding a colour reagent 3,3’,5,5’-tetramethylbenzidine (TMB) for 15 minutes in 
the dark, or until colour was sufficiently developed.  The absorbance was read on a plate 
reader at 450nm using a Multiskan plate reader with standard curve values programmed 
using a 4PL curve fit.  QC samples were run to calculate inter assay coefficients of 
variation (CoV), and all samples were run in duplicate and sample variation used to 
calculate intra assay CoV. 
 Serum uric acid measurement  
Uric acid content was measured in pooled plasma using an Amplex Red kit (Invitrogen). 
5µl of plasma was pipetted into a 96 well plate and the volume of each well made up to 
50ul with reaction buffer. A set of uric acid standards from 120 to 10µM were prepared 
and pipetted onto each plate. The reaction was started by the addition of a reaction 
mixture containing 50µl of each of Amplex red reagent, uricase and horseradish 
peroxidase.  The plates were then incubated at 37oC for 30 minutes protected from light 
before measurement on a plate reader at 560nm. Unknowns (sample) were calculated 
using the standard curve and expressed as mg/dL. 
2.13 Isolation and screening of candidate probiotic bacterial isolates and 
prebiotic (Jerusalem artichoke) and efficacy assessment in vitro  
 Screening and isolation of lactic acid bacteria       
Excreta samples were serially diluted down to 10^-10. These dilutions were cultured on 
de Mann Rogosa Sharpe (MRS) agar (Oxoid) then incubated for 48 hours at 37°C in a 
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microaerobic atmosphere. After checking for any contamination (clear growth), colonies 
of interest were selected from each of the highest dilution 10^-8 plates then sub-
cultured again on the same media and same conditions to obtain pure cultures. These 
pure cultures were then further tested as described below. Finally six isolates were 
chosen for further study. 
 Morphological and biochemical tests on the isolates  
2.13.2.1 Preparing a standard inoculum of isolates  
Aliquots of MRS (10ml) broth were inoculated with one colony of each chosen LAB 
isolate, and incubated at 37°C microaerobically for 24 hours. Cells of isolates were 
pelleted at 5000 rpm for 20 minutes (Megafuge 16R, Thermos-scientific, Germany), then 
washed twice with 10 ml PBS and re-suspended in PBS again.  The number of viable cells 
was counted by a viable count and the suspension was diluted to 10^-6 using the 
absorbance (Optical Density - OD) as an indicator.  
2.13.2.2 Stock culture of LAB isolates  
Stocks of each individual isolate were prepared by growing the pure cultures that were 
obtained from section 2.13.2.1 on MRS broth for 24 hours, then the broth was 
centrifuged(10000rpm/10mints) to obtain a pellet and thereby concentrate the 
bacterial cells.  A stock was made from the concentrated cells and mixed with glycerol 
at a ratio of 70:30 broth: glycerol in 1ml cryo-vials and stored at -80°C.          
2.13.2.3 Gram staining  
Gram stain was used to determine the Gram status of the isolates. Isolated cultures were 
grown in MRS agar at 37°C for 24 hours to obtain fresh cultures for Gram staining. One 
colony was selected for Gram staining by using the procedure described below (M. L. 
Kaplan and Kaplan 1933, Bartholomew and Mittwer 1952). 
A 0.2µl loop was used to mix a small amount of the colony with sterile water on a 
microscope slide. The slide was then dried. Colonies were fixed by exposure to a flame 
3-4 times for about 5 seconds. Crystal violet was used for staining for 1 minute, then the 
slide was washed with tap water. Gram’s iodine was applied to the slide for 1 minute, 
the slide was then washed with tap water and acetone/ alcohol applied to decolorise for 
5-10 seconds. The counterstain, safranin, was applied for 30 seconds and washed with 
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tap water. Finally, the slide was dried and light microscopy used to determine if the 
isolates were potential LAB which are known to be Gram positive.  
2.13.2.4 Catalase test    
Catalase enzyme activity on hydrogen peroxide was used as a diagnostic tool to assess 
presence or absence of the enzyme: the formation of gas bubbles (as catalase breaks 
down hydrogen peroxide into water and oxygen) were deemed to indicate the presence 
of the catalase enzyme. As Lactic Acid Bacteria (LAB) catalase negative, presence of 
bubbles indicated isolates were not LAB. Overnight cultures of each single isolate were 
grown on MRS agar at 37°C under microaerobic conditions. Catalase activity was 
investigated by 3% hydrogen peroxide solution (one drop) onto a randomly chosen 
colony. The test was deemed positive if bubbles were observed within 5-10 seconds and 
negative if not.  
2.13.2.5 Production of acids (pH assessment)  
Each LAB isolate was grown in 10 ml of MRS broth after being inoculated with one colony 
of each of the isolates then incubated at 37°C under microaerobic conditions for 24 
hours. The pH of the broth was measured by using a pH meter (Mettler-Toledo, UK) for 
each single isolate. This test was performed in quadruplicate. The pH of the broth after 
incubation was compared with the initial pH. 
  Genotypic Identification 
2.13.3.1 Identification of Lactobacillus genera using 16s rDNA  
2.13.3.1.1  DNA extraction  
The DNeasy Blood & Tissue Kit (Qiagen, Manchester, UK) was used to extract the DNA 
from the LAB isolates with some modifications described below. One colony, obtained 
following growth on MRS agar, was inoculated into 10 ml of MRS broth for overnight 
growth (12h) at 37°C microaerobically. Then, the protocol below was followed: 1.5 ml 
of culture was placed into a 2ml Eppendorf tube and the cells pelleted and washed twice 
in PBS by centrifugation at 5000 rpm (Hettich, Germany) for 5 minutes. Afterward the 
washed cells were lysed by adding 180µl of lysis buffer which was prepared by adding 
20mg Lysosome into 1 ml Gram positive buffer (Sigma-Aldrich, UK) incubated at 37°C for 
3 hours.  Protein was removed the as 25µl of proteinase K and 200ul AL buffer were 
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added and the tube incubated at 65 °C for 6 hours after mixing by vortex. Then the DNA 
was bound on the column by adding 200ul ethanol (96-100%) to the lysed cells, mixing 
thoroughly before applying into the DNeasy Mini spin column. The column was 
centrifuged at 8000 rpm for 1 min and the flow-through and collection tube were 
discarded. Then the DNA was cleaned up by placing the spin column in a new 2 ml 
collection tube, and 500 µl Buffer AW1 added, then centrifuged for 1 min at 8000 rpm. 
Then column was placed in a new 2 ml collection tube and 500 µl Buffer AW2 added, 
before centrifugation for 3 min at 14,000 rpm to dry the DNeasy membrane. The column 
was then placed in 1.5 ml tube and centrifuged for 1 mins at 15000 rpm.  Finally the DNA 
was eluted by placing the DNeasy Mini spin column in a clean 1.5 ml and 50 µl nuclease 
free water pipetted onto the DNeasy membrane, incubated at room temperature for 5 
min, then centrifuged for 1 min at 8000 rpm to elute the DNA. The quantity and quality 
of DNA was determined using a Nanodrop-2002 Spectrophotometer (Fisher, UK). DNA 
was stored at -20 °C until further processing.   
2.13.3.1.2 Sequencing the DNA  
The V4 hypervariable region of the 16S rRNA gene was amplified from genomic DNA 
using forward primer 515F: GTGCCAGCMGCCGCGGTAA and reverse primer 806R: 
GGACTACHVGGGTWTCTAAT (Earth Microbiome, 2015) using the 2x KAPA HiFi HotStart 
ReadyMix, and primers:  
PCR amplification carried out using 25 μl reaction mixtures of 2.5 µl microbial DNA (5 
ng/µl); 5 µl Amplicon PCR Forward Primer (1 µM); 5 µl Amplicon PCR Reverse Primer (1 
µM) and 12.5 µl 2x KAPA HiFi HotStart ReadyMix (KAPA-Germany). This was added into 
a 96 well plate which was sealed before PCR was performed in a thermal cycler 
(Techne,TC-512, UK)  using the following program: 95°C for 3 minutes; 25 cycles of: 95°C 
for 30 seconds;  55°C for 30 seconds; 72°C for 30 seconds; 72°C for 5 minutes. The PCR 
products were run through 1.5% agarose gel electrophoresis and bands analysed to 
check the product (amplicon) quality. Were run on 100 volts for 45 mins after loading 
2µl of loading dye (Cleaver, MP-250v,UK),  and 5µl of  amplicon.  These were then 
imaged under UV light (Syngene, G: box, USA). The 16S V4 amplicon was using 20 µl of 
AMPure XP beads and then incubated at room temperature for 5 minutes. The plate t 
was  placed on a magnetic stand (FastGene MagnaStand, YS, Germany)  for 2 minutes or 
until the supernatant had cleared. The supernatant was then discarded and the beads 
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washed twice with freshly prepared 80% ethanol before being allowed to air‐dry for 10 
minutes. The Amplicon was then suspended with 52.5 µl of 10 mM Tris pH 8.5 and gently 
mixed before incubating at room temperature for 2 minutes with 50 µl of the clear 
supernatant was transferred to a new 96‐well PCR plate.  
Index PCR which was performed as follows: 5 µl of DNA was transferred into another 
new 96‐well plate and the Index 1 and 2 primers arranged. The 96‐well PCR plate with 
the 5 µl of re-suspended PCR product DNA was placed in the TruSeq Index Plate Fixture 
(Illumina, USA) and the following reactions were set up: 5 µl amplicon (DNA), 5 µl 
Nextera XT Index Primer 1 (N71-12) horizontally, 5 µl Nextera XT Index Primer 2 (S51-8) 
vertically, 25 µl of 2x KAPA HiFi HotStart ReadyMix, 10 µl PCR Grade water. This mixture 
was gently mixed and the plate was covered with Microseal. Then centrifuged at 1,000 
× g at 20°C for 1 minute after which a PCR was performed on a thermal cycler:  95°C for 
3 minutes, 8 cycles of: 95°C for 30 seconds 55°C for 30 seconds 72°C for 30 seconds, 72°C 
for 5 minutes, the hold at 4°C. The Index PCR product was cleaned up as above with: 56 
µl of AMPure XP beads added to each well of the Index PCR plate, and gently pipetted 
mix up and down and incubated at room temperature for 5 minutes. Then the plate was 
placed on a magnetic stand for 2 minutes or until the supernatant cleared. It was then 
removed and the supernatant discarded. Then the beads were washed with freshly 
prepared 80% ethanol twice. Then, carefully, excess ethanol was removed then the 
beads were air‐dried. Next, 27.5 µl of 10 mM Tris at pH 8.5 was added to each well of 
the Index PCR plate and incubated at room temperature for 2 minutes. Twenty five µl of 
the supernatant was then carefully transferred from the Index PCR plate to a new 96‐
well PCR plate.  
For validate 1 µl of the final library was run on a tape-station DNA 1000 (Agilent, USA) 
to verify the size. Library Quantification, Normalization, and Pooling were performed as 
follows: DNA concentration was calculated in nM, based on the size of DNA amplicons 
as determined by an Agilent Tape station 1000. Then the library was diluted to 4 nM 
using 10 mM Tris pH 8.5. Aliquot 5 µl of diluted DNA from each library was pooled; the 
MiSeq reagent cartridge was removed from ‐15°C storage and thawed at room 
temperature. DNA was then denatured by combining the following volumes in a 
microcentrifuge tube: 4 nM pooled library (5 µl) and 0.2 N NaOH (5 µl), vortexed briefly 
then centrifuged at 280 × g at 20°C for 1 minute before incubating for 5 minutes at room 
temperature. Then 990 µl of pre‐chilled Hybridization Buffer HT1 was added to the tube 
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containing denatured DNA (10 µl) Library resulting in a 20 pM denatured library in 1 mM 
NaOH and placed on ice until use PhiX as a sequence control was denatured and diluted 
to 4 nM by combining 10 nM PhiX library (2 µl) and 10 mM Tris pH 8.5 (3 µl). Then 4 nM 
PhiX library (5 µl) and 0.2 N NaOH (5 µl) was combined in a microcentrifuge tube and 
vortexed briefly before incubating for 5 minutes at room temperature to denature the 
PhiX library into single strands. Then 990 µl pre‐chilled HT1 (20 pM) PhiX library was 
added to the tube containing 10 µl denatured PhiX library to result in a 20 pM PhiX.  This 
was then diluted to the same loading concentration as the Amplicon library to get 8mM 
by mixing 20 pM denatured library and Pre‐chilled HT1 (360 µl). The Amplicon Library 
and PhiX Control were combined in volume of 570 µl and 30 µl respectively. This was 
then set aside on ice until it was time to heat denature the mixture immediately before 
loading it onto the MiSeq v3 reagent cartridge. At which point the mixture was 
incubated at 96°C for 2 minutes by using a heat block. Afterward the tube was mixed 
and placed in the ice‐ water bath.  Finally the template allocations of samples was set 
up in the Illumina sheet  then the combined sample library and PhiX, was loaded into 
the hole in the Miseq cartridge then loaded it in the machine using version 3 (300 × 2) 
chemistry on the MiSeq instrument (Illumina Inc., USA) according to manufacturer’s 
instructions.  
2.13.3.1.3 Bioinformatics analysis  
The data obtained from sequencing were analysed by Dr Alan McNally at University of 
Birmingham.   
 Evaluation the phenotypic characteristics of the isolates 
2.13.4.1  Viability of isolates at 42°C 
Isolates were tested for their ability to survive at the incubation temperature of 42°C 
(representing broiler chickens core body temperature). This was performed by 
spreading 100 µl of standard inoculum (10^6) on MRS plates with each isolate and 
incubating at either 37°C as a standard or 42°C for 48 hours, in microaerobic conditions. 
The level of growth was compared to ascertain the viability of the isolates. 
2.13.4.2  Tolerance to oxygen  
MRS plates were inoculated with overnight growth of isolates and incubated at 37°C for 
48 hours at  three different levels of oxygen; aerobically in the aerobic incubator (LEEC, 
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UK), microaerobic atmosphere (Don Whitley DG250 Anaerobic Workstation, UK ) and in 
an anaerobic atmosphere created using anaerobic jars (Thermoscientific, UK) with a 
gaspack (ANAEROGENTM COMPACT from Oxoid). After 48 hours, plates were checked 
for the growth of bacteria and given + for growth and – for no growth and this test was 
performed in triplicate. 
2.13.4.3 Antibiotic resistance  
The disc diffusion method (Moubareck, et al. 2005) was used to screen the LAB isolates 
for antibiotic susceptibility. The test was performed by spread plating the standard 
inoculum of isolates on MRS plate using cotton swab in three directions to cover all the 
plate. Then the plates were left to dry for 30 minutes. The antibiotics discs (Oxoid,UK) 
of Gentamycin 10 (GM), Ampicillin 10 (Ap), Cefmetazole 30(CAZ), Ciprofloxacin 5 (CIP), 
Cefotaxime (CTX), Tetracycline (TE), Cefoxitin 10 (FOX) and Rifampicin 5(RD) were placed 
on the plate, with distances around the discs of about 2cm, the plates were incubated 
at 37°C at microaerobic atmosphere. A clear zone (no growth) around the discs was 
measured by ruler and recorded. This test was carried out in triplicate and repeated 
twice.  
  Assessment of antibacterial activity against Campylobacter 
strains 
2.13.5.1  Preparation of cell free supernatant (CFS)   
MRS broth (10ml) was inoculated with 200µl of standard inoculum, and incubated for 
24 hours. The culture was centrifuged at 15000 rpm for 15 minutes at 4°C then the 
supernatant was centrifuged again in the same conditions in order to remove all 
bacterial cells.  Finally it was filtered using a 0.2µm filter (Minisart, Germany) and stored 
at -20°C until use.  
2.13.5.2 Campylobacter suspension preparation: 
Three strains of Campylobacter jejuni were chosen: RM1221 (broiler chickens isolate), 
NCTC11168 (human isolate) and 01/51 (human isolate). A suspension of each 
Campylobacter strains was prepared by growing of each strain on charcoal-
cefoperazone-deoxycholate agar (CCDA) plate for 48 hour at 37°C in microaerobic 
atmosphere. The bacterial cells were pelleted by centrifugation at 5000 rpm at 4°C for 
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15 minutes then washed with PBS twice and re-suspended in PBS buffer and diluted to 
get a 10^6 cfu/ml with PBS.    
2.13.5.3 Inhibition test  
The supernatant of LAB isolates were used to determine the activity against 
Campylobacter by following the protocol described by (Collado, et al. 2005) with some 
modifications. CCDA plates were prepared and 1ml of 10^6 cfu/ml Campylobacter 
suspension was spread over the plate surface using a cotton swab and left at room 
temperature for 15 minutes to dry. A well of 5 mm diameter was created using the base 
of a sterile 1ml pipette tip in the agar, leaving a distance around each well about 2cm. 
CCDA plates were then left in a gas jar with Campypack (Oxoid, UK) in the fridge to dry 
for 2 hours. Wells were filled with 50µl of CFS then left in fridge for 1-2 hours to absorb 
the supernatant. The plates were incubated in a microaerobic atmosphere at 37°C for 
48 hours then the inhibition zone observed and measured in mm using ruler.  
2.13.5.4 Detection of hydrogen peroxide production  
The LAB isolates were evaluated for production of hydrogen peroxide by culturing 
bacteria on MRS plates prepared by (Dec, et al. 2014) mentioned. Plates were 
supplemented with 2.5 mg of 2, 39.5,59-tetramethylbenzidne (TMB); (Sigma-Aldrich) 
and 0.1 mg horseradish peroxide (Sigma-Aldrich) to each 10 ml of media. Plates were 
spotted with 20µl of the standard inoculum of isolates and incubated at 37°C  
microaerobically for 48 hours. After incubation the plates were exposed to air for about 
30 minutes. Blue colour in the colonies indicated H2O2 production from isolates. This 
test was repeated twice.   
2.13.5.5 Evaluation the ability to survive in the intestinal gut environment 
2.13.5.5.1 Tolerance of Bile salts 
The sensitivity of isolates to bile salts was performed according to (Ashraf and Smith 
2016)Ashraf and Smith, (2016) by supplementing MRS broth with different levels of bile 
salts. 96 wells plates were used for this purpose, which were filled with 200µl MRS broth 
with final concentration 10^4 of isolates then and 0%, 0.25%, 0.50%, 0.75%, 1% w/v of 
bile salts (Ox gall B3883 Sigma-Aldrich ,UK) were added to the wells. In addition, 2 
inoculum-free wells of each level of bile salt addition were used as controls. The increase 
of turbidity in the well was deemed to indicate bacterial growth. The optical density was 
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monitored (Cytation-imaging readers, Bio-rad- USA) at 600 nm at 0, 1, 2, 3, 4, 12 and 
24hours. In addition to non-inoculated broth to compare the density. After 48 hours 
100µl of the broth was cultured on MRS agar to check that the turbidity was due to the 
growth of bacteria.  
2.13.5.5.2  Tolerance of Sodium Chloride (NaCl) 
Tolerance to sodium chloride (NaCl) was assessed to ensure the LAB isolates were able 
to withstand presence of salt which is added into the broiler chickens diets at about 0.5% 
(NRC,  1994). The viability of LAB isolates was performed by culturing in MRS broth 
containing varying levels of NaCl (sigma, UK). Ten concentrations of NaCl were added to 
the broth to examine the highest in which the isolates can survive. 0%, 1%, 2%, 3%, 4%, 
5%, 6%, 7, 8%, 9% and 10% of NaCl were added to the MRS broth and a 96 well plate 
were filled with this mixture of 180µl MRS broth (NaCl) and 20 µl of standard inoculum 
of each isolate. The plates were then incubated at 37°C in a microaerobic atmosphere. 
The optical density over time was measured at 600mn wavelength using a microplate 
reader (Cytation-Imaging Reader, Bio-rad, USA) at 0, 2, 4, 6, and 24 hours. A non-
inoculated broth was added as well to compare the density of the broth as a standard. 
Then, after 24 hours 100µl of the broth was cultured on MRS agar to check that the 
turbidity was due to the growth of bacteria. All tests were carried out in triplicate. 
2.13.5.5.3  Tolerance of acid  
Acid tolerance was carried out to assess whether the isolates could survive at low pH 
levels such as the proventriculus pH of 2 (Svihus 2011). The procedure described by 
(Menconi, et al. 2014) was carried out as follows. A 96 well plate was used for this test 
and the wells were filled with 180µl of MRS broth which was adjusted to different levels 
of pH 1, 2, 3, 4, 5 and 6, by use of HCl.  Each broth was inoculated with 20µl of standard 
inoculum. Plates were incubated at 37°C in a microaerobic atmosphere, and the optical 
density was monitored (CYTATION-imaging readers, Bio-rad, USA) at 600 nm at time 
points 0, 1, 2, 3, 4 and 5 hours. In addition, a non-inoculated broth was used to compare 
the density and 100µl of the broth was cultured on MRS agar to check the viability of 
bacteria.  The test was performed in triplicate. 
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  Utilisation of Jerusalem artichoke (Inulin) as source of carbon by 
LAB isolates.  
Readymade culture media usually contains glucose as a carbon source. In this study 
glucose was replaced with Jerusalem artichoke (JA) plant. Three types of broth were 
made (Table 2:2) comparing standard broth medium prepared with glucose, a second 
broth supplemented with commercial inulin (SENSUS, Netherland) in place of glucose 
and a third type of media supplemented with JA plant. Tubers of Jerusalem artichoke 
plant were prepared by grinding the dried tuber. A 96 well plate was used for this test, 
wells filled with the media described above and inoculated with 0.2% of standard 
inoculum. The growth of isolates was determined at two time points (0 and 24 hours) as 
previously described. 100µl of the broth was cultured on MRS agar to check the viability 
of bacteria.  
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Table 2:2 Composition of standard and prepared media supplemented with commercial 
inulin and Jerusalem artichoke.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Preparation of broiler chickens dietary supplements of probiotic 
from isolates  
MRS broth were inoculated with 0.2 % of standard inoculum using 500mL bottles and 
incubated for 16 hours at 37°C microaerobically. Bacterial cells were collected by 
centrifugation of the broth at 5000 rpm for 20 minutes at 4°C. The cells were washed 
twice with PBS then homogenised with 100% PBS (W/V) then the mixture of 
cryoprotectant was added at 100% skimmed milk (W/V) and 5% sucrose (W/V) before 
Ingredient 
Amount (g/litre) 
 
standard 
Inulin 
(pure) 
Jerusalem 
artichoke 
Peptone 10.0 10.0 10.0 
Meat extract 8.0 8.0 8.0 
Yeast extract 4.0 4.0 4.0 
D(+)-Glucose 20.0 0.0 0.0 
Dipotassium hydrogen 
phosphate 
2.0 2.0 2.0 
Sodium acetate 
trihydrate 
5.0 5.0 5.0 
Triammonium citrate 2.0 2.0 2.0 
Magnesium sulfate 
heptahydrate 
0.2 0.2 0.2 
Manganous sulfate 
tetrahydrate 
0.05 0.05 0.05 
Tween-80 1 ml 1 ml 1 ml 
Inulin 0.0 20.0 0.0 
Jerusalem Artichoke 0.0 0.0 20.0 
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mixing thoroughly by vortex (Stuart, UK). This mixture was incubated at 4°C for 1 hour 
before freezing to adapt the bacteria for snap freezing in the next step. The tubes of cold 
isolates were submerged in liquid nitrogen for about 5-10 minutes until frozen. They 
were then stored at -80°C for 24 hours before drying. A freeze dryer (Bench Top Pro, SP 
Scientific, USA) was used to dry the mixture of bacterial cells and cryoprotectant which 
was applied under pressure of about 510 millibar (mb) and  -56°C  for  12-18 hours until 
dried. Dried product was then ground using a coffee grinder (Russell, China) and kept in 
the fridge until to be used in broiler chickens feed. The concentration (CFU) of product 
was determined; 100mg of organisms powder was added to 900µl PBS then serial 
dilutions up to 10^-10 were made which were then cultured on MRS agar and incubated 
at 37°C microaerobically. This product was diluted to 10^-9 with skimmed milk to be 
used in broiler diet. Skimmed milk was used to dilute the dried product to 10^-9 CFU of 
each isolate. All diluted products of 6 isolates were mixed in one bottle and stored at 4c.  
 Assessment of the viability of bacterial cells during the 
preparation of the broiler chickens feed supplements   
The viability of bacteria was checked at several different points during processing: 
before freezing, after freezing and after drying, viability was determined by viable counts 
(CFU). 100 mg of dried product was weighed into 900µl PBS and serial dilutions carried 
out then cultured on MRS agar for 24 hours at 37°C at microaerobic atmosphere, before 
the CFU was counted. All tests were performed in triplicate.  
  Preparation of Jerusalem artichoke tubers  
Jerusalem artichoke tubers were obtained from the wholesale market in Baghdad, Iraq. 
Clay, undesirable materials and damaged tubers were removed. The tubers were 
cleaned with tap water to remove dust and clay that stuck on the tubers. The cleaned 
tubers were cut into small pieces and sliced to 2-3mm in thickness using a food processer 
(Kenwood FP126 Food Processor) and were then dried at room temperature for 2 hours. 
The sliced tubers were then further dried using an air-drier cabinet (locally made) at 
60°C for 12 hours. The dried tubers were packed and sealed in double polyethylene bags. 
The packed, dried JA were then shipped to the UK. In the UK, the dried tuber pieces were 
packed well in boxes with an appropriate amount of silica gel (Fisher, UK) to keep it dry 
and avoid moisture absorbance and stored at room temperature. JA were further 
processed to be added in broiler chickens feed. It was ground in two steps first using 
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mixer (KENWOOD, UK) to get small pieces then using coffee grinder (Russell, China). 
Finally the powder was sifted using sieve of mesh size 2mm. 
  
   Determination of the content of inulin in Jerusalem artichoke 
The inulin content of the Jerusalem artichoke was determined in duplicate using the 
Fructan HK Assay Kit and following the protocol recommended by the supplier 
(Megazyme International, Bray, Ireland) where samples are ground and extracted in hot 
water. One gram of sample was added to 400 mL of hot (80°C), distilled water which was 
placed on a hot-plate with a magnetic-stirrer and stirred and heated (80°C) for 20 
minutes. The solution was allowed to cool at room temperature then transferred into a 
500 mL volumetric flask and the volume was adjusted to the mark with distilled water. 
The sample was then mixed thoroughly by shaking the flask. The solution was filtered 
through a Whatman No. 1 (9 cm) filter paper and analysed immediately. Aliquots (0.2 
Ml) were analysed (containing approximately 0.1 to 2.0 mg/mL of fructan) by dispensing 
into the bottom of glass test-tubes (16 x 100 mm). Then, 0.2 mL of solution 3 
(sucrase/maltase mixture) was added to the tube and incubated at 40°C for 30 min, and 
then 0.5 mL of buffer 2 (100 mM sodium acetate buffer, pH 4.5) was added following 
vigorous stirring on a vortex mixer (called ‘Solution A’). 0.2 mL aliquots of Solution A (in 
duplicate) were added to the bottom of plastic spectrophotometer cuvettes (3 mL 
volume, 1 cm light path), then 0.1 mL of solution 4 (fructanase solution) was added to 
the bottom of one cuvette, and 0.1 mL of buffer 2 was added to the second cuvette. The 
contents were mixed thoroughly and the cuvette was covered with Parafilm. The 
A B 
Figure 2:1  Jerusalem artichoke plant used in this study 
A: fresh Jerusalem artichoke tuber, B: dried ground Jerusalem artichoke  
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covered cuvettes were incubated at 40°C for 30 min in a dry hot block heater to effect 
complete hydrolysis of fructan to fructose and glucose. The absorbance was read at 340 
nm by spectrophotometer (JENWAY, 7315 Spectrophotometer, Bibby Scientific Ltd, UK) 
at 25°C. The amount of inulin was expressed in terms of fructan concentration 
   Collecting and preparation of tissue samples  
After euthanizing the birds and opening the carcass, the whole Fabricia of Bursa, 5 cm 
from the middle of ileum and the paired caeca were collected from the birds 
immediately in sterile tubes and placed in cold polystyrene box about 4C.    
2.13.11.1 Preparation of tissue samples for RNA extraction    
Tissue from the Fabricia of Bursa and ileum were directly placed in petri dishes. Which 
were washed with sterile PBS and a cut in pieces of about 0.2- 0.5 cm2 then stored in 
cryovials containing 500µl RNAlater buffer (R0901, Sigma, UK) to protect RNA with 
immediate RNase inactivation, tissue samples were stored overnight at 4°C before being 
transferred to -80°C for storage until processing for RNA extraction.  
    Preparation of the samples for total count of LAB and 
Campylobacter       
Caeca were separated and one caecum was placed in sterile tube in a cold box (4c) then 
transported to the lab. When in the lab, approximately 3 grams of content was placed 
into Eppendorf tubes and stored at -20°C. The second, whole caecum was further 
processed for culturing.   
2.13.12.1  Culturing the content of caeca for LAB    
One gram of caecal content was weighed into 9ml of PBS tube then homogenised using 
a vortex (Stuart, UK) and serial dilutions carried out until 10^-10. The appropriate 
dilution was cultured in three replicates on MRS agar and incubated for 24 hours at 37°C 
at microaerobic atmosphere. All colonies that showed similar small, white or creamy 
appearance were counted.             
2.13.12.2 Culturing the tissue of caeca for LAB 
From the isolated caeca, one cm2 of tissue was placed into 9ml of PBS tube,  
homogenised using a Homogenizer (IKA® T 18 ULTRA-TURRAX® Basic, Brazil) then serial 
dilutions were carried out until 10^-7 was achieved. Next, the appropriate dilution was 
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cultured in three replicates on MRS agar and incubated for 24 hours at 37°C at 
microaerobic atmosphere. Afterward all colonies that showed similar small, white or 
creamy appearance were counted. 
2.13.12.3 Culturing the content of caeca for Campylobacter   
One gram of caecal content was placed  into 9ml of PBS tube,  homogenised using a 
vortex (Stuart, UK) and a serial dilutions carried out until 10^-10. Then the appropriate 
dilution was cultured in three replicates on CCDA agar and incubated for 24 hours at 
37°C at microaerobic atmosphere. Afterward all colonies with tiny, grey appearance 
were counted.             
2.13.12.4 Culturing the tissue of caeca for Campylobacter  
One cm2 of caecal tissue was placed into 9ml of PBS tube, then homogenised using a 
Homogenizer (IKA® T 18 ULTRA-TURRAX® Basic, Brazil) then serial dilutions carried out 
until 10^-7 was reached. Then, the appropriate dilution was cultured in three replicates 
aces on CCDA agar and incubated for 24 hours at 37°C at microaerobic atmosphere. 
Afterward all colonies with tiny, grey appearance were counted.             
2.13.12.5 RNA extraction from Fabricius of bursa and ileum  
Samples that had been prepared according to methods described in section 2.13.11.1 
had RNA extraction performed using the RNeasy Plus Mini Kit (Qiagen, Manchester, UK). 
Total RNA was purified from broiler chickens tissues following the manufacturer’s 
instructions. Stabilised tissue samples (Bursa of Fabricius and ileum) in RNAlater 
previously frozen at -80°C were thawed at room temperature and 40mg was weighed 
(Ohaus, AP110S, Switzerland) into a 2ml eppendorf  tube  of 600 µl RLT buffer then lysed 
and homogenised using cordless motor Pellet Pestle, (Z359955, Sigma, UK) to release 
cellular RNA. Buffer RLT contains β-mercaptoethanol and guanidine thiocyanate which 
lyses the cells and protects the RNA by inactivating RNases. Ethanol was then added to 
lysates to provide suitable binding conditions before samples were bound to RNeasy 
silica membranes (spin columns) by centrifugation at 10000 x g for 15 seconds. 
Subsequently    buffer RW1 and buffer RPE washes were carried out respectively to 
remove contaminants from the spin column. Finally, RNA was eluted into clean 1.5 ml 
tubes, using 100 µl RNase-free water, by centrifugation at 1300 x g for 15 seconds.  
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2.13.12.5.1 Quantification and purity of RNA. 
The concentration and quality of RNA was determined using spectral analysis by 
NanoDrop spectrophotometer ND-1000 (Fisher Scientific, UK). RNA concentration was 
automatically calculated in ng/µl which was at least 100 ng/µl to be used in the cDNA 
synthesis. RNA purity is also calculated as the ratio of absorbance at 260 nm and 280 nm 
(A260/A280). Extracted RNA was stored at -80°C until cDNA synthesis. 
2.13.12.5.2 cDNA synthesis 
 cDNA was prepared from 1 µg RNA using the iScript™ cDNA synthesis Kit (BioRad, 
Hercules, CA). The reaction mix was made using 4µl of 5x iScript, 1 µl iScript reverse 
transcriptase and 15 µl diluted RNA with nuclease–free water to make a total volume of 
20 µl. cDNA synthesis conditions were performed using Thermal Cycler (Techne, TC-
4000, UK) using the following conditions:25°C  for 5 min, 46°C  for 20 min and 95°C  for 
1 min. The cDNA samples were stored at -20oC until use for qrtPCR.   
2.13.12.5.3 Quantitative real-time PCR (qrtPCR) 
The mRNA gene expression levels of three cytokines, IFNγ, IL-10 and IL-6, were 
determined. The primers and house-keeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were chosen as previously described from papers and double 
checked for target identity using GenBank in the National Centre for Biotechnology 
Information (NCBI) which are all are listed in table 2:3. The expression level of GAPDH 
was used for data normalisation. Real-time PCR was performed in microplates.  Each 
sample was subjected to real-time PCR in duplicate and the mean values of the 
duplicates were used for subsequent analysis. The Ct values of genes of interest were 
normalised to an average Ct value of the GAPDH (ΔCt) and the gene fold expression of 
each cytokine was calculated as 2–ΔCt. These expression levels were then used for 
comparative data analysis. 
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 Table 2:3 Target genes and primers sequences used in this study  
RNA 
TARGET 
Primer Sequence Reference 
GAPDH 
F-GCCGTCCTCTCTGGCAAAG 
R- TGTAAACCATGTAGTTCAGATCGATGA 
(Mott, et al. 2008) 
INF-G 
F 5′-GCCCTCCTCCTGGTTTCAG-3′, 
R 5′-TGGCACCGCAGCTCATT -3 
(Rothwell, et al. 
2004, Kristeen-Teo, 
et al. 2017) 
IL-6 
F 5'-CAGGACGAGATGTGCAAGAA-3' 
R 5'-TAGCACAGAGACTCGACGTT-3' 
(Waititu, et al. 2014) 
Il-10 
F CGGGAGCTGAGGGTGAA 
R GTGAAGAAGCGGTGACAGC 
(G. Li, et al. 2010, 
Lourenço, et al. 
2016) 
2.13.12.5.4 Real-time quantitative RT-PCR  
The full protocol for Real-Time Quantitative PCR reactions were carried out in duplicate 
using IQ TM SYBR Green Superscript (BioRad, Hercules, CA) on a BioRad instrument 
CFX384 (Bio-Rad, USA).  Amplification was carried out in a total volume of 20 µl in an 
Icycler IQ™ PCR 96 well plate (BioRad, Hercules, CA). Reaction mixture was composed of 
10 µl IQ SYBR Green supermix (BioRad, Hercules, CA), 2 µl of a primer sets, 4 µl of cDNA 
mixed with 4 µl H2O. RT-PCR conditions were 38 cycles 95°C for 3 min, 95°C 15 sec of, 
60° C 30 seconds and  melting point analysis at 55° C,. PCR products were subsequently  
stored at -20° C. The MyiQ Single-Color Real Time PCR Detection software was utilized 
for data analysis instrument CFX384 (bio-rad, USA). 
2.13.12.5.5  Analysis of qPCR results by 2Ct method  
The calculations of 2Ct were performed as (Livak and Schmittgen 2001) which 
included calculating the arithmetic mean of Ct Values then normalizing the values using 
housekeeping gene to target gene. The values were normalized using control birds Ct 
= Ct (Experimental animal) - Ct (Control animal). Relative quantity of the target gene 
calculate of following the equation: 
  Mean relative fold change = 2-Ct (where relative fold change is the relative quantity 
of mRNA transcripts in experimental to that of control). 
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  Gut microbiota analysis  
2.13.13.1.1 DNA extraction: 
In this step DNA was extracted using a QIAamp fast stool mini kit (QIAGEN, Manchester, 
UK) and the manufacturer’s instruction method was used for DNA extraction with some 
modification. 200 mg of sample was weighed into in a sterilized 2ml eppendorf tube, 
then  500μl of fresh lysozyme solution was added, then the samples were incubated at 
37°C for 30 minutes with vortex for 15 seconds then the centrifuged for 5 min at 15000 
rpm to lyse the cells. Then, to remove the inhibitors from samples, one ml of Inhibit EX 
Buffer was added and the mixture vortexed continuously until the stool sample was 
thoroughly homogenized. The mixture was then centrifuged for 1 min at 13000 rpm. In 
the meantime to remove the protein 15μl of proteinase K was pipetted into a new 2 ml 
Eppendorf tube. Then, 200μl of supernatant was pipetted from the samples that had 
been cleaned from inhibitors in previous step into the 2 ml Eppendorf tube containing 
proteinase K. Then, 200μl of Buffer AL was added and mixed for 15 seconds, then this 
mixture was incubated at 70°C for 10 min. After incubation 200 μl of ethanol (96–100%) 
was added to the lysate, and mixed by vortexing for precipitation. Afterward 600μl 
lysate from the final step was carefully applied to the QIAamp spin column. This was 
then centrifuged at 13000 rpm for 1 min. Then, the QIAamp spin column was placed in 
a new 2 ml collection tube, and the filtrate with tube was discarded. The rest of lysate 
was loaded again to apply all of the lysate on the column. The DNA was then cleaned-
up by adding 500 μl of Buffer AW1 into QIAamp spin column. Then, the mixture was 
centrifuged at 13000 rpm for 1 min. Then, the QIAamp spin column was placed in a new 
2 ml collection tube, and the collection tube containing the filtrate was discarded. 
Carefully, the QIAamp spin column was opened and 500 μl Buffer AW2 was added and 
centrifuged at 13000 rpm for 3 min. The QIAamp spin column was transferred into a 
new, labelled 1.5 ml Eppendorf tube and 100 μl nuclease free water was pipetted 
directly onto the QIAamp membrane. This was incubated for 3 min at room 
temperature, then centrifuged at 12000 rpm for 1 min to elute the DNA. Finally, the 
extracted DNA was stored on ice until the concentration of DNA and purity were 
determined using a Nanodrop-1000 Spectrophotometer.  
 64 
 
2.14   Statistical analysis of data 
All data was analysed using the SPSS software version 21 or 24 for Windows (IBM 
Statistics, 2013). After KS testing to test normally distributed, statistical analysis was 
carried out using either Kristal Wallis independent sample analysis, or one way ANOVA 
to investigate the effect of dietary treatment on FCR, feed intake and body weight gain 
(per bird). Treatment means were separated using a Tukey post hoc test and significant 
level was tested at P ≤0.05.   
In the pilot study that conducted to assess the natural occurrence of Campylobacter in 
the local area. Four sites were screened for the levels of Campylobacter: the NTU 
research poultry unit across eight trials and a free range adult layer paddock at 
Nottingham Trent University and broiler and adult layer free range birds at a commercial 
farm. The results indicated that there were no Campylobacter detected in the NTU 
poultry research unit during all trials. Also there was no effects of type of feed or broiler 
chickens age on the prevalence of Campylobacter. The commercial farm was negative 
for Campylobacter   presence before thinning but it became positive after thinning,  
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3 Chapter three: 
Evaluation of a new Lactobacillus strain as a probiotic agent  
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3.1  Introduction 
One approach to post slaughter reduction of Campylobacter contamination is the use of 
probiotic bacteria to increase the ability of the microbiota of the bird to maintain health 
of the GIT (Santini, et al. 2010). (Ghareeb, et al. 2012) demonstrated that providing 
chicks with a probiotic supplement via the drinking water decreased the count of 
Campylobacter in broiler chickens. However, there are several possible ways of 
supplying probiotics to broiler chickens such as, mist spraying, via feed, oral gavage, 
application to the vent lip and via drinking water. (Eckert, et al. 2010) stated that 
administering Lactobacillus-based probiotics either by drinking water or feed improved 
the body weight significantly compared with control treatment, from 15 days of age until 
48 days. These authors also reported that Lactobacillus via drinking water can improve 
the body weight and feed conversion of broiler chickens within commercial 
environments. Institute of Food Research (IFR) microbiologists have isolated and 
patented a novel strain of Lactobacillus johnsonii: FI9785 from broiler chickens. The 
FI9785 strain was originally found to act as a competitive exclusion agent to 
control Clostridium perfringens in poultry, but more recently the strain was also shown 
to be able to compete with Campylobacter in vitro (Dertli, Mayer and Narbad 2015). This 
finding prompted the evaluation of FI9785 in live birds, which allowed investigations 
into whether this bacteria enhances the immune function and improves the GIT health 
of broiler chickens. Before examining this bacteria in poultry to see whether it has 
probiotic functionality, the FI9785 strain needed checking for stability outside the bird 
in possible cryprotect mediums. Hypothesis of the study is that Lactobacillus johnsonii 
are to survive in water and feed and its can keep the viability in the gut of chicks.    
The aim of this work was to evaluate the efficacy of a novel strain of Lactobacillus 
johnsonii (LB) isolated and patented by the Institute of Food Research as a probiotic This 
overarching aim was met via two studies that were designed to determine the efficacy 
of Lactobacillus johnsonii as a probiotic. The first study investigated whether the 
environmental conditions associated with each proposed delivery were detrimental to 
survivability. The next study examined the most appropriate method of colonising the 
intestinal tract of the birds.   
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3.2 Delivering the LB into chicks gut 
The first aim of this investigation was to establish a method for delivery of the novel 
Lactobacillus strain that gives the required consistent colonisation of this strain within 
target regions of the GIT (primarily caeca and colon). Options evaluated included either 
through drinking water, mixed into feed or mist spraying the chicks immediately post 
hatch. The second aim was to verify the impact of probiotic on bird performance and 
examine probiotic efficacy as a gut health enhancer. 
 Preparation of probiotic  
These works were done by Institute of Food Research (IFR) Lactobacillus johnsonii 
FI9785 cells were proliferated by the on de Man, Rogosa and Sharpe (MRS) broth using 
a controlled fermenter with a nitrogen gas supply. The harvested cells were collected, 
centrifuged and freeze dried before mixing with skimmed milk as cryoprotect. Cells were 
stored at 4oC until use. Batches from different fermentation runs were mixed thoroughly 
before use in the bird studies. 
3.2.1.1 Survivability of L. Johnsonii FI9785 in water and feed 
L. Johnsonii 9785 had been proliferated as described previously, a pilot study assessing 
its survivability in two potential delivery mediums (feed and water) was assessed.  
Survival of FI9785 in different types of water at room temperature was examined at IFR 
by taking one gram of dried cells and adding to a set volume of different types of water: 
fresh hot tap water, fresh cold tap water, water left standing overnight and distilled 
water. Samples were taken after five different periods of time: 0, 2, 4, 6 and 24 hours 
before culturing on MRS selective media and microaerobic incubation for 48 hours at 
37°C.  Colony forming units (CFU) of L. Johnsonii FI9785 were numerated according to 
the morphology of this strain in the suitable dilution. All microbiological analyses were 
performed in duplicate and the average values were used for statistical analysis. 
To test the survival  of L. Johnsonii FI9785 when stored in broiler chickens feed at room 
temperature, the procedure below was followed: 1g of dried cells of L. Johnsonii was 
added to 9 gram of diets in different tubes and stored for 10 different periods time 0, 6, 
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24, 48, 120, 144, 168, 192, 216 and 240 hours. A set volume of PBS was then added to 
each feed sample before culturing an enumeration as described for water. 
 Ethics and welfare  
As described in chapter 2 (section 2.5). 
 Bird trial room setup  
 For each bird trial, treatments were placed around the room in an attempt to avoid 
cross contamination between treatment pens. Pen distribution in the NTU poultry 
research unit is shown in figure 4:1. Different nipple drinker lines were also used for 
each treatment.  
 
Figure 3:0:1 Pen layout of NTU poultry research unit with entry doors marked ‘D’ 
For both bird trials, the control group were situated under the ventilation inlet so as to 
reduce the risk of transport of LB between pens via air flow from the treatment pens 
into the control pens. Diet allocation for bird trial LB01 are shown in figure 4.2  
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pen Treatment  Pen  treatment 
1 Control  25  
2 Control  26  
3 Control  27  
4 Control  28  
5 Control  29  
6 Control  30  
7  31 Control  
8  32 Control  
9 LB 33 Control  
10 LB 34 Control  
11 LB 35  
12 LB 36  
13 LB 37  
14 LB 38  
15 LB 39  
16 LB 40  
17 LB 41  
18 LB 42 Control  
19 LB 43 Control  
20 LB 44 Control  
21 LB 45 Control  
22 LB 46 Control  
23 LB 47 Control  
24 LB 48 Control  
 
Figure 3:0:2 Diet allocation for bird trial LB01 
 Diet presentation and formulation  
Starter diets were made at NTU using previously prepared commercial style mash diets. 
Diets were mixed to ensure homogeneity and a portion was removed to be mixed with 
freeze dried Lactobacillus Johnsonii, which was premixed with milk powder as a cry- 
protect. The LB treatment was mixed in a plastic bag to avoid contamination and once 
mixed the individual pen feed bags were weighed from this one mixed bag. Diets were 
analysed for nutritional composition as described in chapter 2 section 2.10). 
 Trial design for LB01 
80 male Ross 308 birds were divided at day 1 post hatch into four groups (treatments) 
with 5 birds per pen and four replicate pens per treatment. The study was conducted 
for 10 days with treatments as below:   
A) Control (birds fed basal feed free of LB with standard rearing) 
B)  Spray (birds sprayed at the hatchery with a suspension of LB)  
C) Feed (birds fed LB supplied as a feed additive until day 7 then fed basal diet) 
D) Water (birds supplied with LB via drinking water until day 5). 
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All pens were given water which had been stood overnight to remove chlorine via bell 
drinkers for the first 5 days of the study.  
3.2.5.1 Feed preparation and delivery 
A basal diet was mixed from previously manufactured trial diets formulated to meet 
nutritional requirements for the age and strain of the birds. The diet was weighed into 
individual bags for each pen for all diets apart from the feed treatment which was 
manufactured as described in section 3.2.4. 
 Treatments 
 A - Control treatment: No lactobacillus was added to this diet  
B - Feed treatment: 100g of freeze dried LB cells were weighed and mixed into 2kg of basal 
diet in a plastic bag before 500g weighed out into individual bags, one for each replicate 
pen on this treatment.  
C - Water treatment: batches of the water treatment was made up on a daily basis, using 
water de-chlorinated as previously described for the first 5 days of the study. Freeze 
dried LB (10g) was added per 300ml water and mixed before dispensing into the 
appropriate bell drinkers.  
D - Spray treatment:  birds were sprayed at the hatchery in their cardboard container and 
transported in a separate vehicle to the other birds to avoid cross contamination. The 
spray treatment was made up in de-chlorinated water using 40g of LB in 500ml. This was 
dispensed from a spray bottle until all birds were all visibly wet and the bottle was then 
reweighed to allow the dosage to be calculated. Each bird received 1.7ml of LB 
treatment. Care was taken to maintain the temperature in the transport vehicle to avoid 
chilling the chicks.   
3.2.6.1 Collecting and preparation of bird trial LB01 samples  
Body weight, feed intake and FCR were recorded on day 5 and 10 on a per pen basis as 
described in chapter2. Eight birds from each treatment were euthanized at day 5 and 10 
post hatch. Crop, jejunum, ileum, caeca and colon digesta were collected from each bird 
and place in a zipped bags. All tissues collected were placed in a polystyrene box with 
ice and transferred to IFR to be cultured on the same day by me with help from the IFR 
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team. At IFR the fresh tissues were aseptically opened in sterile petri dishes and one 
gram of tissue with tissue content were diluted 10-fold by weight in PBS and 
mechanically homogenized using a homogenizer. The samples were then serially diluted 
in PBS and appropriate dilution was added to the MRS agar before following the culture 
process previously described for enumeration of lactobacilli.  
 Statistical analysis  
All data analysis was carried out using SPSS v 22. After KS testing to confirm normality, 
treatments effects were compared to control using one way ANOVA with a tukey post 
hoc test for all parameters measured. Significant difference between means was 
declared at (P≤ 0.05).  
3.3 Results 
 Measurements parameters of trial LB01  
Figure 3:3 shows survival of L. Johnsonii FI9785 in different types of water over time at 
room temperature. The results for tap water left overnight are similar to distilled water 
or better.  This indicates tap water left standing overnight is the best water-based 
delivery medium but fresh hot or cold tap water seem to have no great detrimental 
effect on the viability of L. Johnsonii FI9785.  
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Figure 3:3 Viability of L. Johnsonii FI9785 in different types of water at room temperature 
over 24 hours period.  
[Data presented a logarithms of Colony forming unit of LB (L. Johnsonii FI9785)per gram of 
water (log cfu/g)] 
 
Figure 3:4 shows that for feed, the count of LB remained in the log 8 order of magnitude 
which indicates that there was no major degradation in the CFU of L. Johnsonii when 
stored up to 240 hours (10 days) at room temperature in broiler chickens feed.  
 
Figure 3:4 Viability of L. Johnsonii FI9785 in the broiler chickens diet at room 
temperature (25°C).  
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 Enumeration of L. johnsonii in the intestinal bacteria of broiler 
chickens  
Figure 4.5 shows that there were differences between treatments in L. johnsonii 
colonisation of different parts of broiler chickens GIT at day 5. 
 
Figure 3:5 Day 5 L. Johnsonii colonisation of different broiler chickens tissues. 
* control (feed –LAB), water, feed and spray (+LAB) 
 
 
Figure 4.6 shows the colonisation of L. Johnsonii of different broiler chickens tissues at 
day 10   and indicates that the there was no different in the level of L. Johnsonii 
colonisation of the caeca (There are no error bars as not provided by IFR).   
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Figure 3:6 LB01Day 10 L. johnsonii colonisation of different broiler chickens tissues with 
S.E. 
* control (feed –LAB), water, feed and spray (+LAB) 
 
 Tables 4:1 show the effects of LB delivery method on weekly body weight body weight 
gain, feed intake and FCR  during 1-5 and 5-10 days of age, and cumulatively. Table 4:1 
illustrates that there were significant differences between the effects of the four 
treatments on the body weight and body weight gain at day 5 of age, with supply via 
water producing a substantial increase in body weight gain compared to any other 
treatment. Also this table shows no difference between treatments in weight gain but 
significant overall effects of LB on feed intake by day 10 as the birds in the treatment 
groups consumed higher than control group. However, from table 4.1 the improved 
performance associated with water supply of probiotic was transitory and the 
cumulative treatment effect was lost by day 10, and similarly, the altered feed intake 
was also not apparent when considered cumulatively. 
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Table 3:1 Effect of Lactobacillus delivery method on bird performance from day 5 to day 
cumulative at 10 LB01 
 
(Differing superscript letters within one column denote means are significantly different 
at p < 0.05 level). *FCR: feed conversion ratio 
 
 
 
 
 
 
 
Performance Treatments P 
value Control Spray Water Feed 
Body weight 
(g) day 1 
49±1.46 47±2.13 47±1.87 48±2.10 0.78 
Body weight(g) day 5 89±1.52a 87±2.64a 98±1.91b 89±3.17a 0.02 
Body weight gain(g) 
day 1-5 
39±0.27a 39±1.79a 51±0.87c 41±1.74ab ˂0.01 
Feed intake(g)  day 1-
5 
61±13.38 54±4.47 60±4.79 58±5.25 0.92 
FCR* 
day 1-5 
1.21±0.03 1.37±0.13 1.15±0.08 1.40±0.09 0.20 
Body weight(g) 
day 10 
187 
±8.02 
183 
±7.52 
207 
±9.73 
183 
±13.03 
0.29 
Body weight gain(g) 
day 5-10 
97 
±7.94 
96 
±5.40 
107 
±8.50 
93 
±9.73 
0.96 
Feed intake(g) 
d 5-10 
158 
±8.78a 
192 
±5.27ab 
190 
±16.34ab 
243 
±2.73b 
0.01 
FCR  5-10 
1.64 
±0.10 
1.89 
±0.0 
1.8 
±0.20 
2.18 
±0.14 
0.28 
Body weight gain(g) 
day 0-10 
137±8.82 135±7.38 160±11.19 135±12.28 0.27 
F I(g)D0-10 269±28.13 282±14.76 290±19.83 339±6.62 0.11 
FCR  0-10 2.01±0.32 1.979±0.11 1.83±0.16 2.39±0.16 0.41 
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3.4  Discussion 
Figure 4:3 shows survival of L. Johnsonii FI9785 in different types of water over time at 
room temperature. The results for tap water left overnight are similar to distilled water. 
This is likely due to evaporative loss of chlorine. Although fresh hot or cold tap water 
seem has no great effects on the viability of L. Johnsonii FI9785. However, tap water left 
standing overnight was chosen for practical reasons as the best way of efficiently 
delivering the L. Johnsonii bacteria to the birds via their drinking water. For feed viability, 
results showed that there was no major degradation in the CFU of L. Johnsonii when 
stored up to 240 hours (10 days) at room temperature in broiler chickens feed. This 
indicates that this strain is able to survive when mixed and stored in broiler chickens 
diets with no detrimental effects. 
Results of bird trial LB01 use of different delivery routes resulted in apparently no 
significant differences between treatments in colonisation of different parts of broiler 
chickens GIT compared to control at day 5. However, as the data provided by IFR was 
without S.E, this did not allow rigorous investigation into the differences among 
treatments.  The level of L. Johnsonii colonisation of different broiler chickens tissues at 
day 10 of bird trial LB01 indicates that there was no different among all methods of 
delivering   feed was the optimum method for delivering probiotic bacteria.; Therefore, 
food will be chosen as a delivery method for this strain of L. Johnsonii as it the easiest 
way in the broiler chickens farm. Interestingly, there was substantial colonisation by L. 
Johnsonii of the early GIT regions of the in control birds, without obvious cause. It is 
unclear what happened, but there are two possible hypotheses; firstly there may be 
contamination of these birds by the FI9785 strain. The rationale behind this theory is the 
high level of this bacteria found in the crop and, because the crop is at the beginning of 
the broiler chickens GIT, which mean that the high level of LB present from the first part 
of gut  this is suggest that contamination via the feed. Another hypothesis is that this 
strain is not IFR FI9785 strain but a wild Lactobacillus Johnsonii strain which cannot be 
visually discriminated from FI9785. The rationale behind this theory is that, because of 
the level of LB was higher in the control (which was not given the probiotic) and in the 
spray delivery method (which was given only one dose) than in the water and feed 
treatments. Moreover, in the crop of control and spray method, which is the section of 
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GIT in the beginning of feed journey, the level of LB was high, which means these birds 
were still receiving LB at the time of sampling.  In contrast, in the birds of the feed and 
water treatments, which were delivering LB at the time of sampling, the level of LB was 
low.  
However it was difficult to consider either of these hypothesises without identifying and 
confirming by PCR the precise strain of L. Johnsonii found in the control fed birds. As this 
line of work was discontinued by IFR and no primers for L. Johnsonii FI9785 were 
available, it as was not determined whether the control-fed birds in trial LB01 were 
contaminated with the IFR strain or simply colonised by other wild type L. Johnsonii 
strains. 
Bird trial LB01 investigations into the effects of LB delivery method on weekly body 
weight, body weight gain, feed intake and FCR during 1-5 and 5-10 days of age, and 
cumulatively indicated that there was no significant effects of adding LB to feed until 
day 10 of age. The lack of bird performance differences between the various LB delivery 
routes mean that the decision over optimum delivery route could be based on intestinal 
colonisation levels alone. 
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3.5   Conclusion 
In conclusion, while both feed and water present viable routes for delivering probiotic 
supplements, delivery via feed avoids issues associated with water sanitisation and also 
provides the highest level of intestinal colonisation. The efficacy of the novel LB strain L. 
Johnsonii FI9785 indicate it promotes a protective immune response but does not 
appear to improve bird growth performance in a low pathogen environment. A major 
challenge for this work was the apparent contamination of the control samples with L. 
johnsonii. The differences that found between treatments do not support 
contamination, but as the strain could not be identified without appropriate primers for 
PCR, this cannot be verified.  
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Chapter Four: 
Evaluation of a new Lactobacillus strain as a probiotic feed additive for 
poultry 
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44:1  Introduction 
The gastrointestinal tract (GIT) is a very important organ for maintaining health, as the 
majority of pathogens affecting poultry enter through the GIT with feed or water, and 
absorption of nutrients is also controlled by the health status of the GIT (Celi, et al. 
2017). The mucosal layer of the GIT covers the epithelial surface and acts as an interface 
between the external and internal environment. Its function is as a medium for 
protection, lubrication and transport between the epithelial cells and lumen (Perry 
2006). The predominant component of mucin is mucin-type glycoprotein, which is 
produced by the mucus- secreting goblet cell (Smirnov, et al. 2004).   Campylobacter 
colonised broiler chickens can persist with a high rate of colonisation until the slaughter 
stage and beyond (Svetoch and Stern 2010). Any residual Campylobacter associated with 
the carcass post-slaughter presents a risk to human health (Public Health England, 
2016).   
One approach to post slaughter reduction of Campylobacter contamination is the use of 
probiotic bacteria to increase the ability of the microbiota of the bird to maintain health 
of the GIT via the mechanisms described earlier (Santini, et al. 2010). (Ghareeb, et al. 
2012) demonstrated that providing chicks with a probiotic supplement via the drinking 
water decreased the count of Campylobacter in broiler chickens. However, there are 
several possible ways of supplying probiotics to broiler chickens such as, mist spraying, 
via feed, oral gavage, application to the vent lip and via drinking water. (Eckert, et al. 
2010) have stated that administering Lactobacillus-based probiotics either by drinking 
water or feed improved the body weight significantly compared with control treatment, 
from 15 days of age until 48 days. (Eckert, et al. 2010) also reported that Lactobacillus 
via drinking water can improve the body weight and feed conversion of broiler chickens 
within commercial environments. Institute of Food Research (IFR) microbiologists 
isolated and patented a novel strain of Lactobacillus johnsonii: FI9785 from broiler 
chickens. The FI9785 strain was originally found to act as a competitive exclusion agent 
to control Clostridium perfringens in poultry, but more recently the strain was also 
shown to be able to compete with Campylobacter in vitro (Dertli, et al. 2015). This 
finding prompted the IFR team to approach NTU in order to test FI9785 in live birds, 
which allowed investigations into whether this bacteria enhances the immune function 
and improves the GIT health of broiler chickens. Before examining this bacteria in 
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poultry to see whether it has probiotic functionality, the FI9785 strain needed checking 
for stability outside the bird in possible cryprotect mediums. The hypothesis of this study 
are to minimise the Campylobacter in the broiler gut and to improve the performance.  
The aim of this work was to evaluate the efficacy of a novel strain of Lactobacillus 
johnsonii (LB) isolated and patented by the Institute of Food Research as a probiotic in 
meat broiler chickens. This overarching aim was met via three studies that were 
designed to determine the efficacy of feeding Lactobacillus johnsonii as a probiotic to 
broiler chicks. A subsequent bird trial utilised the most efficacious method to deliver LB 
and monitored the level of Campylobacter colonisation in birds fed LB for 7 days 
compared with a control group without probiotic over a 28 day trial period. 
4.1 Delivering the LB into chicks gut 
The first aim of this investigation was to establish a method for delivery of the novel 
Lactobacillus strain that gives the required consistent colonisation of this strain within 
target regions of the GIT (primarily caeca and colon). Options evaluated included either 
through drinking water, mixed into feed or mist spraying the chicks immediately post 
hatch. The second aim was to verify the impact of probiotic on bird performance and 
examine probiotic efficacy as a gut health enhancer. 
 Ethics and welfare  
For each bird trial husbandry and ethical clearance procedures were carried out as 
described in chapter 2 (section 2.5). 
 Bird trial room setup  
 For each bird trial, treatments were placed around the room in an attempt to avoid 
cross contamination between treatment pens. Pen distribution in the NTU poultry 
research unit is shown in figure 4:1. Different nipple drinker lines were also used for 
each treatment.  
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Figure 4:4:1 Pen layout of NTU poultry research unit with entry doors marked ‘D’ 
 
For both bird trials, the control group were situated under the ventilation inlet so as to 
reduce the risk of transport of LB between pens via air flow from the treatment pens 
into the control pens. Diet allocation for bird trial LB02 are shown in figure 4.2.  
pen Treatment  Pen  treatment 
1 Water  25  
2 Water  26  
3 Water  27  
4 Water  28  
5  29  
6  30  
7  31  
8 Feed  32  
9 Feed  33  
10 Feed  34  
11 Feed  35  
12  36  
13  37  
14  38  
15  39  
16  40  
17  41  
18  42 Spray   
19  43 Spray 
20 Control  44 Spray 
21 Control  45 Spray 
22 Control  46  
23 Control  47  
24  48  
 
Figure 4:4:2 Diet allocation for bird trial LB02  
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 Diet presentation and formulation  
Starter diets were made at NTU using previously prepared commercial style mash diets. 
Diets were mixed to ensure homogeneity and a portion was removed to be mixed with 
freeze dried Lactobacillus Johnsonii, which was premixed with milk powder as a cry- 
protect. The LB treatment was mixed in a plastic bag to avoid contamination and once 
mixed the individual pen feed bags were weighed from this one mixed bag. Diets were 
analysed for nutritional composition as described in chapter 2 section 2.10). 
 Trial design for LB02 
144 male Ross 308 birds were divided at day 1 post hatch into two groups (treatments) 
with birds were fed either a control or test diet containing used the feed delivery of LB 
and compared this head to head with a control diet to monitor effects on gut 
colonisation of both LB and Campylobacter and to monitor bird performance up to d28. 
One replicate was a pen containing 4 or 5 birds on d1 (total 72 birds per treatment 
group). The sides of the control pens were covered at day 3 with plastic sheeting to 
minimise cross-contamination between treatments. In the pens with 5 birds (odd 
numbered pens), one bird was culled on D5 to assess the colonization of LB. 
 Diet presentation and formulation  
 Treatments were Control (birds fed basal diet throughout) and test (birds fed basal diet 
containing lactobacillus at 50g per kg feed for first 7 days). Diets were fed  to the birds 
as a starter feed for days 1-20 and grower feed for days 21-28 with feed and water 
available ad libitum throughout the trial. 
A basal diet was mixed from previously manufactured trial diets formulated to meet the 
age and strain of the birds using a 100kg ribbon mixer for a minimum of 5 minutes. A 
grab sample was taken during the feed weighing prior to the trial for analysis. Diet was 
prepared fresh on d4 to allow treatment to continue until d7. From d21, all birds were 
fed a commercial grower pellet until d29.  Growth performance assessments for bird 
trial LB02  
Mean bird weight, feed intake and FCR per pen were determined on d1, d7, d14, and 
d28 as described in chapter 2 (section2.5). At the end of the performance measurement 
period (28 days) the European Production Efficiency Factor (EPEF) was calculated, based 
on the age of broilers at euthanasia (days), the average live body weight (kg / head), 
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viability (%) and feed conversion ratio: Liveability (%) x live body weight at end trial (kg) 
x 100 x age of end trial (days) x feed conversion ratio.  
 Collecting and preparation of bird trial LB02 samples for gut 
microflora analysis 
 At day 14 post hatch, nine chicks per treatment were euthanized and gut microflora 
samples collected and assessed as described below. Remaining birds were euthanized 
at the end of the trial (day 29). Culturing for trial LB02 was conducted across two sites: 
the IFR microbiology laboratories in Norwich, and also at the NTU microbiology 
laboratories at their Clifton campus. For NTU cultures, caeca samples were collected 
post mortem by placing excised caeca in bags and transporting to the culture labs on 
ice, where caeca were opened and samples collected using a charcoal swab. 
Additionally, fresh excreta from the pens were swabbed or collected in swab tubes 
before transporting on ice to the culture labs.  Immediately upon arrival at the 
microbiology laboratories, 1g of gut contents from the ileum and caecum samples from 
each chick were aseptically removed and used for the assessment of gut microflora 
population changes using standard microbiology (culture techniques) as described in 
Section 2.13.12.2. Preparation of samples for culturing involved differing serial dilutions 
for caecal and excreta sampling respectively, before adding 20 µl from the appropriate 
dilution to petri dishes of selective media and incubation under microaerobic conditions 
for 48 hours at 42oC.  Colonies of Campylobacter were enumerated in individual plates, 
then, the mean calculated to give a final count value for each bird sample.  
Additionally, on day 29, L. Johnsonii culturing was performed at IFR. Upon arrival at IFR, 
tissues were aseptically opened in sterile petri dishes and one gram of tissue (including 
digesta content) was diluted 10x w/v in PBS  and mechanically homogenized. The 
samples were then serially diluted in PBS for enumeration of lactobacilli. An appropriate 
dilutions were cultured on MRS and under microaerobic conditions at 37oC for 48 hours.  
 Collecting and preparation of bird trial LB02 samples for immune 
parameters  
Immediately post mortem, blood samples were collected and pooled from 2 birds per 
pen into EDTA tubes and multiple aliquots of plasma stored at -20oC for IgA and IgM and 
uric acid concentrations.  Finally on the day of sampling, mucin layer thickness in jejunal 
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tissue was assessed by excision of a 1 cm section of jejunum with mucin content 
measured as described in chapter 2 section 2.11. Determination of IgA and IgM 
concentration in the plasma was subsequently determined using ELISA kits (Bethyl 
Laboratories) as described at chapter 2 section 2.12. Plasma uric acid concentration was 
also determined from another plasma aliquot via Amplex Red uric acid kits (Invitrogen) 
as described at chapter 2 section 2.12.   
 Statistical analysis for both Bird trial LB02 
All data analysis was carried out using SPSS v 22. After KS testing to confirm normality, 
treatments effects were compared to control using one way ANOVA with a tukey post 
hoc test for all parameters measured. Significant difference between means was 
declared at (P≤ 0.05).  
4.2 Results 
 Measurements parameters of trial LB02 
From figure 4:7 it can be seen that there was no significant difference between the two 
groups in the CFU of Campylobacter, although there was a numerical reduction in 
Campylobacter colonisation of birds fed the probiotic.   
 
Figure 4:3 Mean values with SE of caecal colonisation of Campylobacter   in caeca of 
control and L. Johnsonii probiotic-fed birds at day 28 (LB02). 
Tables 4:1 also show the probiotic had no significant effects on the productive 
performance of birds in this trial up to three weeks of age.  
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Table 4:1 Effect of probiotic on week 1, 2, 3, 4 and cumulative bird performance   
Performance 
Treatment 
P value 
Control Probiotic 
Body weight (g) day 1 35.61±0.69 35.9±0.79 0.674 
Body weight (g) day 7 113.1±4.38 114.75±3.62 0.774 
Body weight gain (g) 7 77.49±3.81 78.84±3.17 0.787 
Feed intake (g) 7 150.23±15.68 121.59±3.89 0.095 
FCR 7 1.94±0.17 1.56±0.06 0.059 
Body weight (g) day 14 321.09±12.0 329.32±11.3 0.623 
Body weight gain (g) 14 207.98±8.23 214.56±8.20 0.575 
Feed intake (g) 14 311.73±15.22 305.55±9.98 0.737 
FCR 14 1.52±0.09 1.44±0.04 0.435 
Body weight (g) day 14 321.09±12.08 329.32±11.30 0.623 
Body weight (g) day 21 688.09±28.60 676.4±22.61 0.751 
Body weight  gain (g) 21 367.09±18.26 347.08±14.12 0.396 
Feed intake  (g) 21 497.97±22.15 486.73±22.37 0.724 
FCR 21 1.36±0.02 1.42±0.07 0.425 
Body weight (g) day 21 688.09±28.60 676.4±22.61 0.751 
Body weight  (g) day 28 1233.39±41.02 1154.95±26.66 0.121 
Body weight gain (g) 28 545.29±18.443a 478.55±7.942b* 0.003 
Feed intake (g) 28 837.09±20.20 802.29±8.32 0.127 
FCR 28 1.551±0.04b 1.681±0.02a 0.019 
Cumulative body weight 1233.39± 41.02 1154.95± 26.66 0.121 
Cumulative  body weight 
gain 
1197.77±40.70 1119.05±26.181 0.116 
Cumulative Feed intake 1797.03±41.69 1716.17±27.09 0.116 
Cumulative FCR 1.511± 0.02 1.542± 0.03 0.48 
(Differing superscript letters within one column denote means are significantly different at p ≤ 
0.05 level). *FCR: feed conversion ratio, ± values indicated SE 
 
Table 4:1 shows that there was no significant effect (p≤0.05) of probiotic in the diets on 
the productive performance of the broiler chickens in week 4, apart from body weight 
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gain and FCR. In week four of age the body weight gain significantly (p≤0.05) decreased 
in the LB treatment birds. This degradation in body weight began in week 3 but was not 
significant (p≤0.05). Also table 4:1 illustrates that the probiotic has no significant 
(p≤0.05) effects on overall productive performance of the birds over 4 weeks. 
Uric acid concentration in serum was recorded as a measure of antioxidant status 
(Cohen, Klasing and Ricklefs 2007). Table 4:9 shows there were no significant effects of 
probiotic addition on uric acid concentration in the blood plasma of birds, indicating that 
the probiotic does not appear to exert anti-oxidative effects on birds. Thickness of mucin 
layer in the jejunum (expressed as µg Alcian blue released per cm tissue) was 
significantly (P<0.05) increased from 32.06µg to 43.85µg. Also, table 4:9 shows 
concentration of IgA in the plasma blood of probiotic treated birds was increased more 
than two-fold, but IgM was not significantly altered.  
Table 4:2 Effect of probiotic on uric acid, IgA and IgM in serum and jejunal mucin 
thickness  
 
Uric acid 
(µg/dl) ±SE 
IgA 
(µg/ml) ±SE) 
IgM 
(µg/ml) ±SE) 
Mucin thickness* 
(µg) ±S.E.) 
Control 
10.28 
±0.595 
234.7 
±21.65 
410.4 
±73.39 
32.06 
±1.351 
Probiotic 
9.47 
±0.527 
624.5 
±37.82 
358.9 
±66.81 
43.85 
±3.262 
P Value 0.314 <0.001 0.693 0.002 
*Alcian blue released per cm tissue, ± values indicated SE 
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4.3 Discussion 
Results of bird trial LB02 indicated that there was no significant difference between two 
groups in the CFU of Campylobacter, probably because the unit was negative for 
Campylobacter before sampling so Campylobacter did not establish well in the broiler 
chickens GIT, as this bacteria needs time to colonise the gut of birds (Newell 2002). In 
addition, the closed mesh barriers between the pens do not allow birds to move from 
pen to pen to spread Campylobacter around the unit. It is also possible that insufficient 
birds were sampled to account for inherent variability between individual birds. For this 
reason, caecal samples from additional birds already archived from this trial were 
cultured in an attempt to increase replication to ascertain whether observed numerical 
differences actually represent significant differences between the two treatment 
groups. Unfortunately, culturing of previously frozen samples resulted in cfu levels many 
orders of magnitude lower than fresh culturing, so this line of investigation   was 
redundant. 
Performance table 3.1 shows the probiotic had no significant effects on the productive 
performance of birds in this trial up to three weeks of age. This may be due to the non-
commercial rearing conditions of the NTU poultry unit (low stocking density, high 
standards of husbandry and low pathogen exposure). Also, the NTU feeding system 
creates a high level of spillage resulting in falsely high feed intakes, particularly during 
week 1.   
Table 3:1 shows that there was no significant effect (p˂0.05) of probiotic in the diets on 
the productive performance of the broiler chickens in week 4, apart from body weight 
gain and FCR. In week four of age the body weight gain significantly (p<0.05) decreased 
in the LB treatment birds. This degradation in body weight began in week 3 but was not 
significant (p<0.05). In addition, this decline in body weight gain also correlated  with 
the body weight at day 28 as they were both decreased during week 4 in the LB 
treatment, while the FCR has increased significantly (P<0.05) in the probiotic treatment. 
Many other research publications show probiotics do not  improve the body weight or 
affect performance (Lutful Kabir 2009) but it is unusual to find a negative effect of 
probiotic usage on weight gain. It is possible that the probiotic bacteria has competed 
with the birds on the food, hence this birds consumed more feed which caused the 
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increasing FCR or it may be the skimmed milk has negatively affected digestibility of the 
feed, although there is no reported literature supporting this theory. 
Table 3:1 illustrates that the probiotic has no significant (p˂0.05) effects on overall 
productive performance of the birds over 4 weeks, which is in keeping with many other 
reported findings; possibly because our poultry unit invokes relatively benign microflora 
to colonise the GIT of newly placed chicks, so addition of the probiotic does not lead to 
substantial alteration.  
Results of LB02 showed that there were no significant effects of probiotic addition on 
uric acid concentration in the blood serum of birds, indicating that the probiotic does 
not appear to exert anti-oxidative effects on birds. However, there are some indications 
that the probiotic exerts an immune response in the birds: thickness of mucin layer in 
the jejunum (expressed as µg Alcian blue released per cm tissue) was significantly 
(P<0.05) increased from 32.06µg to 43.85µg. Also, table 4:9 shows concentration of IgA 
in the plasma blood of probiotic treated birds was increased more than two-fold, but 
neither IgG nor IgM were significantly altered. A similar Ig response to probiotic 
supplementation of meat chicken was also reported by (Haghighi, et al. 2006), who 
found that oral gavage of chicks at day 1 post hatch with three strains of probiotic 
(Lactobacillus acidophilus, Bifidobacterium bifidum, and Streptococcus faecalis) resulted 
in increased IgG and IgA in all probiotic-fed birds. 
The increased mucin layer thickness suggests this strain of L. Johnsonii has ability to 
stimulate the goblet cells to increase the production of mucin, which may play a role in 
protecting the epithelium from attachment by pathogenic bacteria. These heightened 
mucosal immune responses concur with several other studies suggesting probiotics 
enhance the immunity of broiler chickens. A similar increased mucin layer thickness 
associated with including a probiotic in chicken feed was found by (Forte, et al. 2018) 
where it was found that dietary inclusion of Lactobacillus acidophilus resulted in 
increased ileal mucin layer thickness. However the performance data derived from LB02 
are not in agreement, as (Forte, et al. 2018) found bird body weight and feed intake of 
probiotc-fed birds in their study was improved, while in this study the was no significant 
effect on these parameters.   
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Other researchers also report mixed growth performance responses to use of probiotic 
supplements. (De Cesare, et al. 2017) found that dosing chicks with Lactobacillus 
acidophilus D2/CSL (CECT 4529) improved body weight was at day 15 of age. In contrast, 
(Olnood, et al. 2015) used  four strains of Lactobacillus (tentatively identified 
as Lactobacillus johnsonii, Lactobacillus crispatus, Lactobacillus salivarius and an 
unidentified Lactobacillus sp) in broiler chickens diets  and found there were no 
significant differences on the body weight, feed intake and body weight gain at day 21 
of the age of broiler chickens. 
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4.4  Conclusion 
In conclusion, studies into the efficacy of the novel LB strain L. Johnsonii FI9785 indicate 
it promotes a protective immune response but does not appear to improve bird growth 
performance in a low pathogen environment. A major challenge for this work was the 
apparent contamination of the control samples with L. johnsonii. The differences that 
found between treatments do not support contamination, but as the strain could not be 
identified without appropriate primers for PCR, this cannot be verified. The subsequent 
studies were carried out without any form of collaboration, and focussed on in house 
development of a potential probiotic supplement and prebiotic support via Jerusalem 
artichoke as a source of inulin.
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Chapter five: 
5Assessment of Lactic acid-bacteria isolates derived from the intestines 
of apparently healthy free range poultry as a potential probiotic agent 
for broiler with Jerusalem artichoke as a potential prebiotic
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5.1 Introduction  
Probiotic supplement has been defined as a live microbial feed supplement which 
has a positive effect on the health of an animal through altering the balance of 
intestinal microflora (Fuller 1989). Lactic Acid Bacteria (LAB) are one of the most 
important microorganism groups in the intestine of animals as well as humans. 
Species within the genera of Lactobacillus and Bifidobacterium are the predominant 
microorganisms in gastrointestinal microbiota in the human and animal (Guarner and 
Malagelada 2003). Lactobacillus is the most commonly selected genus to be used as 
a probiotic in humans as well as in animals (Moreira, et al. 2005, McCoy and Gilliland 
2007). Lactobacilli are classified as Gram-positive, catalase-negative, non-
sporulating, anaerobic fermentative bacteria, which are acid-tolerant and have 
particular sensitivity to oxygen (Kleerebezem and Hugenholtz 2003). Lactobacillus 
strains can be used as probiotic agents in the early life of chicks to improve the gut 
microflora, and are commercially available as feed supplements for poultry (O'Dea, 
et al. 2006). However, there is a substantial cost involved in the purchase of 
commercially-derived probiotics from multinational companies, which could be 
avoided if strains of Lactobacillus that appear to maintain intestinal health in poultry 
could be isolated and cultured on a more regional level. Also there are a many studies 
that have confirmed the activity of probiotic to minimise the Campylobacter spp. in 
the broiler (Santini, et al. 2010) which in turn can produce fewer contaminated 
broiler chickens products for consumers.      
If a LAB strain is to be used as a successful probiotic it must exhibit some important 
characteristics. First of all the strain should have an antagonistic activity against 
pathogenic bacteria. In addition a candidate bacteria should be able to survive not 
only in the gastrointestinal environment (Fontana, et al. 2013) but must also maintain 
their viability during processing and storage. Requirements during the processing 
steps include: viability after freezing and drying, and ability to survive in 
environments containing different levels of oxygen. Key features of survival in the 
gastro-intestinal tract include; tolerance to strongly acidic pH, contact with bile salts 
and sodium chloride; and the bacteria should able to survive at 42°C temperature 
(chicken core body temperature ) (Giloh, Shinder and Yahav 2012).  
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Inulin is a non-digestible plant oligosaccharide that can be used as a prebiotic to 
selectively stimulate growth of Lactobacillus and Bifidobacterium while limiting 
growth of non-beneficial bacteria in the intestine, which leads to improve the host 
health (Gibson, et al. 2004, Coudray, et al. 2005). Jerusalem artichoke is a plant that 
is successfully grown widely around the world under different climate environments, 
which is renowned for storing a relatively high amount of inulin (McLaurin, Somda 
and Kays 1999).  
The aim of this study was to isolate strains of LAB from the excreta of apparently 
healthy broiler chickens that have been shown to be Campylobacter free, despite 
exposure in a free range management system and to then screen these isolates for 
the essential attributes of probiotic bacteria as well as to test their inhibitory activity 
against Campylobacter which is a known human pathogen commonly isolated from 
the chicken intestine. A secondary aim was to source and prepare Jerusalem 
artichoke plant material as a source of inulin and to assess its potential as a prebiotic. 
Hypothesis of this works are the isolates of LB from apparently healthy, mid-aged  
outdoor pet chickens are potential probiotic agent and also JA plant is good source 
for prebiotic in broiler chicken feed.   
5.2  Method        
 Screening the chicken for Campylobacter spp.   
Details in section 2.4   
 Screening and isolation of lactic acid bacteria       
As explained in section 2.13.1 
 Identification of isolates  
5.2.3.1 Morphological and biochemical tests on the isolates 
Details in section 2.4   
5.2.3.1.1 Gram staining  
Gram stain was used to determine the Gram status of the isolates from fresh growth 
as explained in section 2:13:3:2.  
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.  
5.2.3.1.2 Catalase test    
Catalase test was performed to check if isolates are catalase negative or positive 
(catalase producer or not) by using 3% hydrogen peroxide solution.  
5.2.3.1.3 pH of growth broth  
pH of broth was measured by using  pH meter (Mettler-Toledo, UK). The pH of the 
broth after incubation was compared with the initial pH of broth. 
5.2.3.2 Genotypic Identification: 
5.2.3.2.1  DNA extraction  
Details in the section 2:13:3:1:1  
5.2.3.2.2 Gene sequencing (16S rDNA)  
Details in the section 2:13:3:1:2 
 Assessment of antibacterial activity against Campylobacter 
strains.  
As explained in section 2:13:5 
  Detection of hydrogen peroxide production  
Details in the section 2:13:5:4 
 Evaluation the phenotypic characteristics of the isolates as 
probiotic agent to survive in the intestinal gut environment  
5.2.6.1 Viability of isolates at (relatively high temperature) 
Details in the section 2:13:4:1  
5.2.6.2  Tolerance to oxygen  
Details in the section 2:13:4:2 
5.2.6.3 Antibiotic resistance  
Details in the section 2:13:4:2 
Iso
20 
Iso
40 
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5.2.6.4 Tolerance of Bile salts 
Details in the section 2:13:5:5:1 
5.2.6.5 Tolerance of Sodium Chloride (NaCl) 
Details in the section 2:13:5:5:2 
5.2.6.6 Tolerance of acid  
Details in the section 2:13:5:5:3  
 Utilization of Artichoke Jerusalem (Inulin) as source of carbon 
by LAB isolates.  
Basal MRS broth medium was used as a standard and compared with media in which 
the glucose was replaced with either the same amount of artichoke powder or 
commercial inulin (SENSUS, Netherland). The growth of isolates was determined by 
measuring the absorbance (optical density (O.D600)) using plate reader (CYTATION-
imaging readers-Bio-rad, USA) at different time points: zero, 12 and 24 hour. 
 Preparing the isolates as probiotic (chicken feed supplements) 
The cells of bacteria, grown in broth media, were pelleted and washed with PBS then 
resuspending in PBS, skimmed milk and sucrose which then mixed thoroughly by 
vortex and freeze drying . 
 Preparation of product as feed supplement  
Dried product was diluted to 109 cfu with skimmed milk to be use in broiler chickens 
feed.  
 Assessment the viability of bacterial cells during the 
preparation of broiler chickens feed supplements   
Details in section 2:13:8 
 Preparation of Jerusalem artichoke tubers  
 Details in section 2:13:9 
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   Determination of the content of inulin in Jerusalem artichoke 
plant 
Details in section 2:13:9:10 
5.3 Results  
 Screening the broiler chickens for Campylobacter spp. and 
Lactobacillus  spp.  
 The results confirmed that all collected samples from the broiler chickens at 
Brackenhurst animal unit were Campylobacter free. The morphologic characteristics 
confirmed that they are probably LAB, therefore 6 isolates that has the characteristic 
of LAB (white or creamy) from highest dilution were selected for further tests 
Anupama and Sharma (2017).       
 Morphological and biochemical tests on the isolates  
5.3.2.1 Catalase, Gram stain and acid production  
Table 5:1 shows that all LAB isolates were Gram positive, catalase negative and rod-
shaped. All selected isolates decreased the pH of the broth media below pH 6 which 
as initial pH (before incubation). Lowest pH was in the broth of isolate 6 (pH 3.42) 
while the highest pH was of isolate 1 (pH 4.03).  
Table 5:1 Morphological characteristics of selected lactic acid bacteria isolates  
 
 
 
 
 
 
Isolates pH of broth Gram stain Catalase test Cells shape 
1 4.03 + - Rod 
2 3.75 + - Rod 
3 3.72 + - Rod 
4 3.97 + - Rod 
5 3.50 + - Rod 
6 3.42 + - Rod 
Initial media pH 6.5    
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 Evaluation the phenotypic characteristics of the isolates as 
probiotic agent to survive in the intestinal gut environment    
All isolates were able to grow at both temperatures 37°C and 42°C (broiler chickens 
intestine temperature). All showed ability to grow at all three different levels of 
oxygen. Either with or without oxygen in addition to low level of oxygen.       
5.3.3.1 Identification of LAB   
5.3.3.1.1 Genetic identification analyses of isolate (16S rRNA)  
16s rRNA was used to identify the genus and species of the 6 isolates. This technique 
was able to identify the isolates to species level. Table 5:2 shows that at genus level 
all isolates were belonging to the Lactobacillus genus. While at the species level, 
isolates 1, 2, 3 and 5 belong to species Lb reuteri while isolate 4 was Lb fermentum 
and isolate 6 was Lb salivarius.  
Table 5:2 Genus and species of selected LAB isolates identified by 16S   
ID of Isolate Genus Species 
1 Lactobacillus reuteri 
2 Lactobacillus reuteri 
3 Lactobacillus reuteri 
4 Lactobacillus fermentum 
5 Lactobacillus reuteri 
6 Lactobacillus salivarius 
  
5.3.3.1.2 Susceptibly of LAB isolates to antibiotics test  
Antibiotics discs were used examine the susceptibly of these 6 isolates toward a 
range of antibiotics. Table 5:3 shows that all LAB isolates were sensitive to antibiotics; 
Ampicillin, Rifampicin and Cefotaxime. While antibiotics ciprofloxacin and ofloxacin 
have no action toward the LAB isolates as there was no zone around the disc.  The 
susceptibility of isolates to gentamicin was low or negative as the zone of inhibition 
was small. Tetracycline had variable activity toward the isolates, as the highest 
sensitivity was of the isolate 5 and 1, while isolates 2, 3, 4 and 6 all seem have similar 
zone of sensitivity toward Tetracycline. 
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Table 5:3 Prevalance of resistance of LAB to selected antibiotic  
Isolate 
Antibiotics 
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L. reuteri + ++++ _ ++ +++ ++++ _ 
L. reuteri + ++ _ _ ++ ++++ _ 
L. reuteri + +++ _ + ++ ++++ _ 
L. fermentum - ++++ _ _ ++ ++++ _ 
L. reuteri + +++++ _ +++ +++ ++++ _ 
L. salivarius - +++++ _ + ++ +++ _ 
              -no zone, +less 2mm, ++5mm, +++7mm, ++++ 9mm, ++++11mm 
 
5.3.3.1.3 Antimicrobial activity of lactic acid bacteria isolates   
The antimicrobial activity of the 6 isolates was tested to investigate their activity 
towards pathogenic bacteria. Three different strains of Campylobacter were chosen 
as indictors. Table 5:4 and figure 5:1 show that all isolates have an inhibitory activity 
towards the three strains of Campylobacter. It seems that the highest activity was for 
isolate 6 against all three strains of Campylobacter. While the lowest activity was of 
isolates 3 and 4 toward 01/51 strain.  
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Figure 5:1 Inhibition zone of Campylobacter jejuni by cell –free supernatant of LAB 
isolates 
  
Campylobacter strains are; left top 01/51, right top RM1221 and the bottom is NCTC 11168. 
Wells of 6 isolates supernatant on each plate from left top to right top; strain1 (L. reuteri), 
strain2(L. reuteri), strain 3 (L. reuteri), strain 4 (L. fermentum), strain 5(L. reuteri), strain 6(L. 
salivarius) 1, 2, 3, 4, 5 and 6 while middle well is the control (only MRS broth)  
 
 
 
  
01/51(wild type) RM1221 (chicken)  
NCTC 11168 (human) 
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Table 5:4 Antimicrobial activity of LAB isolates cell-free supernatant toward three 
strains of Campylobacter performed by agar well diffusion method 
Isolates 
 
Inhibition activity against  strains of 
Campylobacter jejuni 
RM1221 01/51 NCTC 11168 
1 +* ++ ++ 
2 ++ ++ ++ 
3 ++ + ++ 
4 ++ + ++ 
5 ++ ++ ++ 
6 +++ +++ +++ 
* Diameter of inhibition zone + 4-8 ++ 10-12mm, +++ 13-15  
5.3.3.1.4 Hydrogen peroxide production 
All isolates were tested for production of H2O2 which is consider as antimicrobial 
substance that is produced by Lactobacillus bacteria. This was done by detecting the 
blue halo around the colony on the plate using supplemented agar media. Results 
show  that Isolates 1, 3, 4 and 6 were positive for H2O2 production as there was a halo 
of blue colour around the colonies of isolates. While isolates 2 and 5 were negative 
of H2O2 production as there was no halo around the growth (data not shown).  
5.3.3.1.5 Tolerance of isolates to Bile salts 
The sensitivity of LAB strains to bile salts was tested on MRS broth containing 
different levels of bile salts. Figure 5:2 present the survivability of LAB isolates in the 
supplemented media with 0, 0.25, 0.50, 0.75 and 1% of bile salts. This figure show 
that all isolates were able to survive and grow in the inoculated medium with 
different levels of bile salts. Level zero was as standard to compare the growth in    
the MRS broth as figure present the results.   
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Figure 5:2 Survival of LAB isolates in the media supplemented with   0, 0.25, 0.50.075 and 1% of bile salts.   
A: strain1 (L. reuteri), B: strain2 (L. reuteri), C: strain 3 (L. reuteri), D: strain 4 (L. fermentum), E: strain 5(L. reuteri), F: strain 6(L. salivarius) 
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5.3.3.1.6 Tolerance of isolates to sodium chloride (NaCl) 
Figure 5:3 show that in general the growth of bacteria decreased as concentration of 
NaCl increased. However it seems that the growth of isolates was unaffected 
significantly at the concentrations of 1 and 2% of NaCl which was close to the 
standard media (0%) as the absorbance (O.D) were similar. In the other levels of NaCl 
the growth of bacteria was decreased when the concentration of NaCl increased. At 
3% the growth was less but still close to standard. At concentrations 4 and 5% there 
was delay of growth until 6 hours then growth increased rapidly by 24 hour. While at 
level 6% there was minimal growth, a high levels (7-10%) seem that viability was 
much lower. 
5.3.3.1.7 Tolerance of isolates to acidic media 
Isolates were examined whether they could grow and survive in the low level of pH 
in the intestinal gut of broiler chickens. Figures 5:4 and table 5:5 show that all isolates 
can grow at pH 4, 5 and 6, although, growth at pH 4 was less. At pH 2 and 3 growth 
low but they were still viable as table 7 shows.  
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Figure 5:3 effect of NaCl in the media on the viability of LAB isolates at levels 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10%. 
 A: strain1 (L. reuteri), B: strain2(L. reuteri), C: strain 3 (L. reuteri), D: strain 4 (L. fermentum), E: strain 5(L. reuteri), F: strain 6(L. salivarius) 
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Figure 5:4 Growth of LAB isolates in MRS broth varying pH over different time points.    
*A: strain1 (L. reuteri), B: strain2(L. reuteri), C: strain 3 (L. reuteri), D: strain 4 (L. fermentum), E: strain 5(L. reuteri), F: strain 6(L. salivarius) 
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Table 5:5 viability of LB isolates from the acidified broth  
 
Isolate 
Growth of isolates  from the broth  (pH) 
2 3 4 5 6 
1 +* + ++ ++ ++ 
2 + + ++ ++ ++ 
3 + + ++ ++ ++ 
4 + + ++ ++ ++ 
5 + + ++ ++ ++ 
6 + + ++ ++ ++ 
*+ low growth, ++ good growth
  Utilization of Jerusalem artichoke (JA) plant by isolates  
The isolates were screened for their ability to use the JA plant as a carbon source for 
their growth. Three supplements were used in the broth media, glucose (standard), 
Inulin and Artichoke, number of bacteria increased over 24 hours of incubation for 
all isolates. Figure 5:5 show that the count of bacteria was increased after 24 hours 
on the broth that supplemented with artichoke instead of glucose. The growth of 
isolates on inulin broth was the lowest while the highest growth was in the broth of 
artichoke.    
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Figure 5:5 growth rate (O.D600nm) of LAB isolates in media containing different carbon source; prepared with glucose-base (standard), inulin 
(commercial) and Jerusalem artichoke plant.  
*A: strain1 (L. reuteri), B: strain2 (L. reuteri), C: strain 3 (L. reuteri), D: strain 4 (L. fermentum), E: strain 5(L. reuteri), F: strain 6(L. salivarius) 
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 Viability of bacterial cells during preparation of probiotic 
product  
 Isolates were examined for viability during processing to ensure they retained 
viability at different stages of production as feed supplements. As figure 5:6 shows 
that there was no big drop in the survival of all LAB isolates during different steps of 
processing. It seems that the drying has the greatest influence on the viability, 
however the biggest drop of just 1.5 logs was seen for isolate 3.  
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Figure 5:6 Effects of preparation of isolates probiotic product on the viability of 
bacterial cells.  
* strain1 (L. reuteri), strain2 (L. reuteri), strain 3 (L. reuteri), strain 4 (L. fermentum), strain 5 (L. 
reuteri), strain 6(L. salivarius) 
 
 Inulin content of Jerusalem artichoke and utilisation in the 
culture media  
Inulin content was measured in the dry JA plant to determine the concentration of 
inulin in the Iraqi JA. The concentration of inulin was 52% of the dry matter of tuber.  
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5.4 Discussion  
Lactobacillus isolates were isolated from Campylobacter-free chicken and examined 
to be used as a probiotic agent in broiler chickens feed. Six isolates were selected for 
further investigation. In addition JA plant was examined to be used as a prebiotic 
supplement in broiler chickens. Evaluation of the isolates included three steps: First 
was the morphologic and phenotypic properties of the isolates to identify them. 
Secondly, the isolates were examined for their activity toward Campylobacter and 
their survival in vitro in environments created to mimic the stresses faced by the 
organisms during passage through the intestinal gut of broiler chickens. Finally, 
isolates were examined for viability during preparation as feed supplements. 
Jerusalem artichoke was also examined for its ability to be used as a carbon source 
for Lactobacillus.  
The morphology and biochemical tests confirmed that all isolates were thought to be 
LAB which allowed for further tests. Genetic examination confirmed that the isolates 
all belonged to the Lactobacillus genus with three species identified: Lb reuteri, Lb 
fermentum and Lb salivarius. All the three species of Lactobacillus are common 
species in the broiler chickens gut and they have all been used previously as probiotic 
organisms to improve the health and performance of broiler (Olnood, et al. 2015, 
Shokryazdan, et al. 2017). Further validating use as a probiotic agent in this study.  
 All LAB isolates were inhibitory against the three chosen species of Campylobacter. 
This result agree with the findings of others studies (Santini, et al. 2010), in which 
Lactobacillus isolates from chicken were able to inhibit the growth of Campylobacter. 
Also (Ghareeb, et al. 2012) found that Lb. salivarius and Lb. reuteri, Enterococcus 
faecium and Pediococcus acidilactici did inhibit the growth of Campylobacter jejuni. 
Some of them are able to produce H2O2 which is one important mode of action of LAB 
to be used as probiotic as an antimicrobial agent against pathogenic bacteria (Servin 
2004). All isolates in this study remained viable at low pH (2 and 3) for up to 5 hours. 
They were also able to survive with additional bile salts at the levels 1% in the media 
for 24 hours and viability has maintained 6% on NaCl.   
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The results of the current study are consistent with other research (Jin, et al. 1998, 
Hassanzadazar, et al. 2012) which found that Lactobacillus isolates from chicken or 
humans have tolerance to a simulated gut environment. The concentration of inulin 
in the Iraqi JA was 52% of the dry matter of the tuber. This level of inulin in the dried 
plant is considered as a concentrated supplement, also it is acceptable as the JA will 
be added in small amount in the feed of broiler chickens. In addition using the dried 
plant matter is easier for handling and storage and it can be added to and mixed with 
other supplements. The LAB isolates were able to use JA powder as a source of 
carbon. This result confirms the findings of (Kunová, et al. 2011, Nagpal and Kaur 
2011) as they found that some Lactic Acid Bacteria are able to use inulin as source of 
carbon in the media. Also the growth of LAB in the media containing the JA was 
higher than in the standard media (glucose) and this may be because the powder was 
a raw plant which contained other nutrients such as minerals (Lachman 2008). Also 
it seems that growth in media with pure inulin (Frutafit®) was lower than with other 
supplements, so the growth on inulin from artichoke was better than on the pure 
inulin. This level of inulin in the plant made the Jerusalem artichoke powder an 
attractive feed supplement in the broiler chickens diets. 
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5.5 Conclusion  
The aim of this study was to screen LAB isolates from chicken for their possible use 
as candidate probiotics. All tests that have been carried out on these isolates can 
confirm that the isolates have the characteristics of lactic acid bacteria and they have 
an activity toward Campylobacter as a pathogenic bacteria indictor. Also they belong 
to the genus of Lactobacillus and its species that have already been used as probiotics 
in human and animal. In addition isolates are able to keep their viability during 
freezing and drying and they can survive in the environments of gastrointestinal gut 
of broiler chickens. This evaluation suggests that these isolates that were isolated 
from chicken can be used as a potential probiotic agent in the diets of chicks. It also 
seems that the artichoke plant is good source for inulin to be used in chicken as a 
prebiotic.  As all six candidate probiotic strains appeared to be viable candidates for 
potential use in broiler chickens diets, all were therefore taken forward for 
assessment in vivo in bird trial LB03. 
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6 6 Chapter six: 
The influences of prebiotic, probiotic and synbiotic 
supplements on the performance of broiler chickens 
 114 
 
6.1 Introduction 
Currently there is a growing interest of scientific research on the role of probiotics, 
prebiotics and synbiotic as effective alternatives to the use of antibiotics in animal 
nutrition (Alloui, Szczurek and Swiatkiewicz 2013, Cheng, et al. 2014). Additionally, 
several researchers have discussed the effect of probiotic, prebiotic and synbiotic on 
poultry performance. 
Gut microflora contribute to the digestion, absorption and the metabolism of dietary 
carbohydrates, protein, lipids and minerals and the synthesis of vitamins. Therefore 
any interruption that occurs in the balance of gut microbiota is likely to affect 
nutrient digestion and absorption which in turn, could affect bird health and 
performance. Gut microflora play an important role in nutrition and health status of 
the host as it has been extensively reported that intestinal microflora balance is 
beneficially influenced by prebiotic and probiotic (Kim, et al. 2011, Semova, et al. 
2012, Daliri and Lee 2015).    
Supplementation with probiotics and prebiotics has been used to improve the 
performance of broiler chickens. (Shokryazdan, et al. 2017) reported that feeding 
probiotic (Lactobacillus salivarius) has led to achievement of live body weight of meat 
chickens at 42 days of age which were higher significantly (P≤0.05) than control fed 
birds. (Mountzouris, et al. 2010) observed that diets containing 108 cfu probiotic/kg 
increased the body weight of broilers significantly (P<0.05) comparing with control 
group without probiotic.  (Mookiah, et al. 2014) showed that use of prebiotic brand 
(IMO) which contains monnaologosaccharide , probiotic of 11 Lactobacillus strains 
and combination of both (synbiotic) in poultry feed significantly (P<0.05) improved 
body weight gain of broiler chickens at 22-42 and 1-42 days of age, and feed 
conversion compared with control group.  
This experiment aimed to study the effects of dietary supplements of prebiotic 
(Jerusalem artichoke), probiotic (novel Lactobacillus isolates) and synbiotic 
(combination of both) in the chicken feed on the performance during different ages. 
The specific hypothesis for this chapter is that the isolates could be a good resource 
as probiotic agent to be used in chicken feed.   
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6.2 Method   
  Trial design 
6.2.1.1 LB03 Trial design 
216 male Ross 308 broilers were ordered by NTU from PD Hook and collected from 
their Cote (Oxford) hatchery. The birds were divided at day 1 post hatch into six 
groups (treatments) with the birds that fed a control diets by using the feed delivery 
of LB and compared this control diet to monitor effects on gut colonization of both 
LB and Campylobacter, immune function and to monitor bird performance at day 7, 
21 and 42. Husbandry and ethical clearance procedures were carried out as described 
in chapter 2 section 2.5. One replicate was a pen containing 6 birds on d1 (total 36 
birds per treatment group). Diet allocation is shown in appendix H. In the pens with 
6 birds. The unit was divided and sealed into two sides: probiotic and non-probiotic, 
using plastic sheeting to minimise cross-contamination by Lactobacillus isolates 
(probiotic).  
  Diet mixing and sampling Diet Formulation 
All trial diets were manufactured on site and fed as mash. A basal diet was mixed 
from previously manufactured trial diets formulated to meet the age and strain of 
the birds. A grab sample was taken during the feed weighing prior to the trial for 
analysis. The composition and analysis of all the trial diets are provide in the 
corresponding chapter 2 section 2.6. To avoid any cross contamination all non-
probiotic (prebiotic) diets were manufactured, weighed and removed from the feed 
room before making probiotic diets. Equipment used for mixing of probiotic diets 
were flushed with wheat (then wheat discarded) cleaned thoroughly and sprayed 
with hycolin and left for 7 days before manufacture of non-probiotic diets. 
5kg of diet was weighed into individual bags for each control pen. For the treatment 
pens, an appropriate quantity of freeze dried LB cells to meet the concentrations 
specified in table 6:1 were weighed and mixed into a plastic bag then weighed out 
for each treatment pen. Supplements were mixed with small amount of feed then 
added and mixed with the weekly allocated basal diet volume.  
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The 6 dietary treatments for LB03 are shown in table 3:, with 6 replicate pens per 
treatment. Birds were all fed a starter mash until d14 then a commercial grower 
pellet until d28 then finisher until 42. The dietary treatments for LB03 are shown in 
table 6:1. Briefly, birds were fed the following diets: T1 (Control - birds that fed basal 
diet); T2 (prebiotic - birds fed 5% JA powder);  T3 (prebiotic - birds fed 10% JA 
powder); T4 (probiotic - birds fed mix of isolates of Lactobacillus(LB) at level 10^9 
CFU/kg; T5(synbiotic - birds fed basal diet +LB+5% JA); T6 (synbiotic - birds fed basal  
diet +LB+10%JA). 
Table 6:1 Dietary treatments for bird trial LB03 
Diet Treatment 
Control(T1) standard feed throughout 
Prebiotic (T2) Artichoke prebiotic level 1(5 g/kg feed) 
Prebiotic (T3) Artichoke prebiotic level 2(10 g/kg feed) 
Probiotic (T4) 10^9 CFU of each of 6 isolates of Lactobacillus 
Synbiotic (T5) Probiotic +prebiotic level 1 
Synbiotic (T6) Probiotic +prebiotic level 2 
 
 Birds and Husbandry 
Institutional and national guidelines for the care and use of animals (Animal Scientific 
Procedures Act, 1986) were followed and all experimental procedures involving 
animals were approved by the School of Animal, Rural and Environmental Sciences 
Ethical Review Group. Commercial guidelines for the care and husbandry of Ross 308 
broilers were followed in all studies (Aviagen, 2008). Any mortalities were recorded 
along with the date and weight of the bird and reason if culled.  All birds sampled 
were euthanised by cervical dislocation as determined by DEFRA (DEFRA, 2007) and 
the Animal Scientific Procedures Act (ASPA, 1986).  
 Feed Intake 
Feed intake was measured as explained in section 2.7  
  Bird Weights 
Bird weight was measured as explained in section 2.8 
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 Feed conversion ratio (FCR) was calculated as follows  
 FCR (kg feed/kg gain) = cumulative feed intake (kg)/total weight gain (kg); 
 Body weight gain (BWG)   
BWG (grams on period) = BW (g) at the end of each week - BW (g) in first of the week. Viability (%) 
= chicks remaining at the end of period (%);  
 European Production Efficiency Factor was calculated as 
follows:  
European Production Efficiency Factors (EPEF) EPEF = [Viability (%) X BW (kg) / age 
(day) X FCR (kg feed/kg gain)] X 100         
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6.3 Results  
Tables 6.2 shows the effects of supplements of prebiotic, probiotic and synbiotic on 
the weekly body weight of birds fed each diet. While some differences in weekly 
mean bird body weight were identified, a consistent response was not observed 
across all weeks. As expected, no significant differences in bird body weight were 
observed on day 0. At day 7 only probiotic treatments affected the body weight 
which was 118.51g in the T4 comparing to 134.82g in the control. By day 7 a 
significant decrease in body weight of chicks fed diet T4 (probiotic alone) was 
observed. However, this negative effect on bird body weight was lost at day 14 where 
there was no significant difference between treatments, although it should be noted 
that T4 remained numerically the lowest value on day 21, a significant decrease in 
body weight was observed in all birds fed diets containing probiotic either alone or 
in combination with the prebiotic supplement (diets T4, T5 and T6). On day 28, no 
significant differences in body weight were observed but interestingly at this time 
point, the errors terms associated with each mean value began to differ substantially, 
and the variability in error terms remained for the rest of the study. 
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Table 6:2 Effect of prebiotic, probiotic and synbiotic on weekly live body weight (g), 
of broiler chicken (Mean ± standard error).  
 (a, b) data with the same superscript in the same row are not significantly different (P≤0.05). 
T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 
10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 CFU/kg.T5 
(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed Basal diet +LB+10%JA. L, linear, Q, 
Quadratic.   
Tables 6:3 shows the effects of supplements of prebiotic, probiotic and synbiotic on 
the weekly body weight gain of birds fed each diet on day 7 and day 14 no significant 
differences were observed between diets. On day 21, a significant decrease in body 
weight gain (corresponding to the previously described decrease in body weight for 
these treatments) was observed in all birds fed diets containing probiotic either alone 
or in combination with the prebiotic supplement (diets T4, T5 and T6). In contrast 
however, on day 28, significant differences in body weight gain were observed as 
interestingly, the body weight gain for birds fed diets T4, T5 and T6 was higher than 
for birds fed the other treatments. On day 35 and 42 a numerical reduction was 
observed in body weight gain of birds fed diet T6 compared to other diets, but this 
Day  T1 T2 T3 T4 T5 T6 P value  
D0 
40 39 39 38 38 37 0.326 
L*( 0.63) 
Q (0.69) 
±0.70 ±0.66 ±0.50 ±0.98 ±0.80 ±0.81 
D7 
134 134 124 118 128 123  0.294 
L(0.101) 
Q (0.306) 
±4.37 ±4.63 ±7.80 ±5.34 ±5.49 ±5.53 
D14 
343 338 310 298 330 322 0.674 
L(0.445) 
Q (0.267) 
±16.43 ±16.50 ±18.75 ±25.03 ±25.52 ±24.43 
D21 
809a 804 a 791a 645b 681b 627b 0.002 
L(0.001) 
Q (0.884) 
±29.17 ±33.13 ±33.03 ±44.73 ±34.74 ±50.41 
D28 
1298 1256 1177 1185 1241 1127 0.411 
L(0.091) 
Q (0.747) 
±39.62 ±33.78 ±59.61 ±78.48 ±52.03 ±83.45 
D35 
2052 2006 1878 1965 1976 1783 0.164 
L(0.039) 
Q (0.793) 
±57.67 ±46.85 ±59.57 ±107.84 ±69.79 ±87.21 
D42 2885 2791 2667 2807 2843 2550 0.138  
L(0.086) 
Q (0.674) 
 ±73.80 ±77.35 ±81.25 ±120.82 ±96.13 ±98.61 
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effect were not significant. Overall cumulative body weight gain was not significantly 
different between treatments but numerically reflected the pattern of growth seen 
for each dietary treatment.  
Table 6:3 Effect of prebiotic, probiotic and synbiotic on weekly body weight gain (g) 
of broiler chicken (Mean ± standard error).   
 (a, b) data with the same superscript in the same row are not significantly different (P≤0.05). 
T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 
10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 CFU/kg.T5 
(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed basal diet +LB+10%JA.  
Table 6:4 shows the effects of supplements of prebiotic, probiotic and synbiotic on 
the weekly and cumulative feed intake of birds fed each diet on days 7, 14, 21 and 
28
Body 
weight gain 
T1 T2 T3 T4 T5 T6 P value 
D7 
94 
±4.13 
94 
±4.15 
85 
±7.54 
80 
±5.61 
90 
±5.23 
85 
±4.90 
0.354 
L(0.161) 
Q(0.309) 
 
D14 
208 
±12.27 
204 
±13.90 
186 
±13.71 
197 
±15.47 
201 
±21.67 
199 
±19.50 
0.942 
L(0.688) 
Q (0.3) 
 
D21 
466 a 
±29.80 
465 a 
±17.57 
481 a 
±21.84 
347 b 
±27.23 
350 b 
±16.85 
304b 
±30.57 
0.002 
L(0.03) 
Q (0.233) 
 
D28 
489a 
±40.92 
452a 
±15.37 
405b 
±31.33 
539a 
±47.15 
560a 
±22.81 
500a 
±34.26 
0.012 
L(0.066) 
Q (0.456) 
 
D35 
754 
±24.51 
750 
±17.18 
701 
±8.67 
780 
±48.94 
735 
±27.51 
656b 
±31.62 
0.063 
L(0.071) 
Q (0.187) 
 
D42 
832 
±18.61 
785 
±58.44 
788 
±28.37 
842 
±31.17 
867 
±40.36 
766 
±49.08 
0.452 
L(0.92) 
Q (0.625) 
Cumulative 
2845 
±73.43 
2752 
±77.38 
2628 
±81.26 
2769 
±120.38 
2805 
±95.42 
2512 
±98.03 
0.133 
L(0.088) 
Q (0.67) 
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and 35, no significant differences in feed intake were observed. However, at day 42, 
a substantial, significant increase in feed intake was observed for all birds fed diets 
containing the probiotic, either alone or in combination with the prebiotic 
supplement (diets T4, T5 and T6). For day 42, feed intake (FI) was 1981.74, 2129.31, 
2131.89g for diets T4, T5 and T6 respectively compared to 1545.71 gram for control-
fed birds. This resulted in a significantly higher cumulative feed intake for birds fed 
diet containing low levels of symbiotic treatment (T5) compared to all other diets:  
feed intake (FI) was 5298.84, 5060.83, 4926.27g for diets T4, T5 and T6 respectively 
compared to 4583.61g for control-fed birds 
Table 6:4 Effect of prebiotic, probiotic and synbiotic on feed intake (g) of broiler 
chicken (Mean ± standard error).  
 (a, b) data with the same superscript in the same row are not significantly different (P≤0.05). 
T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 
10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 CFU/kg.T5 
(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed basal diet +LB+10%JA.  
 
Day 
Treatments 
P value 
T1 T2 T3 T4 T5 T6 
D7 
120 118 120 112 120 123 0.943 
L(0.815) 
Q (0.519) 
±3.15 ±9.39 ±10.84 ±9.02 ±3.54 ±6.26 
D14 
312 315 301 281 280 299 0.643 
L(0.214) 
Q (0.457) 
±11.80 ±14.48 ±16.70 ±25.22 ±20.41 ±17.05 
D21 
505 
±18.56 
479 
±24.73 
478 
±26.86 
484 
±30.28 
507 
±28.68 
455 
±37.77 
0.810 
L(0.518) 
Q (0.898) 
D28 
913 931 894 896 972 917 0.866 
L(0.716) 
Q (0.842) 
±40.54 ±62.73 ±56.69 ±47.65 ±33.63 ±31.99 
D35 
1186 1215 1128 1168 1288 1132 0.353 
L(0.985) 
Q (0.855) 
±32.66 ±36.89 ±25.09 ±48.26 ±106.85 ±42.17 
D42 
1545b 1459b 1434b 1981a 2129a 2131a 0.004 
L(0.02) 
Q (0.225) 
±93.92 ±15.12 ±36.38 ±50.77 ±58.74 ±208.96 
Cum. 4583b 4520b 4358b 4926b 5298a 5060b 0.006 
L(0.001) 
Q (0.443) 
 ±171.34 ±108.60 ±131.40 ±190.95 ±153.21 ±266.22 
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Tables 6:5 shows the effects of supplements of prebiotic, probiotic and synbiotic on 
the weekly and cumulative feed conversion ratio (FCR) of birds fed each diet. Table 4 
also shows the European Production Efficiency Factor (EPEF) associated with each 
diet. On day 7 and day 14 no significant differences in FCR were observed between 
diets. On day 21, a significant deterioration in FCR was observed in all birds fed diets 
containing probiotic either alone or in combination with the prebiotic supplement 
(diets T4, T5 and T6). On day 28 and day 35, no differences between treatments were 
observed. On day 42, a substantial, significant deterioration  in FCR was observed in 
all birds fed diets containing the probiotic, either alone or in combination with the 
prebiotic supplement (diets T4, T5 and T6), which corresponded to the substantial 
increase in feed intake recorded during this week for birds fed these diets. 
Cumulative FCR reflected the effects observed in week 6: a substantial, significant 
deterioration in all birds fed diets T5 and T6.  The calculated EPEF values for birds fed 
diets containing the probiotic, either alone or in combination with the prebiotic 
supplement (diets T4, T5 and T6) were also poorer that all other diets. 
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Table 6:5 Effect of prebiotic, probiotic and synbiotic on feed conversion ratio of 
broiler chicken and EPEF (Mean ± standard error).   
 (a, b) data with the same superscript in the same row are not significantly different (P≤0.05). 
T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 
10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 CFU/kg.T5 
(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed basal diet +LB+10%JA.  
 
 
 
 
 
 
 
 
FCR 
Treatments  
T1 T2 T3 T4 T5 T6 P value 
D7 
1.27 1.26 1.41 1.41 1.35 1.36 0.475 
L(0.094) 
Q ( 0.85) 
±0.04 ±0.10 ±0.07 ±0.08 ±0.07 ±0.09 
D14 
1.51 1.56 1.65 1.38 1.42 1.45 0.663 
L(0.768) 
Q ( 0.373) 
±0.05 ±0.09 ±0.10 ±0.05 ±0.07 ±0.06 
D21 
1.11b 1.03b 0.99b 1.41a 1.45a 1.52a 0.00 
L(0.03) 
Q (0.076) 
±0.09 ±0.03 ±0.04 ±0.06 ±0.06 ±0.07 
D28 
1.91 2.08 2.39 1.72 1.75 1.88 0.82 
L(0.204) 
Q (0.41) 
±0.12 ±0.18 ±0.23 ±0.18 ±0.10 ±0.16 
D35 
1.58 1.62 1.61 1.51 1.66 1.67 0.118 
L (0.06) 
Q (0.23) 
±0.03 ±0.07 ±0.04 ±0.06 ±0.04 ±0.06 
D42 
1.86b 1.92b 1.83b 2.36a 2.47a 2.66a 0.00 
L (0.004) 
Q (0.094) 
±0.11 ±0.18 ±0.06 ±0.08 ±0.07 ±0.21 
Cumulative 
1.61b 1.65b 1.66b 1.78b 1.89a 2.01a 0.00 
L(0.043) 
Q (0.079) 
±0.04 ±0.05 ±0.05 ±0.03 ±0.05 ±0.06 
EPEF 426.44a 405.81a 383.92a 376.33a 359.25b 302.74b 0.001 
L(0.003) 
Q (0.34) 
 ±15.55 ±19.85 ±18.42 ±19.78 ±19.75 ±13.93 
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6.4 Discussion 
The aims of this study were to investigate the effects of dietary supplementation with 
prebiotic, probiotic and synbiotic on the chicken performance. The performance of 
control-fed birds in this study was and other trials that have been conducted at 
poultry unit at NTU, data were in a similar range, indicating the data in trial LB03 is a 
reasonable representation of the level of performance that could be expected for 
this strain of bird raised in the NTU poultry unit. Interestingly, field data gathered 
from Iraq in 2018 (Rashaad, personal communication, 1 Feb2018) (see appendix K) 
on Ross 308 male performance was similar to that achieved at NTU. 
The results of the present study showed that overall there was no significant 
combined, linear and quadratic (p≤0.05) effects of supplements of prebiotic (JA) on 
the body weight, body weight gain, feed intake, feed conversion ratio and European 
Production Efficiency Factor. Meanwhile there were negative effects of probiotic 
either with or without prebiotic on the performance of chicken. Body weight was 
decreased at day 7 and 21 in the treatment 4 (probiotic), the early effect at day 7 
may be as a results of addition of Lactobacillus strains in the chicken diet. This results 
were in line with those of (Panda, et al. 2000), as these authors also did not find any 
significant difference in the BWG of chickens that given feed containing probiotics L. 
acidophilus and Streptococcus faecium compared with control. Awad, et al. (2009) 
also found that adding supplement of probiotic has no effect on the body weight at 
day 35 along with body weight gain, but they found that synbiotic supplementation 
has affected these performance significantly (p≤0.05). Other authors reported no 
effect from any form of pre- pro or symbiotic supplementation: Sarangi, et al. (2016) 
observed that using prebiotic, probiotic and synbiotic in feed of chicken did not affect 
the body weight, feed intake and FCR until day 42 of age. (Salehimanesh, et al. 2016) 
reported that using additives of prebiotic, probiotic and synbiotic in the broiler 
rations did not significantly BW and BW gain. However, (Saiyed, et al. 2015) added 
prebiotic, probiotic and synbiotic in the broiler diet, and stated that these additives 
affected the body weight gain positively, as gain was significantly higher in the 
treatments in the first week, although there were no effects of these supplements 
from week 2 to 6. While most authors have reported no effect, in the current study 
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at day7 (week1) probiotic diets negatively affected the body weight and at day 21 
and 42 both probiotic and synbiotic treatments negatively affected the body weight. 
(Abdel-Hafeez, et al. 2017) found that chicks fed diets supplemented with probiotic, 
prebiotic and synbiotic either with or without feed restriction exhibited higher body 
weight and feed efficiency than chicks fed the control diets.  
Overall in this study, undesirable effects on the chicken performance were associated 
with dietary treatments containing the Lactobacillus strains as feed consumption 
increased, and body weight declined, which resulted in a high FCR values. These 
negative results may be due several different reasons; first, as a result of supplement 
itself, which may be due to the competition for nutrients between these probiotic 
and the birds themselves, as this bacteria require nutrients such as simple 
carbohydrates and minerals (Wasielewski, et al. 2016). Another possibility is that the 
species of LB used in the pro- and synbiotic diets directly cause weight loss: there 
were 4 strains of Lactobacillus that were reuteri, which Fak and Backhed (2012) 
indicated may initiate loss of weight when administered to humans.  
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6.5 Conclusion 
This study revealed that prebiotic of Jerusalem artichoke has no effects on the 
performance of chicken of this study at all ages. However prebiotic has been used in 
this study in high level relatively (5 and 10%) so, a lower level may be need to be used 
to investigate the effects on the chicken performance. It is clear that the probiotic 
supplements alone or mixed with prebiotic has negatively affected the performance 
of broiler but the effects varied with bird age and levels of prebiotic mixed with 
probiotic. Effects of probiotic and synbiotic which led to the degradation in the body 
weight and increased feed intake and FCR may have been due to the strain action of 
the bacteria that were selected as candidate probiotic strains. Finally use of prebiotic 
supplements in chicken feed needs further research investigating both higher or 
lower supplementation levels and different ages of chicks to gain more information 
about it. Also these candidate probiotic strains should be studied using lower levels 
in the diet and finally, isolates should be examined separately not as mixture. In order 
to gain a deeper understanding into the modes of action behind the effects 
associated with these supplements, gut microbial investigations were undertaken 
next. 
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Chapter seven: 
Effects of additives of prebiotic, probiotic and synbiotic into 
on the caeca microbiota in broiler  
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7 7:1 Introduction  
Gut microbiota play an important role in animal growth, digestibility and nutrient 
absorption (Celi, et al. 2017), and can modulate the immunity of the host 
(Purchiaroni, et al. 2013). There are many factors that can manipulate this 
community in the gut for instance, age, diet, stress, rearing, and environmental 
factors (Wei, et al. 2013; Ranjitkar, et al. 2016). Prebiotic, probiotic and the mixture 
of both (synbiotic) substances have all been used in chicken feed as feed additives. 
The use of probiotics in chicken feed has been shown to maintain the gut microflora 
(Daliri and Lee 2015). Also (Kim, et al. 2011) observed that dietary supplementation 
with prebiotic Fructooligosaccharides (FOS) increased the diversity of Lactobacillus in 
the chicken gut. Both inulin and FOS are prebiotic agents (Kelly 2008) which are 
fermented by certain lactic acid bacteria and Bifidobacterium, which in turn have 
been attributed to being beneficial to the host as potential probiotic microorganisms 
(Kaplan and Hutkins 2003, Roberfroid 2007). Nabizadeh (2012) found that the 
addition of inulin to feed may increase Bifidobacterium numbers and decrease E. 
coli numbers in the caecal content of chicken. Also, probiotic isolates from poultry 
such as lactobacilli were also found to ferment FOS (Saminathan, et al. 2011). 
One of the valuable benefits of manipulating the intestinal microbiome is that 
microflora in the gut can contribute to resistance to pathogenic bacteria and 
decrease infection in the gastrointestinal tract of chicken (Vieira, Teixeira and 
Martins 2013). Hence, considerable efforts have been invested in studying probiotics 
and their application in human and animal health have led to the knowledge that 
probiotic therapy can be a prudent intervention strategy. Use of probiotics to control 
and prevent pathogenic bacterial contamination and infection both in poultry and in 
humans from species such as Campylobacter, Escherichia coli, Salmonella spp. And 
Clostridium spp. is based on the advantages derived from manipulation of the gut 
microflora (La Ragione, et al. 2004; Murry, Hinton J and Buhr 2006, Alemka, et al. 
2010). Until recently, many microbial groups present within a microbiome remained 
undetected due to the limitations of standard classical microbiological methods. The 
limitations associated with culturing may be due to species-species interdependence 
in certain situations, and or due to a lack of knowledge of the particular nutritional 
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requirements of these non-culturable microbes (Muyzer 1999); (Lu, et al. 2003b).  
The development of modern molecular approaches make it possible to identify 
different bacterial populations in environmental samples without cultivation 
(Harmsen, et al. 2000). Using the 16s rRNA gene sequencing technique makes the 
study of the poultry microbiota more comprehensive and gives more information 
about the species breadth of these communities (Wei, et al. 2013). In the hypothesis 
of this study are that the prebiotic and probiotic could manipulate the caeca 
microbiota positively and minimise the level of campylobacter in the gut of broiler.    
This study aimed to investigate the effects of the Jerusalem artichoke plant as an 
inulin-based prebiotic as well as newly isolated strains of Lactobacillus as probiotic 
and a mixture of them (synbiotic) on the Campylobacter count in the caeca of 
chicken. Both traditional colony counts were carried out on the caecal content at day 
1, 7, 21 and 42, as well as a culture-independent method based on 16s rRNA gene 
sequencing at day 7 and 42.  
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7.1 Methods  
Caeca were collected from trial LB03 birds post mortem and then stored at 4 C prior 
to culturing and DNA extraction.  
 Sample preparation 
As explained in section 2:13:3 
7.1.1.1 DNA extraction 
As explained in section 2:13:3:1:1 
7.1.1.2 Sequencing the DNA  
As explained in section 2:13:3:1:2 
7.1.1.3 Bioinformatics analysis 
As explained in section 2:13:3:1:3 
  
 
  
 131 
 
7.2 Results  
7.3 Prevalence of Campylobacter spp. in the poultry unit and chicken 
gut  
All the caeca collected during the trial for all treatments were screened for the 
presence of Campylobacter at 7, 21 and 42 days of the trial in addition to day 1 of 
age before feeding the chicks all of which were negative.  In addition the poultry unit 
was screened before the trial started and this was also free of Campylobacter.  
7.4 Microbial composition of the caeca   
 Culture-dependent method  
7.4.1.1 Microbial composition of the caeca at day 1  
At day 1 chicks before treatment were screened for lactic acid bacteria (LAB) and 
Campylobacter in the caeca. The colony counts (CFU) as shown in table 7:1 were 
between 10.7 to 11.07 log10. Meanwhile chicks were free of Campylobacter at this 
age.  All colonies counted were similar in colour creamy/white and in size similar size. 
Table 7:1 Total count of LAB and Campylobacter in the caeca of chicks at day one 
 Samples  Log CFU 
Sample 1  10.7 
Sample 2 11.07 
Sample 3 10.84 
Sample 4 11 
Mean  10.92 
Four caeca samples were chosen randomly from chicks at day 1.    
7.4.1.2 Microbial composition of the caeca at days 7, 21 and 42  
Table 7:2 shows  that, on day 7,  as expected there was a higher concentration of LAB 
in the digesta than that found associated with the tissue, indicating the large 
proportion of LAB is adherent to caecal tissue. The levels of LAB in the caecal content 
and tissue did not change significantly (p≤0.05) by the addition of prebiotic, probiotic, 
and synbiotic, although the low level synbiotic treatment showed a trend (P=0.056) 
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toward lower LAB colonization in tissue. However LAB in tissue was linearly affected 
by the treatments.  Also, there was no Campylobacter detected in the caeca for any 
of the treatments. 
Table 7:2 Effect of prebiotic, probiotics and synbiotic feed supplements on the 
microbial composition of the tissue and contents of the caeca at day7 mean of CFU 
(log10 per gram of sample). 
Samples 
Treatments P value(2) 
T1(1) T2 T3 T4 T5 T6 
LAB in tissue  
6.69 
±0.39 
6.68 
±0.61 
6.74 
±0.36 
6.19 
±0.37 
6.13 
±0.49 
6.30 
±0.52 
0.056 
L(0.017) 
Q(0.813) 
LAB in digesta 
10.59 
±0.71 
10.79 
±0.48 
10.84 
±0.10 
10.71 
±0.29 
10.42 
±0.56 
10.46 
±0.53 
0.194 
L(0.27) 
Q(0.244) 
Campylobacter spp.  
in digesta and  tissue  
Nil Nil Nil Nil Nil Nil 
 
Nil 
(1)T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 
10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 
CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed basal diet +LB+10%JA. 
Data are shown as mean of CFU log ± S.E (n=6) in comparison to those from controls. (2) P value 
indicates significant difference compared to control at (P≤0.05). 
Table 7:3 shows that, on day 21 the levels of LAB in the caecal content and tissue 
were slightly lower than levels found on day 7. As on day 7 LAB levels in both caeca 
content and tissue did not change significantly (p≤0.05) by the addition of prebiotic, 
probiotic, and synbiotic but it was significant linearly in the content. Also, there was 
no Campylobacter detected in the caeca for any of the treatments at all studied ages.  
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 Table 7:3 Effects of supplements of prebiotic, probiotics and synbiotic on CFU of 
tissue and content of caeca at day 21 mean of CFU (log10 per gram of sample). 
(1)T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) 
birds fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 
CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6(synbiotic)  birds fed Basal diet +LB+10%JA. 
Data are shown as mean of CFU log ± S.E (n=6) in comparison to those from controls. (2) P value 
indicates significant difference compared to control at (P≤0.05). 
Table 7:4 shows that on day 42 the levels of LAB in the caecal content and tissue were 
intermediate between those recorded for day 7 and 21. On day 42 LBA levels did not 
change significantly (p≤0.05) by the addition of prebiotic, probiotic, and synbiotic and 
there was no Campylobacter detected in the caeca for any of the treatments.  
Table 7:4 Effects of supplements of prebiotic, probiotics and synbiotic on CFU of tissue and 
content of caeca at day 42 data shown in mean of CFU (log10 per gram of sample). 
Samples 
Treatments P value(2) 
T1* T2 T3 T4 T5 T6 
LAB in tissue  
5.92 
±0.62 
6.20 
±0.88 
5.90 
±0.73 
5.61 
±0.32 
5.81 
±0.70 
5.83 
±0.60 
0.807 
L(0.414) 
Q(0.792) 
LAB in digesta 
10.12 
±0.44 
9.83 
±0.53 
9.96 
±0.44 
9.93 
±0.43 
10.05 
±0.35 
9.96 
±0.57 
0.921 
L(0.844) 
Q(0.779) 
Campylobacter spp.  
in content and  tissue  
Nil Nil Nil Nil Nil Nil 
 
(1)T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds 
fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 10^9 
CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed Basal diet 
+LB+10%JA. Data are shown as mean of CFU log ± S.E (n=6) in comparison to those from controls. 
(2) P value indicates significant difference compared to control at (P≤0.05). 
 
 
samples 
Treatments P value(2) 
T1(1) T2 T3 T4 T5 T6 
LAB in tissue  
5.33 
±0.39 
5.15 
±0.34 
5.32 
±0.15 
5.66 
±0.46 
5.07 
±0.23 
5.49 
±0.52 
0.129 
L(0.489) 
Q(0.983) 
LAB in digesta  
9.77 
±0.59 
9.64 
±0.19 
9.56 
±0.49 
9.06 
±0.81 
9.08 
±1.01 
8.67 
±1.14 
0.166 
L(0.009) 
Q(0.737) 
Campylobacter spp.  
in content and  tissue  
Nil Nil Nil Nil Nil Nil 
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 Population of microbiota in the caeca Culture-independent 
method 
Molecular level screening (metagenomics) via 16s rDNA was used in this analysis to 
determine the microbiota profile in the caeca of chicken fed all treatments and control diets.   
7.4.2.1  Quality of the sequencing run 
The quality of sequencing data stated that a total of 31,488,628 raw sequencing reads 
were generated which is relatively fair enough as Illumina recommended that the 
total reads should between 44-50 million for the kits that used in this study, however, 
they stated that some factors such as sample quality and type  can affect the number 
of  reads. The quality score (%≥ Q30) 88.32% which relatively high as the kit supplier 
(Illumina) recommended that the quality score should be above 70% for the kit that 
been used in this study (Illumina, 2018).   
7.4.2.1.1 Bacterial abundance in the caeca content  
Figure 7:1 shows relative abundance of the top 7 genera in the caeca content of 
chicken trial, as determined by 16s rDNA and only the percentage above For the 
genus level only those with a greater than 2% abundance were chosen to be 
discussed abundance of genera were chosen to discuss in addition to Bifidobacterium 
and Escherichia/Shigella as they are important genera which is considered as 
pathogenic bacteria.    
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Figure 7:1 Means of Relative abundance (± S.E) of the 7 dominating genera in the caecal contents of control birds and those treated with the 
various feed supplements at day 7.   
*T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) 
at level 10^9 CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6(synbiotic)  birds fed Basal diet +LB+10%JA. Data are shown as mean of abundance bars of S.E (n=6) in 
comparison to those from controls. Stars indicate significant difference compared to control at (P≤0.05). 
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The effects of supplements on the phyla of Firmicutes and Proteobacteria were 
variable. From tables 7:5 and 7:6, it can be seen that from the error bars that the 
variation between individual replicates was high and the differences between mean 
values were not significant at (p≤0.05) for many of the results. At day 7 Firmicutes 
phylum was increased in the treatments of supplements. However the increment 
was significant (p≤0.05) at T2 (5%prebiotic), T3 (10% prebiotic) and T6 (10% prebiotic 
+ probiotic) meanwhile in treatments T4 (probiotic) and T5 (5%prebiotic+probiotic) 
differences were not enough to reach significant difference to control (p≤0.05). In 
contrast the Proteobacteria phylum also appeared affected by the additions but it 
was decreased in the treatments compared with control however differences were 
not significant (p≤0.05). Meanwhile, no significant effects were observed at day 42 
on the Firmicutes phylum. Moreover, the abundance of Proteobacteria not affected 
by the supplements at both days. 
Table 7:5 Means of Relative abundance (± S.E) of Firmicutes and Proteobacteria 
phylum in the caeca content of control and treatment at day7. 
* T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 
10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus (LB) at level 10^9 CFU/kg. T5 
(synbiotic) birds fed basal diet +LB+5% JA. T6 (synbiotic) birds fed Basal diet +LB+10%JA. Data are 
shown as mean of abundance ± S.E (n=6) in comparison to those from controls. Different in superscript 
in the same row indicates significant difference compared to control at (P≤0.05).  
 
 
 
 
 
 
Phylum 
Treatments 
T1* T2 T3 T4 T5 T6 
P 
value  
Firmicutes 
88.57(b) 
±1.62 
95.14(a) 
±0.91 
95.24(a) 
±0.94 
93.97(b) 
±1.05 
93.74(b) 
±0.57 
95.71(a) 
±0.85 
0.04 
Proteobacteria 
8.901 
±0.20 
5.658 
±0.60 
2.314 
±0.42 
3.927 
±0.32 
3.063 
±0.72 
2.954 
±0.35 
0.07 
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Table 7:6 Means of Relative abundance (± S.E) of Firmicutes and Proteobacteria 
phylum in the caeca content at day 42  
Phylum 
Treatments 
P value 
T1* T2 T3 T4 T5 T6 
Firmicutes 92.13 
±2.92 
92.62 
±3.28 
89.91 
±2.81 
94.81 
±0.66 
94.36 
±1.53 
95.89 
±0.87 
0.07 
Proteobacteria 
0.76 
±0.20 
1.29 
±0.59 
1.46 
±0.41 
1.35 
±0.32 
1.50 
±0.72 
1.16 
±0.34 
0.08 
* T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds 
fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus (LB) at level 10^9 
CFU/kg.T5 (synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed Basal diet 
+LB+10%JA. Data are shown as mean of abundance ± S.E (n=6) in comparison to those from 
controls.  
At the genera level shown in figures 7:1 and 7:2, Lactobacillus was the most abundant 
genus in the caeca of all groups (both control and treatments) with a relative 
abundance ranging from 24% - 32%.  There was no significant difference (p≤0.05) in 
the abundance of Lactobacillus between any of the treatments and the control. 
There was a differences in the relative abundance of Genera of Bifidobacterium spp., 
Lachnospiraceae, Enterococcus, Ruminococcaceae, and Escherichia/Shigella 
however they were not significantly affected by the supplements at day 7. Also there 
was no difference in abundance of Bifidobacterium spp., Lachnospiraceae, 
Ruminococcaceae, and Escherichia/Shigella at day 42 (figure 7: 2).  Meanwhile at day 
7, the abundance of Faecalibacterium was affected by some of the supplements:  it 
was significantly (p≤0.05) higher in T2 (5% prebiotic) and T4 (probiotic) than in 
control-fed birds. At the day 42 (figure 7: 2), it seems that the variability in the 
replicates was higher than at day 7. Meanwhile, Erysipelotrichaceae genus was 
affected significantly (p≤0.05) by the supplements as it was decreased in all 
treatments comparing with control. Here in this study, at age 42 the community was 
shifted significantly (p≤0.05) of some genera, as Enterococcus disappeared at day 42 
while Blautia and Erysipelotrichaceae did not appear among the most abundant 
genera at day 7 but came to prominence as the birds grew older (Figure 7:2).  
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Figure 7:2 Means of Relative abundance (± S.E) of the 7 dominating genera in the caecal contents of control birds and those treated with the 
various feed supplements at day 42.  
*T1 (Control), birds that fed basal diet. T2 (prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) 
at level 10^9 CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6(synbiotic)  birds fed Basal diet +LB+10%JA. Data are shown as mean of abundance bars of S.E (n=6) in 
comparison to those from controls. Stars indicate significant difference compared to control at (P≤0.05)  
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7.5 Discussion   
The aim of this study was to investigate the influence of dietary supplementation of 
a prebiotic (Jerusalem artichoke tuber), probiotic 6 isolates of Lactobacillus and a 
combination of both (synbiotic) on caecal microflora profile of broiler chickens. The 
Lactic Acid Bacteria (LAB) were  present in relatively high numbers in the caecal 
contents of chicks at day one, which continued throughout the trial and it seems 
there was no significant changes in number at all treatments and  ages. The LAB were 
grown on MRS agar as selective media and  because MRS media can grow wide range 
of LAB genera (Oxoid, 2017) which include Lactobacilli, Lactococci, Enterococci, 
Streptococci, Leuconostoc and Pediococci (Pessione 2012) in addition to 
Bifidobacterium (Sule, et al. 2014). Hence, may be all of these genera were counted 
which gave similar count in general.   
Throughout the trial chicks that were screened for Campylobacter were also 
negative.  This may be because of the cleaning and disinfectant regimen that is used 
in the NTU poultry unit. The number of LAB in the digesta and tissue the caeca were 
not affected by the prebiotic, probiotic and synbiotic supplements of at ages 7, 21 
and 42 days. The reason for this is likely due to the fact that MRS media was not 
selective enough for Lactobacillus and allowed the growth of a wide variety of LAB. 
As seen from the figure 7:1 and 7:2 and table 7:5 and 7:6 the Firmicutes phylum was 
in high abundance in all birds.  This phylum includes all genera of LAB and when 
grown on the one media they are morphologically similar, therefore they are all 
considered to be LAB. The culture-dependent results from the caecal content and 
tissue showed that there was no difference between control and treatments in the 
numbers of LAB. Therefore perhaps all treatments have similar numbers of colonies 
but not all of them were belong to same species or even same genus of LAB.  
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This absence of an effect of dietary treatment on the numbers of lactobacilli present 
in the caeca of broilers is in agreement findings from many other microbial studies in 
chicken. Olnood, et al. (2015a), who also fed a novel probiotic four strains 
of Lactobacillus (tentatively identified as Lactobacillus johnsonii, Lactobacillus 
crispatus, Lactobacillus salivarius and Lactobacillus sp.)  In the broiler feed, there was 
not a significant (p≤0.05) effect on the LAB in the caecal content.  Also Dibaji, et al. 
(2014) found similar results when they added a synbiotic which consisting of 
(Enterococcus faecium + fructo-oligosaccharides to chicken feed. In contrast,  Dibaji, 
et al. (2014) found that, by adding probiotic containing different strains of 
Lactobacillus, Bifidobacterium, Enterococcus, and Pediococcus to chicken feed, it was 
possible to increase the total number of Lactobacillus significantly in treatments 
comparing with control. However it is important to note that in the current study 
counting included all colonies grown on the plate that were similar in the size and 
colour. This may have introduced some inaccuracies as the edge of each colony was 
not easy to recognise without use of a microscope.  
The results of the Culture-Independent Method (CIM) are shown in the figures 7: 1 
and 7: 2. At both 7 and 42 days of age the Firmicutes was the most dominant phylum 
in the caeca of the chicks. Most of the bacteria within the Firmicutes phylum are 
considered to be Butyrate producers in the gut microbiota of chicken (Varmuzova, et 
al. 2016b), which correlates to the health of the host. In this study Firmicutes was 
significantly (p≤0.05) in higher abundance than in the control at day 7 for all of 
supplements treatments. Here it seems that the prebiotic supplements with 
(synbiotic) or without probiotic have affected the abundance of the Firmicutes 
however probiotic alone could not manipulate this phylum at day 42. It is suggested 
therefore that the prebiotic has encouraged the bacteria belonging to Firmicutes 
phylum to flourish.  
Results of this study revealed that relative abundance of Lactobacillus and 
Bifidobacterium were not affected by the supplements at both days 7 and 42 which 
is in agreement with the results of many other studies.  Fukata, et al. (1999) found 
that addition of gut content to chicken feed did not bring about differences in 
lactobacilli or Bifidobacterium in chicken caeca at day 7 or day 21.  This finding is not 
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in agreement with Nabizadeh (2012) who found that the addition of inulin to the 
chicken feed increased the count of Bifidobacterium in the caeca. Also, Shang, et al. 
(2010), when they added the inulin to layer hen feed, reported that lactobacilli were 
not affected by this addition but Bifidobacterium level was increased in the 
treatments. (Samal, et al. 2015) found that adding 6% of JA powder into rat feed 
improved the total count of Bifidobacterium in the caecum.  (Rebole, et al. 2010) 
found that adding inulin to the laying hens’ diet led to an increase in Bifidobacterium 
in the caecal content.  
At day 7, the abundance of organisms within the Faecalibacterium genus increased 
in all treatments but it was only significant (p≤0.05) in T2 (5%prebiotic) and T4 
(probiotic). This increase in the abundance of these bacteria may be because of these 
supplements made the environments preferable for Faecalibacterium. These results 
are consistent with (Park, et al. 2016) who found that when adding prebiotic-based 
Mannanoligosaccharide (MOS) the abundance of the Faecalibacterium genus was 
increased in the treatment compared with the control.  Faecalibacterium is also 
known as one of the butyrate-producing genera (Wang, et al. 2016, Egshatyan, et al. 
2016, Pryde, et al. 2002). Butyrate has been shown to have anti-inflammatory activity 
(Van Immerseel, et al. 2010, Celasco, et al. 2014). Findings of this study were in 
agreement with (Ramirez-Farias, et al. 2009); (Wang, et al. 2017) when they used 
prebiotic and probiotic respectively.  
Blautia is a genus belong to the phylum Firmicutes which has been traditionally 
believed to carry genes related to polysaccharide metabolism which is thought to 
enhance the efficiency of energy harvesting by the host (Kasai, et al. 2015).  During 
this metabolism, acetate is also produced (Kettle, et al. 2015, Turroni, et al. 2016), 
which has been shown to improve intestinal defence and protects the host against 
lethal infection (Fukuda, et al. 2011). However not all published support this 
mechanism. The results from this trial are in agreement with what (Krumbeck, et al. 
2015) found when they used a prebiotic (galactooligosaccharides) in humans as they 
observed an increase in the Blautia genus. Findings of this study are not in agreement 
with the findings of (van Zanten, et al. 2014) who found that the addition of a 
synbiotic to human food did not increase the abundance of Blautia, but actually 
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brought about a decrease compared with the non-treated control. The genus 
Erysipelotrichaceae was decreased in the caecal content at day 42. The importance 
of these bacteria is in inflammation which is related to disorders of the 
gastrointestinal tract in humans (Chen, et al. 2012, Dinh, et al. 2015). Findings of  this 
study were in agreement  with  (Neveling, et al. 2017) when they added probiotic 
strains that were isolated from chicken which consisted  
of L. crispatus, L. gallinarum,  L. johnsonii, L. salivarius, Enterococcus faecalis and  
Bacillus  amyloliquefaciens to the chicken diet found that degradation in  the 
abundance of this Erysipelotrichaceae genus, while (Tanner, et al. 2014) found that 
using FOS in swine feed increased the abundance of Erysipelotrichaceae. Meanwhile 
at day 42 abundance of genus of Erysipelotrichaceae was decreased in the 
treatments of supplements compared with control so it may be concluded that these 
supplements modified the gut microflora in a mildly positive manner, as researchers 
found that this genus gives indictor for inflammation (Palm, et al. 2014), hence as in 
this study these supplements caused a degradation in this bacteria. Finally it seems 
that the interaction between prebiotic and probiotic has no effect of the level of this 
genus. 
The abundances of many genera were modified in the current study (either increased 
or decreased) but often they were not changed to reach the declared point of 
significant difference, which may be due to variation among replicates which is 
shown in size of the error bars (S.E). Stanley, et al. (2013b)  studied the microbiota in 
the chicken individually of each single bird of three trials which were similar in feed 
and all conditions. They identified that there was a variation from batch to batch 
across the three trials and in addition they found that the variations were large within 
each trial. Hence, it seems individual bird to bird variation is normal in the gut 
microbiota of chicken. Therefore such studies need large number of replicates to 
minimise the impact of variation among individuals. Another option would be to 
study each single individual separately, as large variation in the caecal microflora of 
chicken still occurs regardless of the conditions of bird experiments.   
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7.6 Conclusion 
This study was conducted to evaluate the effects of prebiotic (JA powder), probiotic 
(6 isolates of lactobacillus) and synbiotic (mix of pre and probiotic) supplements on 
the caecal microbiota of the chicken. Caecal content of chicken at all ages were 
negative for Campylobacter, which did not allow investigation into of the efficacy of 
the supplements in reducing colonisation of the chicken gut by Campylobacter in. To 
rigorously investigate the effects of supplements on the pathogen, it is better to 
challenge the birds by directly introducing the pathogenic bacteria to get more 
applicable results.  This study revealed that it is difficult to do this kind of 
investigation on pathogenic bacteria in poultry without directly challenging the 
chicken - even though this experiment was done in the summer, when the prevalence 
of Campylobacter is likely to be higher, and the biosecurity regime in the unit was 
intentionally reduced to match levels akin to poor practice on a commercial poultry 
farm. Also, the study confirmed that using a culture-based method is a suitable to get 
the profile of gut microbiota. Meanwhile, the molecular-based method appeared an 
appropriate method but the number of replicates must be high enough in order to 
improve the confidence in the results.  
Despite the limitations described above and lack of significant differences between 
control and treated birds for the reasons discussed earlier some keys alteration to 
the microbiome were associated with all treatments. The post-hatch increases in 
Firmicutes phylum and Faecalibacterium genus has some advantages for subsequent 
growth as both are considered to be butyrate producers. Meanwhile at day 42 
abundance of genus of Erysipelotrichaceae was decreased in the treatments of 
supplements compared with control so it may be concluded that these supplements 
modified the gut microflora in a mildly positive manner pre-slaughter. From these 
findings it may be concluded that addition of prebiotic, probiotic and synbiotic have 
positively manipulated the microflora in the gut of chicken. The impact of the altered 
microbiota on the local and systemic immune function was investigated 
subsequently in order to gain a broader understanding of how the supplements 
affect overall health status. 
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Chapter eight:  
Effect of dietary prebiotic, probiotic and synbiotic 
supplement on the immune function 
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8 8:1 Introduction 
Commensal bacteria are in close contact with cells of the gut-associated immune 
system. Modulation of the immune response may occur as a result of interactions 
between host cells and bacteria or their structural components (Macpherson, et al. 
2000). Dietary supplementation of probiotics, prebiotics, or synbiotic has been 
shown to manipulate or maintain the intestinal microbiome in both human and 
animal studies (Mookiah et al., 2014). This can cause a shift in the GIT population in 
favour of beneficial bacteria (e.g. Lactobacillus spp. and Bifidobacterium spp.), which 
in turn can positively affect immune function (Isolauri, et al. 2001, Rafter, et al. 2007), 
therefore, these supplements can be used to enhance immune activity (Kamada, et 
al. 2013). Cytokines are secreted proteins released by cells to communicate and act 
as signal molecules to activate and regulate the immune response.  Shang, et al. 
(2015) claim that using fructo-oligosaccharide (prebiotic) in chicken can upregulate 
the expression of IFN-γ, IL-10 and IL-6.  
There are two ways for supplements to impact on cytokine modulation - directly and 
indirectly. Firstly, supplements may act directly through their actions on the gut-
associated lymphoid tissue, and the second possible route is indirect, as they can 
alter the intestinal tract microflora in a manner that enhances the abundance of key 
microorganisms that themselves directly affect immune function in the gut.   
Furthermore, a balance of commensal bacteria in the gut can work as an efficient 
barrier against pathogen colonization. In addition, it can produce metabolic 
substrates like short chain fatty acids (LeBlanc, et al. 2017) and vitamins, and 
stimulate the immune system in a non-inflammatory manner (Kamada, et al. 2013). 
Therefore, there is a correlation between the composition of the colonizing 
microbiota and variations in immunity. Also, Yitbarek, et al. (2015) found that when 
using synbiotic in the chicken feed will upregulate IFN-γ compared with control. 
These cytokines plays a critical role in mucosal surfaces exposed to a dense 
population of microorganisms to maintain homeostasis and respond efficiently to 
pathogenic challenges.  Cytokines are commonly used as biomarkers to evaluate the 
impact of feed additives on the host immune response (Wigley and Kaiser 2003, 
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Kaiser, et al. 2006). INF-γ, IL-10 and IL-6 are important cytokines influencing health 
of the gastrointestinal tract INF-γ and IL-6 (pro-inflammatory modulators) and IL-10 
(attenuation of inflammatory response)  therefore studying the cytokine profile 
offers insight into understanding how pre- and probiotic supplementation may affect 
immune functions the in chicken. Modern molecular methods like Reverse 
Transcription quantitative Polymerase Chain Reaction (RT-qPCR) enable 
measurement of the relative abundance of messenger RNA for different cytokines 
from relatively small sample volumes (Amsen, de Visser and Town 2009).  
This chapter reports on the immune parameters studied in bird trial LB03, which was 
conducted as described in chapter 6. The objective of this study was to investigate 
the potential effects of pre, pro and synbiotic supplementation in the feed of chicken 
on immune functions by measuring the expression of INF-γ, IL-6 and IL-10 in ileum 
and bursa. These cytokines have been chosen as they are considered as an important 
marker in responses to bacterial infection as pro-inflammatory or anti-inflammatory 
cytokines (Kaiser, et al. 2000, Mühl and Pfeilschifter 2003, Amsen, et al. 2009, 
Isolauri, et al. 2001, Rafter, et al. 2007, Mookiah, et al. 2014, Brisbin, et al. 2008b, 
Macpherson, et al. 2000). The specific hypotheses for this chapter are as follows: INF-
γ and IL-6 gene expression will be up-regulated in response to these supplementation 
in both ileum and Bursa of Fabricius, and concurrently IL-10 gene expression will be 
reduced in each tissue. 
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8.1  Methods  
 Trial design 
This investigation uses material from bird trial LB03 as described in chapter 6. 
  Rationale for selection of target tissues:  
Caeca from all birds in the trial were used to study the microbiota profile in the gut 
as the microbiota profile was considered a key investigative parameter for the overall 
research aim. The tissue preparation requirements for assessing gene expression of 
cytokines and profiling microbiota directly conflict, as for gene expression, fresh 
tissue should be excised and processed as soon as possible after killing the birds using 
a chemical protectant to preserve the mRNA. In contrast, for microbiota profiling, it 
is essential to minimise exposure to air and immediately freeze the samples to arrest 
all biological activity. This makes it difficult to collect content and tissue from same 
caeca so therefore ileum was chosen as the closest site in the intestine to the caeca 
to study the impact of pre, pro and synbiotic supplementation on some aspects of 
immunity.  Also, the bursa of Fabricius was chosen as the unique gland in birds 
considered to be the site of critical development of the B-cell lymphocytes (Ratcliffe 
2006).  
  Collection of the tissues  
On bird trial days 7, 21 and 42 post hatch, one bird per replicate pen was euthanized. 
Tissues from ileum and bursa of Fabricius has excised immediately post-mortem and 
stored in RNAlater at -80 °c until further processing for RNA extraction (detailed in 
chapter 2).   
8.1.3.1 RNA extraction 
The process described in chapter 2, was followed to extract RNA from both tissue 
sources.  
 cDNA synthesis 
Full details described in chapter 2  
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 RT-qPCR 
Primers were chosen from papers (Rothwell, et al. 2004, Mott, et al. 2008, G. Li, et 
al. 2010, Waititu, et al. 2014, Lourenço, et al. 2016, Kristeen-Teo, et al. 2017) and 
checked for target identity using GenBank from the National Centre for 
Biotechnology Information (NCBI). The full protocol undertaken is explained in 
chapter 2. 
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8.2   Results: 
  Quality and quantity of extracted RNA  
There was no significant difference in RNA quality or quantity between the treatment 
groups. Checking RNA integrity is a critical step before cDNA synthesis to ensure that 
DNA is removed for successful mRNA quantification by RT-qPCR (Imbeaud, et al. 
2005). In addition, the majority 260/230 ratios were also found to be in the 
acceptable range of 2.0-2.2, which is used as a secondary measure of nucleic acid 
purity (see appendixes E and F). 
 The effect of prebiotic, probiotic and synbiotic supplements on 
the mRNA expression of IFN-γ, IL-10 and IL-6 in the ileum 
tissue of chicken.   
Figure 8:1 shows that in the ileum, there were no significant differences in expression 
of IFN-γ between treatment at day 7 and day 42, which showed a high level of 
variability between replicates (n=6). However, at day 21, all supplemented groups 
showed a significant (P≤0.05) reduction in IFN-γ expression compared to the control 
group (P≤0.01). 
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Figure 8:1 Fold change of IFN-γ expression in the ileum tissue at days 7, 21 and 42 of 
the age of chicks fed prebiotic, probiotic, and synbiotic. T1 (control).   
T1 (Control), birds that fed basal diet displayed as 1 on axis. T2 (prebiotic) birds fed 5% JA powder. T3 
(prebiotic) birds fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 
10^9 CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic)  birds fed Basal diet 
+LB+10%JA. Data are shown as mean of fold change (2^-ΔΔCt) ± S.E (n=6) in the mRNA level of 
cytokines in comparison to those from control. (*) indicates significant difference compared to control 
at (P≤0.05). 
Figure 8:2 shows the effects of pre, pro, and synbiotic supplements on the fold 
change of IL-10   expression in the ileum tissue at days 7, 21 and 42. The level of IL-
10 was significantly (P≤0.05) low in the ileum tissues of birds at ages 7 and 21 days 
for all treatments apart from T4 (probiotic) at day 7 and T2 (5% prebiotic) at day 21 
as the differences were not significant (P≤0.05) at these treatments. At day 42 of age, 
the supplements have no effects on the levels of IL-10 expression, as the levels in the 
prebiotic and probiotic were close to the level of all treatments and control. 
However, IL-10 expression in tissues from birds fed the synbiotic with the high level 
of prebiotic (10%) was lower than the control, however, it was not significant 
(P≤0.05). 
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Figure 8:2 Fold change of IL-10 expression in the ileum tissue at days 7, 21 and 42 of 
the age of chicks fed prebiotic, probiotic, and synbiotic.  
T1 (Control), birds that fed basal diet displayed as 1 on axis. T2 (prebiotic) birds fed 5% JA powder. T3 
(prebiotic) birds fed 10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 
10^9 CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6(synbiotic)  birds fed Basal diet 
+LB+10%JA. Data are shown as mean of fold change (2^-ΔΔCt) ± S.E (n=6) in the mRNA level of 
cytokines in comparison to those from control. (*) indicates significant difference compared to control 
at (P≤0.05). 
Figure 8:2 shows that in the ileum, there were no significant differences between 
treatment at day 21 and day 42 in the fold change of IL-10   expression of the ileum 
tissue. Which showed a high level of variability between replicates (n=6). However, 
at day 7, all supplemented groups showed a significant (P≤0.05) different in IL-6 
expression compared to the control group (P≤0.01) although this was consistent 
across all the supplemented groups. 
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Figure 8:3 Fold change of IL-6 expression in the ileum tissue at days 7, 21 and 42 of 
the age of chicks fed prebiotic, probiotic, and synbiotic. 
 T1 (Control), birds that fed basal diet displayed as 1 on axis. T2 (prebiotic) birds fed 5% JA powder. T3 
(prebiotic) birds fed 10% JA powder. T4 (probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 
10^9 CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6 (synbiotic) birds fed Basal diet 
+LB+10%JA. Data are shown as mean of fold change (2^-ΔΔCt) ± S.E (n=6) in the mRNA level of 
cytokines in comparison to those from controls. (*) indicates significant difference compared to 
control at (P≤0.05). 
 The effect of prebiotic, probiotic and synbiotic supplements on 
the mRNA expression of IFN-γ, IL-10 and IL-6 in the bursa of 
Fabricius tissue of chicken.    
Figures 8:4, 8:5 and 8:6 show the effects of adding prebiotic, probiotic and synbiotic 
to the diet of chicken at ages 7, 21 and 42 days on the IFN-γ, IL-10 and IL-6 expression 
in the bursa of Fabricius tissue. Results show that dietary supplements of pre, pro 
and synbiotic have no effect (P≤0.05) on the level of all these cytokines in the tissue 
of the bursa at all studied ages of chicken compared to control-fed birds.  
-0.4
0.1
0.6
1.1
1.6
2.1
2.6
3.1
A
ve
ra
ge
 f
o
ld
 c
h
an
ge
 in
 m
R
N
A
 e
xp
re
ss
io
n
  
D7                                              D21                                                D42 
Chicken age
IL-6 ileum
T2
T3
T4
T5
T6
 153 
 
 
Figure 8:4 Fold change of IFN-γ expression in the Bursa tissue at days 7, 21 and 42 of 
the age of chicks fed prebiotic, probiotic, and synbiotic.  
T1 (Control), birds that fed basal diet displayed as 1 on axis. T2 (prebiotic) birds fed 5% JA powder. T3 
(prebiotic) birds fed 10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 
10^9 CFU/kg.T5 (synbiotic) birds fed basal diet +LB+5% JA.T6(synbiotic)  birds fed Basal diet 
+LB+10%JA. Data are shown as mean of fold change (2^-ΔΔCt) ± S.E (n=6) in the mRNA level of 
cytokines in comparison to those from control.  
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Figure 8:5 Fold change of IL-10 expression in the Bursa tissue at days 7, 21 and 42 of 
the age of chicks fed prebiotic, probiotic, and synbiotic.  
T1 (Control), birds that fed basal diet displayed as 1 on axis. T2 (prebiotic) birds fed 5% JA powder. T3 
(prebiotic) birds fed 10% JA powder. T4(probiotic) birds fed mix of isolates of Lactobacillus(LB) at level 
10^9 CFU/kg.T5(synbiotic) birds fed basal diet +LB+5% JA.T6(synbiotic)  birds fed Basal diet 
+LB+10%JA. Data are shown as mean of fold change (2^-ΔΔCt) ± S.D (n=6) in the mRNA level of 
cytokines in comparison to those from controls  
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Figure 8:6 Fold change of IL-6 expression in the Bursa tissue at days 7, 21 and 42 of 
the age of chicks fed prebiotic, probiotic, and synbiotic.  
Vertical axis reset to 1 the value of T1, T1 (Control), birds that fed basal diet displayed as 1 on axis. T2 
(prebiotic) birds fed 5% JA powder. T3 (prebiotic) birds fed 10% JA powder. T4 (probiotic) birds fed 
mix of isolates of Lactobacillus (LB) at level 10^9 CFU/kg.T5 (synbiotic) birds fed basal diet +LB+5% 
JA.T6 (synbiotic)  birds fed Basal diet +LB+10%JA. Data are shown as mean of fold change (2^-ΔΔCt) ± 
S.E (n=6) in the mRNA level of cytokines in comparison to those from control. 
8.3 Discussion  
 Quality and quantity of extracted RNA 
Using intact RNA is a key element for the successful application of modern molecular 
biological methods, like RT-qPCR or microarray analysis. Unlike RNA is highly unstable 
and susceptible to RNAse degradation ubiquitously present in the environment. 
Starting with low quality of degraded RNA may strongly compromise the results of 
downstream applications which are often labour-intensive, time-consuming and 
highly expensive.  The ratio of 260/280 is commonly used as an indicator of the purity 
of RNA in relation to DNA contamination. For this trial, the majority of extracted RNA 
were found in the acceptable range (1.8-2) (Biotek.com, 2017). There was no 
significant difference in RNA quality or quantity between the treatment groups. 
Checking RNA integrity is a critical step before cDNA synthesis to ensure that DNA is 
removed for successful mRNA quantification by RT-qPCR (Imbeaud, et al. 2005). In 
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addition, the majority 260/230 ratios were also found to be in the acceptable range 
of 2.0-2.2 which is used as a secondary measure of nucleic acid purity. Therefore, the 
samples passed the quality checks required to be used for cDNA synthesis and qPCR 
analysis. In addition, RNA extraction provided good yield with a concentration of RNA 
at minimum yield was 100 ng/µl.  
 Interferon-gamma (IFN-γ) 
Interferon-γ (IFN-γ) is considered to be one of the pro-inflammatory cytokines 
(Dinarello 2000). It has a pivotal role in host defence, it is considered as a hallmark of 
innate and adaptive immunity as it is produced in response to infection (Mühl and 
Pfeilschifter 2003). Here, IFN-γ has been chosen as a marker for immunity response 
in inflammation in an early stage. (Kaiser, et al. 2000) found that the level of IFN-γ 
were increased in the chicken tissues that were infected with Escherichia coli or 
strains of Salmonella compared with uninfected tissue. The results of this study show 
that the levels of IFN-γ gene expression in the ileum tissue at day 21 were higher in 
control than in all treatments significantly (p≤0.05). Meanwhile, there was no 
significant difference at days 7 and 42. From these findings; there are two possible 
mechanisms leading to the observed effects. Firstly, the treatments may have had a 
direct biochemical effect on the immune system, or the treatments may have 
indirectly affected the gastrointestinal immune system by modulating the intestinal 
tract microbiome, which in turn produced metabolites that biochemically altered the 
immune system. The most likely of these two mechanisms is that IFN-γ has been 
induced in control and upregulated compared with treatments. This increasing might 
come as results of the response of immune system cells in the ileum against the 
pathogenic bacteria. As described in chapter 7, the percentage of 
Escherichia/Shigella was decreased in the treatments when using prebiotic, probiotic 
and symbiotic, resulting in the birds experiencing a lesser pathogenic challenge. This 
lower pathogenic challenge in the treatment-fed birds may have resulted in no 
requirement for the bird to activate the immune system to produce a high level of 
this cytokines. This findings was also observed in a previous study that studied a 
probiotic involving a pathogen challenge. Haghighi, et al. (2008) used treatments of 
Salmonella serovar Typhimurium only and Salmonella with probiotic of Lactobacillus 
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acidophilus, Bifidobacterium bifidum, and Streptococcus faecalis, they found that 
level of IFN-γ in the caeca of chicken was increased in the first treatment, while in 
the treatment of Salmonella with probiotic the   level of this interferon was 
decreased.  
 Interleukin -10   
IL-10 is a cytokine that has an anti-immune and anti-inflammatory activity (Mosser 
and Zhang 2008).  The key role of this cytokine is inhibiting the production and 
function of pro-inflammatory cytokines, which in turn will regulate the inflammatory 
responses (Yamana, et al. 2004). It has a crucial role in modulating immune and 
inflammatory responses during infection with viruses, bacteria, fungi and protozoa 
(Couper, et al. 2008). 
Results of this study have shown that there were significant (p≤0.05) differences in 
the levels of IL-10 expression in the ileum tissue, which was higher in the control in 
contrast with treatments in ileum tissue at days 7 and 21. While there were no 
significant (p≤0.05) differences at day 42. It seems that the level of IL-10 has 
increased at days 7 and 21 in the control compared to treatments. It could be 
suggested that the supplements have suppressed the pathogens in the gut (ileum) 
that can induce the production of IL-10 in the treatments. (Cyktor and Turner 2011) 
indicated that one of the most important roles of IL-10 is to regulate the immunity at 
the site of infection when it occurs, which means that it will be produced in the case 
of inflammation or when pathogen exist. Hence, the level of IL-10 was in normal level 
in the treatments meanwhile was in a high level in the control this is may be because 
of it was induced by pathogenies.  
 Interleukine-6 (IL-6) 
 IL-6 is considered to be multifunctional cytokines in both pro-inflammatory and 
anti-inflammatory role. It is a keystone cytokine in infection and inflammation, in 
which it can support the maintenance of reactions of immunity (Hunter and Jones 
2015). IL-6 is an inflammatory cytokine, which provides protective role during a 
bacterial infection (Dube, et al. 2004). From the results showed in figure 8:3, it 
appears that the level of IL-6 in control was higher than in the treatments in the ileum 
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at day 7 significantly (p≤0.05). While it seems there were no significant (p≤0.05) 
differences at days 21 and 42. It seems that level of IL-6 has upregulated in the ileum 
tissue control of day 7.  
The explanation for these findings could that because of all the birds were not 
challenge with pathogens and because from chapter 7 there was decreased in the 
Escherichia/Shigella in the ileum (gut) of treatments, and because of this cytokine 
will be induced and upregulated in the case of inflammation (Dube, et al. 2004). 
Therefore, it can argue that in the control this cytokine has induced (high expression 
in response to pathogen). As discussed previously for the other cytokines, it is likely 
that, as pathogens were suppressed by the supplements of prebiotic, probiotic and 
synbiotic in treatment-fed birds, there was no requirement for the treatment-fed 
birds to mount an immune response.   
These findings are consistent with (Huang, et al. 2015) observations when they added 
the inulin to the diet of the broiler, they found that this supplement caused a  
decreasing in the level of IFN-γ and IL-6 at day 21 but there were no effects at day 
42. These findings also agree with the findings reported by (Janardhana, et al. 2009), 
who found that there was no difference between control and treatments when they 
added a prebiotic (fructo-oligosaccharide) to chicken feed. Also, (Brisbin, et al. 
2010b) found that Lactobacillus reuteri and Lactobacillus salivarius did not induce the 
production of IFN-γ and IL-10 in the caecal tonsil cells of chicken.  
(Shang, et al. 2015) found that adding prebiotic (Fructooligosaccharide) to the 
chicken feed did not induce IL-10 in the ileum tissue compared with control. 
Meanwhile, these findings do not agree with findings of Yitbarek, et al. (2015)  when 
they used a synbiotic in chicken feed, as they found that IFN-γ was upregulated in the 
synbiotic treatments compared with control.   
The current finding is not consistent with the findings of Kareem, et al. (2017). When 
they examined the effects of different combinations of inulin and postbiotics 
(secretions of probiotic) on ileum cytokine expression in the broiler chickens, they 
found that IFN-γ was upregulated by the addition of the treatments, and IL-6 was 
downregulated in the tissue of ileum of the broiler. The administration of pre, pro or 
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synbiotic decreased the inflammation, damaged the tissue of the colon, and induced 
the secretion of IL-10 in this tissue as well, and downregulated the production of IFN-
γ (Foye, et al. 2012).  
No significant differences were observed at day 42 for all cytokines and that there 
was no difference in the percentage of Escherichia/Shigella (as a pathogenic 
indicator) between control and treatments (chapter 7), which suggest the level of 
immunity was similar in both control and treatments.    
There were no significant differences observed in the tissue of bursa this may be as 
the variation in the levels of mRNA expression of the studied cytokines were high in 
some replicates, which led to non-significant (p≤0.05) differences between control 
and treatments. Also, it might be due to the numbers of replicates were not enough 
to reach the significance as they were just 6, and because the parameters are 
individual-related. Indeed, the SEM values for ileal tissue which are represented in 
the error bars in the graphs for individual genes and times points, and the SEM values 
for Bursa tissue which are represented in the error bars in the graphs for individual 
genes and timespoints, suggesting more replication would have increased statistical 
power, particularly for the Bursa measurements where little change was observed.  
On the other hand, it could be in relation to the previous chapter 7 as the microbiota 
was not consistent between the replicates of the same treatment, which might lead 
to these variances. Also, it is possible that there was no induction of cytokines by the 
supplements occurred in the tissue of bursa, as seen in the ileum there was no 
induction of the immune system. Therefore, these supplements did not affect the 
immunity in the bursa as well.   
The immune system requires nutrients for normal development and function as does 
any other system in the body (Segerstrom 2007, Selvaraj 2012). When the immune 
system triggered by the infection with a pathogen to defend the body against this 
infection through production of cytokines and other products, these activities need 
energy (Segerstrom 2007)  which in turn will alter the energy partitioning towards 
immune system, which will decrease the productivity of animal (Klasing 2007b). 
Findings of this study revealed that the supplements have downregulated the 
cytokines expression which in other word that the production of theses cytokines 
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was decreased in the treatments of supplements comparing with control in which 
can say the activity of immune system was less in the treatments, therefore the 
energy that vitalised in these birds was less than in the control.  
8.4 Conclusion 
The aim of this study was to investigate the effects of supplements of prebiotic, 
probiotic and synbiotic on the immunity in the tissue of ileum and bursa. It is clear 
that birds fed these supplements exhibited lower expression of cytokine INF, IL-10 
and IL-6 genes via an indirect pathway through inhibition of pathogen colonisation. 
However, this may not be due to down-regulation:  it is clear from chapter 7 that 
treatment-fed birds had decreases in the level of Escherichia/Shigella in the caeca 
(which is close to ileum) so there was no requirement to induce these cytokines to 
invoke as an inflammatory defence response (Dube, et al. 2004). Therefore, it can be 
argued that in the control-fed birds, gene expression for these cytokines has been 
necessarily induced, so they were at a higher level than treatment-fed birds. Also, it 
is possible to use these findings to support the hypothesis of prebiotic, probiotic and 
synbiotic can use to reduce/inhibit the pathogenic bacteria in the gut. Reducing the 
requirement for cytokine production is an important energy-sparing function 
associated with the use of these pre- pro- and symbiotic supplements. The 
implications of these findings and their relationship to previous investigations in this 
project are explored in the final chapter of this thesis. 
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9 Chapter nine: 
Discussion and conclusion 
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9.1 Introduction 
This chapter is split into four sections to discuss the potential of pre-, pro and 
synbiotic supplements as a feed ingredient in the broiler. Firstly, the success of the 
investigations undertaken will be discussed alongside their key findings. Secondly, 
the impact of these conclusions on global poultry production will be discussed 
alongside possible future directions for developing their application. Subsequently, 
key areas for future research and development are outlined and finally, key 
recommendations based on this work are given. 
Concerns over the impact of antibiotic use on human and animal health have led to 
increased interest in the alternative methods of protecting humans and animals from 
gastro-intestinal infectious disease. Prebiotic, probiotic and synbiotic supplements 
have all been shown to provide some level of protection in both humans and animals 
via different mechanisms. One of the most important actions of all these 
supplements is capacity to advantageously modify the microflora of the gut.  
In the animal production sector, commercial probiotic supplements often contain 
many genera and a range of different microbial species and even different strains of 
the same species. The cost of commercial probiotic products is usually justified in one 
of two ways; either use of the supplement creates a demonstrable improvement in 
a desirable feature, or it is used as a form of insurance policy against dysbacteriosis 
– a commonly used term for the poor performance and inflammatory response 
associated with sub-optimal microbial colonisation of the intestinal tract in the post-
antibiotic era (Teirlynck, et al. 2011). In addition to these production-focussed 
features, there is also a strong desire for the action of probiotic bacteria to include 
minimisation of Campylobactor colonisation in the chicken as carcass contamination 
during processing of chicken is considered to be the most common cause of food-
borne Campylobacter poisoning in humans (EFSA, 2014). Alongside probiotic 
products, plant-derived carbohydrate fractions such as fructo-oligosaccharide (FOS) 
have been used commercially as prebiotics to indirectly manipulate the gut 
microflora. Jerusalem artichoke (JA) plant has a relatively high content of this long 
chain oligosaccharide. JA already been used in chicken diet as a prebiotic and it has 
been shown that JA can increase the presence of beneficial bacteria in the gut. This 
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thesis included two studies to examine the bird performance and immunity effects 
of new isolates of Lactobacillus derived from chicken intestine, and further 
examination into JA plant as a source of prebiotic fed alone and in combination with 
previously isolated probiotic microbial strains. 
9.2 Key findings and critique of investigations 
A major challenge throughout this project was achieving baseline Campylobacter 
colonisation of birds. As no Home Office ASPA Licence was in place, it was not 
possible to inoculate the birds to ensure equal spread of Campylobacter infection 
across all pens of birds or even all birds within a pen. The inconsistent initial 
colonisation among the birds made investigations into the impact of pre- pro- and 
synbiotic interventions on Campylobacter levels difficult to achieve. Another issue 
relating to the lack of ASPA Licence was the cleanliness of the experimental setting. 
The NTU poultry research unit was a challenging environment for studying 
colonisation of the poultry intestine due to the rigorous cleaning regime and 
disinfectants that are used in the unit. This approach to hygiene limits opportunity 
for the unit itself to harbour reservoirs of pathogens such as Campylobacter and the 
lack of Home Office ASPA licence permitting re-use of dirty litter did not allow any 
form of robust investigation into methods for reduction of pathogens in the chicken 
gut. 
The first part of this thesis focussed on the strain Lactobacillus johnsonii FI9785 in 
collaboration with the Institute of Food Research (IFR). Previous work by the IFR had 
isolated and examined this strain as probiotic agent to be used in chicken diet 
(Mañes-Lázaro, et al. 2017). The initial IFR investigations worked on this strain to 
examine its ability to cope with environmental stress, and to measure intestinal 
colonisation of birds housed in individual laboratory incubators. Their findings 
prompted them to approach NTU in order to test FI9785 in birds housed in a more 
commercially relevant setting to investigate whether these bacteria can improve the 
GIT health of chicken and reduce the level of Campylobacter.   
Three experiments were designed to determine the efficacy of feeding Lactobacillus 
johnsonii FI9785 as a probiotic to broiler chicks. The first study was in vitro, to 
investigate whether any of the environmental conditions associated with each 
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proposed delivery route for the probiotic would be detrimental to survivability of the 
microbes. Results found that water left standing overnight and distilled water are the 
best water-borne methods to deliver the bacteria while maintaining high viability of 
Lactobacillus. However, widespread use of sanitising agents such as CID2000TM (CID 
Lines, Belgium) indicated feed should also be assessed as an alternative delivery 
route. The following in vivo studies, commenced with a pilot study, conducted to 
examine the most appropriate method of colonising the intestinal tract of the birds. 
Assessment of colonisation of several sections of the intestinal tract showed feed 
was the most appropriate method to deliver these bacteria into chicken gut. 
Subsequently, a larger scale chicken experiment was performed to monitor growth 
performance as well as the level of Campylobacter colonisation in birds fed LB for 7 
days compared with a control group without probiotic over a 28 day trial period. 
Results of this third experiment revealed that FI9785 strain did not affect the 
performance of birds but there was no significant difference in the level of 
Campylobacter. From this study it was concluded that it is possible to produce a 
probiotic agent by isolating beneficial bacteria and feed was a good delivery route 
for colonisation of chicken gut. However the work was stopped by the sponsor (IFR) 
without further investigations into whether control and treated birds were colonised 
different strains of Lactobacillus. 
Working with external collaborators in the early stages of the projects opened an 
interesting investigative opportunity but ultimately created a barrier to progressing 
logically through this programme of work. Collaboratively assessing a scientifically 
well-developed novel strain of Lactobacillus johnsonii bacteria (FI9785) give insight 
into the assessment stages of a candidate probiotic but waiting for the leading party 
to make decisions or provide information was difficult when time for this project was 
limited. Ultimately, a key piece of information (the PCR primers for FI9785 strain) was 
never provided so that the conclusions from these studies lack a definitive answer as 
to the degree of colonisation by strain FI9785 in comparison to wild type 
Lactobacillus strains.  
The second part of this thesis focussed on in-house development of pre- pro and 
synbiotic supplements. The majority of the work was to isolate Lactobacillus strains 
from apparently healthy out door chickens at NTU and then assess them both in vitro 
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and in vivo as candidate probiotic agents in chicken feed. First, six strains of 
Lactobacillus were isolated from adults chicken and examined in vitro for potential 
as probiotic agents: morphological, biochemical and antiprogram tests confirmed 
that these isolates were all belonged to Lactic acid bacteria. In addition, genetic 
testing (16s) confirmed that the isolates were under the Lactobacillus genus. Also 
physiological tests examined these isolates for survivability in the conditions of gut, 
which confirmed that all isolates were able to retain their viability in conditions 
designed to mimic the gut. The isolates also showed in vitro antimicrobial activity 
against Campylobacter. Finally, physiological tests confirmed that all six isolates 
could survive and maintain their viability after processing, which is essential for 
commercial application of these strains as probiotic agents. It was concluded that the 
techniques used to process theses bacteria were successful and can be universally 
applied for production of probiotic bacteria. A weakness to this section of work was 
that the survivability in feed of each isolated strain not measured before bird feeding 
trials were conducted. Molecular assessment to confirm exactly which isolate had 
been produced would have then allowed for in-feed assessment of survivability, but 
the time and cost of undertaking this work was prohibitive, so in vivo trials were 
conducted without confirming in feed survivability. 
Preparation of potential suitable supplements included the sourcing and preparation 
of Jerusalem artichoke (JA) plant as a prebiotic source material. The plant was 
prepared and dried, then the inulin content was measured. It was found that JA 
contains a relatively high concentration of Inulin as half of the dried plant was found 
to be inulin, suggesting this widely available plant could potentially be used as a 
prebiotic in chicken feed.  In addition, all Lactobacillus isolates can use JA as a carbon 
sources as it was found that they all can grow in the media enriched with JA instead 
of glucose.  This finding suggested that JA had additional potential to be mixed as a 
prebiotic with the Lactobacillus isolates to produce a synbiotic.    
The second section of this study was a major in-vivo experiment conducted to 
examine the effects of the supplements prepared with different levels of prebiotic 
alone, or in mixed with probiotic (synbiotic) or probiotic alone in chicken feed. The 
parameters studied included their effects on the gut profile, immune function 
through cytokines and chicken growth performance.  Limited expertise and time did 
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not allow more thorough investigations into immune response towards the chosen 
probiotic and prebiotic supplements.  
The effects of dietary supplements of prebiotic, probiotic and synbiotic in chicken 
feed on the caeca microflora showed that there were effects on the microbial 
community of the gut. A major effect was on faecalibacterium genus, which was 
higher in treatments compared with control at day 7.  This genus was previously 
shown to have some positive effects on performance of chicken (Stanley, et al. 2016, 
Fak and Backhed 2012). However, this study did not present a correlation between 
this genus and performance, as there were no significant differences between 
control and treatments in the body weight, body weight gain, feed intake and FCR. 
These non-effects of probiotic supplements on the performance of chicken are 
conflicted with the findings of (Stanley, et al. 2016)  as they argued that this genus is 
directly related to improve FCR in meat chickens. The level of genus of 
Erysipelotrichaceae was decreased in all treatments which may be considered a 
positive response, as a previous study (Palm, et al. 2014) argued that there is a 
correlation between this genus and illness in humans. In addition, genera of 
Escherichia/Shigella were also in lower abundance in the supplements treatments 
than the control. This suggests that supplements of prebiotic, probiotic and synbiotic 
have affected the growth of this genera, possibly through similar mechanisms to 
those that inhibit pathogenic bacteria such as SCFA production, bacteriocin 
production or competitive exclusion. In addition, the cytokine data indicates that the 
inflammation in the chicken fed treated feeds was lower than in control-fed birds. 
Far more data is available from the 16s rRNA metagenomic screening than that 
covered in this thesis, as the relative new-ness of the technique and limited time 
available to gain expertise in bioinformatics. Future work that which could produce 
more data outputs relating to these supplements but would not require any further 
practical investigations would be wider bioinformatic analysis of the 16s data. 
Results of this study showed that while prebiotic supplements did not affect the 
performance of chicken, the effects of probiotic were substantially negative. 
However, the effects of these supplements on the immune function were similar, 
suggesting therefore use of prebiotic alone is the best practical option to improve 
the health with no effects on the performance. The probiotic treatments are worthy 
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of further investigation, as they did positively affected the health of chicken, but they 
caused degradation in the performance. Key investigations are either using single 
strains to determine their individual effects or using a lower supplementation level 
of the mix, as may be the concentration used was too high or one or more of the 
strains in the mix had a negative effects on the production performance.  Future bird 
trials could also address a major weakness in the current study: limitations to the size 
of the bird trial (number of available pens) that could be conducted at NTU prevented 
any benchmarking against a commercially available supplement. Another positive, 
health-related aspect of these supplements that can argued here is that the effect on 
the pathogen inhibition or cytokines regulation was local and not systemic, as the 
observed modulatory effects were only on the ileal cytokines while there was no 
significant difference in the level of cytokines in the Bursa tissue.  
In summary, the prebiotic and probiotic supplements were equally effective at 
improving on gut health and immunity but prebiotic production is cheap, does not 
need extensive processing, and can be stored at room temperature. Therefore it can 
concluded that focusing on prebiotic development in the future may be the best way 
to improve the microbiota in the animal gut in a commercially viable way with 
minimum risk to health and safety.  
9.3 Potential impact of this project 
From this thesis, it has been shown that there is an economical viable route to 
implementing use of probiotic or prebiotic. However, there some limiting factors 
associated with production of probiotic supplements that must be considered. 
Firstly, the production of probiotics does require some investment in basic laboratory 
equipment. To produce a locally appropriate probiotic supplement for a given poultry 
production area of a developing country, it is necessary to buy the following: a large 
volume centrifuges (minimum 250ml buckets), a freeze drier, a bacterial fermenter 
and access to a basically equipped laboratory (such as clean benches, glassware, 
scales). A microaerobic cabinet was used in this study as it already available in the 
lab and because of Lactobacillus genera are facultative anaerobic and often they 
grow better under microaerobic conditions (Goldstein, Tyrrell and Citron 2015b).  
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A further consideration impacting on potential success in probiotic supplement 
manufacture is the availability of an appropriately qualified microbiologist to ensure 
all skilled procedures are carried out correctly, and also to perform screening of 
batches as a final quality control measure. If incubation is not carried out correctly 
and a contaminated product is made, this could cause a disease outbreak in the birds 
fed the supplement and the negative consequences would greatly outweigh any 
potential benefit, but implementing a simple screening procedure by culturing each 
batch produced would avoid this risk. Similarly, if freeze drying is not carried out 
correctly, the bacterial cells will die before delivery to the bird intestine, leading to 
poor product efficacy, which will have a negative economic impact. 
Artichoke-derived prebiotic does not require major financial investment in its 
production, as the fresh plant cost about £0.75 per kg and because it only needs 
simple (low tech) processing such as washing and drying can be achieved cheaply in 
warm climates. Also artichoke-derived prebiotic does not require low temperature 
for storage, as room temperature (25°C) is sufficient to keep retain its bio-activity. 
However, exact guidelines for Jerusalem Artichoke preparation techniques that are 
viable in a field setting in Iraq need to be developed to ensure the drying temperature 
remains below levels (80°C ) known to damage JA inulin levels (Kriukova, et al. 2018) 
9.4 Recommendations for practical application of these findings: 
1- It seem that prebiotic was more effective than probiotic and synbiotic from the 
results of this study in which can say that using it more cost effective compering 
with probiotic.  
2- Throughout the rearing period, use of a prebiotic supplement such as Jerusalem 
artichoke provides a cost effective method of maintaining a healthy intestinal 
microbiome which in turn can maintain the health and reduce the antibiotic use 
in broiler feed. 
3- Creating mixtures of probiotic microbial strains from local flocks of birds showing 
high health status which is seem to be an effective way of using probiotics in 
poultry. Use of locally ‘successful’ strains which can compete with the pathogenic 
bacteria that are common in the Iraqi farms which in turn can decreased the use 
of antibiotics and improve the health and performance of chicken.      
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4- In the immediate post hatch period, an appropriate mixture of probiotic microbial 
strains should be used to prevent any pathogenic colonisation during this period 
of high vulnerability of the chicks. 
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9.5 Future directions for the field of gut health in poultry 
A major barrier to widespread acceptation of synbiotic use is occurrences where a 
farmer experience an apparent failure of their flock to respond to the supplements. 
This phenomenon is strongly linked to the unique and dynamic microbial populations 
associated with each poultry shed: prescribing use of a generic, unspecified strain of 
bacteria is less likely to aid the farm in ensuring good intestinal health than creating 
a bespoke solution for that farm. By understanding the existing microbial population 
(both pathogenic and benign species), of a geographical region, or even of a given 
shed, it may be possible to create a bespoke probiotic or synbiotic supplement 
exactly meeting the requirements of the situation. 
Some potential routes to reducing use of antibiotics in poultry production are 
hampered by current legislation. It is well established that diversity in the 
microbiome reduces the risk of poor gut health (Human Microbiome Project 
Consortium 2012) and there is a route to colonising the intestine of chicks at 
placement in the shed by leaving in some litter from a previous, healthy batch of 
birds. However, current EU legislation requiring the removal of all litter and the 
implementation of a cleaning regime between batches of birds prevents this option 
being followed. While this EU legislation reduces risk of pathogenic bacteria being 
passed on following a batch of birds with poor gut health, it also prevents any 
benefits being conferred from one batch to the next. A screening programme at the 
end of the growth period to assess whether litter should be removed and a complete 
clean implemented  However, use of probiotic feed additives such that those 
proposed in this thesis provide a more viable route to the same result: ensuring the 
intestinal is appropriately colonised as quickly as possible post hatch. 
Even with the stringent cleaning regimes currently in place, the residual 
microorganisms in the shed impact on gut colonisation to a varying degree. 
Colonisation of the chick gut as soon as possible with benign microbes reduces the 
risk of colonisation by a pathogenic species. This mechanism is currently being 
explored in some commercial hatcheries where viability of adding probiotics via in 
ovo injection in the last three days of egg incubation (de Oliveira, et al. 2014). The 
uncertainty over whether a pathogenic species of microbe will colonise the intestine 
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introduces different views on the usefulness of pre- and probiotic supplements: as 
there is no guarantee that using a supplement will improve performance of the birds, 
many farmer chose not to do so, while others view their use as a form of insurance 
policy. 
In summary, when comparing  between cost of production of Jerusalem artichoke 
plant as prebiotic to improve the health as it does not need much preparation and 
because no side effects on the performance. Production of probiotic need developed 
facilities in addition to some negative effects on the performance therefore it can be 
conducted that using Jerusalem artichoke plant is a more effective way to manipulate 
the gut microflora, which can improve the health of chicken.     
This study can recommended the use of JA plant as prebiotic in chicken feed as it 
improved the immunity and decreased the level of some pathogenic bacteria without 
effects on the performance.   
9.6 Future research  
1- More in-vitro investigations on the six isolated candidate probiotic need to be 
carried out to optimise their potential for use in chickens. In particular, measuring 
SCFA production by supplementing culture media with different prebiotics 
sources would give insight into which prebiotic sources would most efficaciously 
combine to form the best synbiotic.  
2- The project examined only one common poultry gut pathogen; Campylobacter. 
Understanding the inhibition activity of the six isolates against Salmonella and 
E.coli is also extremely important when considering the isolates as candidate 
probiotic strains. 
3- Further experiments need to be done to study the effect of these isolates 
individually in the chicken feed to investigate which isolate showed the most 
positive activity in enhancing gut health and immune function, and which caused 
the negative effects on chicken performance so, these could be excluded.     
4- Tracking the survivability of the six isolates throughout the chicken gut also should 
be undertaken to assess whether they all can survive in the gut conditions. This 
could be achieved by sequencing the whole genome of each isolates and then 
designing a unique primer for each isolate.  
 172 
 
5- Determining the concentration of SCFA produced in the gut of chicken should be 
done to quantify the energy-related effects of these supplements of prebiotic, 
probiotic and synbiotic, as volatile acids such as butyric acid are the important end 
products of some microorganisms in the gut whose beneficial effects on health 
and performance of chicken are through providing an energy source for direct use 
by intestinal epithelial cells.   
6-  These supplements need to be assessed in the chicken diet using challenge 
studies where a dosages of pathogenic bacteria such as Campylobacter and 
Salmonella spp are used to get clear picture on the inhibition activity in vivo 
against each major pathogen, as all birds in the current studies were 
Campylobacter free throughout. 
7- Finally, the supplements need to be studied in the layer and meat breeding flocks 
as other parameters than  body weight are important in these settings, such as 
disease resistance throughout lay. Also, controlling the body weight of meat birds 
before they come into lay is important to maintain health during egg production. 
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Appendix A Bird trial LB01 diet specification and formulation  
 
Diet Control LB 
DM (g/kg) 890.76 900.69 
Ash (g/kg) 48.43 51.48 
Protein (g/kg DM) 22.21 22.19 
GE (MJ/kg DM) 21.87 20.83 
Fat (g/kg DM) 58.49 59.33 
 
Wheat  61.40% 
Soybean meal 48 29.44% 
Soy oil 4.11% 
Salt 0.25% 
Sodium Bicarbonate 0.18% 
DL Methionine 0.40% 
Lysine HCl 0.46% 
Threonine 0.19% 
L-Tryptophan 0.018% 
Limestone 0.95% 
Dicalcium Phos 1.59% 
Vitamin/mineral premix 0.50% 
TiO 0.50% 
Quantum Blue 0.01% 
Econase XT 0.005% 
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Appendix B Bird trial LB02 diet specification and formulation 
 
Ingredient Starter Grower 
Wheat 54.4185 59.025 
Rapemeal 5 5 
Hipro Soya 29.712 29.151 
Soya oil 2.689 3.682 
Limestone 0.7905 0.753 
Salt 0.0985 0.173 
Sodium 
bicarbonate 
0.218 0.206 
MCP 0.94 0.936 
Lysine HCl 0.2255 0.221 
Dl methionine 0.335 0.291 
Threonine 0.08 0.069 
Phytase 0.015 0.015 
Ronozyme 0.015 0.015 
Maxiban 0.063 0.063 
Vit min premix 0.4 0.4 
Fishmeal 5 0 
  100 100 
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Appendix C Bird trial LB03 diet specification and formulation  
 Phase 
Ingredients (%) Starter Grower Finisher 
Barley 5.5 0.9 0 
Rye 10 15 20 
Wheat 45 47.5 47.2 
Soybean meal, 48% CP 26 23 19 
Full fat soybean meal 5 5 5 
L lysine HCL 0.4 0.3 0.3 
DL methionine 0.4 0.35 0.3 
L threonine 0.15 0.15 0.15 
Soya oil 4 4.5 4.75 
Limestone 1.25 1.25 1.25 
Monocalcium phosphate 1.5 1.25 1.25 
Salt 0.25 0.25 0.25 
Sodium bicarbonate 0.15 0.15 0.15 
Premix* 0.4 0.4 0.4 
 
Calculated analysis 
  
 
  
ME MJ/kg 12.75 12.99 13.11 
CP% 21.75 20.49 18.91 
Lys % 1.45 1.29 1.17 
Met + Cys % 1.04 0.96 0.87 
Ca 0.96 0.91 0.91 
Available P 0.48 0.42 0.42 
 
100 100 100 
*Premix content (volume/kg diet): Mn 100mg, Zn 80mg, Fe 20mg, Cu 10mg, I 1mg, Mb 0.48mg, 
Se 0.2mg, Retinol 13.5mg,Cholecalciferol, 3mg, Tocopherol 25mg, Menadione 5.0mg, Thiamine 
3mg, Riboflavin 10.0mg, Pantothenic acid 15mg, Pyroxidine 3.0mg, Niacin 60mg, Cobalamin 
30µg, Folic acid 1.5mg, Biotin 125mg  
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Treatment  Week Phase 
% Dry 
matter % Ash % Fat GE (MJ/kg) N (%) 
Protein 
(%) 
A 1 Starter 87.70 5.46 5.12 16.85 3.53 22.06 
B 1 Starter 87.76 4.48 5.19 17.05 3.44 21.50 
C 1 Starter 88.04 5.12 4.85 16.89 3.29 20.56 
D  1 Starter 88.21 5.62 4.85 16.98 3.33 20.81 
E 1 Starter 87.51 4.61 5.65 16.86 3.39 21.19 
F 1 Starter 87.73 4.66 5.32 16.93 3.43 21.44 
A 2 Starter 87.71 5.91 5.34 16.85 3.3 20.63 
B 2 Starter 87.41 3.56 5.28 17.17 3.04 19.00 
C 2 Starter 88.05 6.41 5.29 16.80 3.34 20.88 
D  2 Starter 87.65 5.58 5.33 17.00 3.54 22.13 
E 2 Starter 87.54 3.67 5.39 16.96 3.29 20.56 
F 2 Starter 87.54 3.11 5.40 17.11 3.19 19.94 
A 3 Grower 87.86 5.16 5.59 17.05 3.13 19.56 
B 3 Grower 87.60 3.81 5.26 17.02 3.19 19.94 
C 3 Grower 88.16 5.00 5.31 16.88 3.03 18.94 
D  3 Grower 88.26 5.24 5.28 17.06 3.25 20.31 
E 3 Grower 87.38 3.54 5.28 16.98 3.01 18.81 
F 3 Grower 87.43 4.06 5.29 17.18 3.33 20.81 
A 4 Grower 88.29 5.66 5.35 17.10 3.19 19.94 
B 4 Grower 89.24 5.02 5.32 16.96 3.09 19.31 
C 4 Grower 86.55 5.22 5.31 17.03 3.28 20.50 
D  4 Grower 86.80 4.69 5.30 17.15 3.05 19.06 
E 4 Grower 88.16 4.59 5.35 17.15 3.01 18.81 
F 4 Grower 88.05 4.50 5.39 17.01 3.18 19.88 
A 5 Finisher 86.89 4.73 5.51 16.84 2.86 17.88 
B 5 Finisher 87.87 4.44 5.27 17.10 3.03 18.94 
C 5 Finisher 86.74 5.48 5.69 17.14 2.92 18.25 
D  5 Finisher 87.30 5.19 5.42 16.99 3 18.75 
E 5 Finisher 87.82 4.11 5.30 17.02 2.82 17.63 
F 5 Finisher 87.81 4.08 5.40 17.05 2.92 18.25 
A 6 Finisher 86.90 5.48 5.96 17.03 3.13 19.56 
B 6 Finisher 87.89 4.95 5.38 17.39 2.81 17.56 
C 6 Finisher 87.92 5.03 5.67 17.19 3.51 21.94 
D  6 Finisher 87.88 5.16 5.63 17.51 2.77 17.31 
E 6 Finisher 87.90 4.53 5.69 16.85 3.1 19.38 
F 6 Finisher 87.95 4.50 5.32 16.86 3.08 19.25 
 205 
 
Appendix D Bird trial LB03 Table Quality of extracted RNA from ileum 
tissue diet  
 
Samples 
D7 
260/280 
D7 
260/230 
D21 
260/280 
D21 
260/230 
D42 
260/280 
D42 
260/230 
T1R1 2.07 2.02 2.05 2.2 2.05 2.2 
T1R2 2.07 1.83 2.04 2.18 2.04 2.18 
T1R3 2.07 1.85 2.01 2.03 2.04 2.11 
T1R4 2.06 2.23 2.01 2.07 2.03 2.08 
T1R5 2.05 1.89 2.04 1.81 2.07 1.71 
T1R6 2.01 2.06 2.05 2.23 2.07 1.73 
T2R1 1.99 2.13 2.07 2.01 2.07 2.01 
T2R2 2.04 2.13 2.07 2.09 2.04 1.87 
T2R3 2.09 2.21 2.01 2.03 2.05 1.88 
T2R4 2.04 2.22 2.05 1.85 2.04 1.76 
T2R5 2.07 2.01 2.04 2.13 2.06 1.75 
T2R6 1.98 1.9 2.06 1.92 2.05 1.67 
T3R1 2.1 1.94 2.05 2.06 2.05 2.06 
T3R2 1.91 1.77 2.0 2.0 2.05 2.17 
T3R3 2.05 2.21 2.06 1.86 2.01 1.68 
T3R4 2.07 2.03 2.07 2.17 2.07 2.28 
T3R5 2.07 2.07 2.04 2.1 2.03 1.88 
T3R6 1.94 1.85 2.06 1.85 2.1 1.73 
T4R1 1.99 2.12 2.05 2.21 2.07 1.98 
T4R2 2.06 2.14 2.05 2.23 2.06 2.27 
T4R3 2.06 2.19 2.05 2.02 2.06 2.19 
T4R4 2.06 1.8 2.03 1.95 2.04 1.88 
T4R5 2.05 1.75 2.06 1.93 2.05 2.04 
T4R6 2.07 2.13 2.06 2.23 2.03 2.09 
T5R1 2.06 1.99 2.06 1.95 2.05 2.1 
T5R2 2.06 2.12 2.05 2.17 2.03 2.07 
T5R3 2.07 2.1 2.06 1.95 2.02 1.94 
T5R4 1.92 1.75 2.06 2.28 2.06 1.77 
T5R5 2.05 1.79 1.99 1.88 2.06 1.79 
T5R6 2.07 2.01 2.07 1.87 2.06 2.11 
T6R1 2.06 1.76 2.07 1.73 2.05 1.93 
T6R2 2.03 1.99 2.01 1.81 2.02 2.16 
T6R3 2.08 2.15 2.03 2.08 2.06 1.91 
T6R4 1.95 1.79 2.03 1.93 2.04 2.18 
T6R5 1.81 1.86 2 2.23 2.06 1.7 
T6R6 2.06 2.1 2.08 2.24 2.06 2.16 
 *T: Treatments, R replicate for all samples Ratio 260/280 as an indicator for the pure RNA of DNA. 
Ratio 260/230 as an indicator for the purity of RNA of all treatments and control  
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Appendix E Bird trial LB03 Table Quality of extracted RNA from the 
Bursa of Fabricius tissue.  
*T: Treatments, R replicate of all samples Ratio 260/280 as an indicator for the purity of RNA of DNA. 
Ratio 260/230 as an indicator for the purity of RNA of all treatments and control 
  
Samples D7 
260/280 
D7 
260/230 
D21 
260/280 
D21 
260/230 
D42 
260/280 
D42 
260/230 
T1R1 1.84 1.59 2 1.96 1.98 2.31 
T1R2 1.97 2.04 1.99 1.79 2.03 1.97 
T1R3 2.07 1.86 2.02 1.56 2.01 1.92 
T1R4 2.08 1.98 2.04 1.57 2.02 1.84 
T1R5 2.03 1.93 1.94 1.72 1.99 2.13 
T1R6 2.03 2.21 1.91 2 2 1.91 
T2R1 1.98 1.74 1.99 2.7 2.01 2.27 
T2R2 2 2.25 2 1.97 2.05 2.02 
T2R3 2.06 1.87 2 2 2.05 1.65 
T2R4 1.99 2.23 2 2.16 2.03 2.22 
T2R5 1.94 1.67 2 1.98 2.03 2.08 
T2R6 1.96 1.7 2 2 2.02 2.28 
T3R1 2.05 2.01 2.01 1.96 1.99 2.1 
T3R2 2 1.9 1.99 1.69 2.01 1.86 
T3R3 2.04 1.96 2.02 1.66 2 2.08 
T3R4 2.04 1.75 2.04 1.67 2.01 2.27 
T3R5 2.01 1.8 1.94 1.72 2 2.01 
T3R6 2.05 2.19 1.91 2.07 2 1.83 
T4R1 2.05 2.13 1.99 2.17 1.99 2.3 
T4R2 2.05 1.91 2.07 1.97 2.05 1.88 
T4R3 1.99 1.92 2.02 2.1 2.03 2.27 
T4R4 2.06 1.64 2.04 2 2.01 2.15 
T4R5 2.02 1.96 2 2.26 2.02 2.24 
T4R6 2.04 1.81 1.98 1.93 2.01 2.24 
T5R1 2.02 2.02 2.01 2.07 2.03 2.24 
T5R2 2.1 2.28 2.07 2.26 2.04 2.26 
T5R3 2.06 2.13 2.06 2.31 2.05 2.25 
T5R4 2.03 2.22 2.06 2.27 2.05 2.16 
T5R5 2.03 2.22 2.07 2.25 2.04 2.22 
T5R6 2.01 2.24 1.99 2 2.02 1.95 
T6R1 1.95 1.79 2.08 2.2 2.04 2.4 
T6R2 2.03 1.82 2.04 2.18 2.01 2.14 
T6R3 2.03 1.56 2.06 1.72 1.92 2.36 
T6R4 2.06 2.08 2.07 1.44 2.02 2.42 
T6R5 2.03 1.99 2.05 2.05 2.04 2.28 
T6R6 2 2 2 2 1.99 2.3 
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Appendix F Table Room Plan Diet Allocation bird trial LB03 
36 T6 
 
 10 T1  
 
9 T3 
35 T5  11 T2  8 T2 
34 T4  12 T3  7 T1 
33 T6  13 T1 6 T3  
32 T5  14 T2 5 T2 
31 T4  15 T3 4 T1  
30 T6  16 T1 3 T3 
29 T5  17 T2 2 T2 
28 T4  18 T3 1 T1 
27 T6    
26 T5     
25 T4  
24 T6 23 T5 22 T4 21 T6 20 T5  19 T4 
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Appendix G lighting regimen for all bird studies  
 
Day Hours of light Hours of dark 
1 23 1 
2 22 2 
3 21 3 
4 20 4 
5 19 5 
6 18 6 
7 to end 18 6 
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Appendix I Performance of chicken (Ross 308) in Iraqi conditions   
  
Age 
day 
Body 
weight 
Weight 
gain 
feed 
intake 
FCR 
7 157 118 143 1.22 
14 440 282 369 1.30 
21 753 312 531 1.70 
28 1149 396 755 1.92 
35 1621 471 975 2.17 
42 2504 882 1505 1.75 
 
